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Determinants of Vacuolating Cytotoxin Production and its 
Impact on Helicobacter pylori Pathogenesis 
 
Introduction: The vacuolating cytotoxin is an important H. pylori virulence factor 
and is naturally polymorphic, one of the most diverse regions being the signal region 
(type s1 or s2). Signal type determines vacuolating activity: type s1 strains are 
vacuolating and are associated with peptic ulcers and gastric adenocarcinoma; and 
type s2 strains are non-vacuolating. Heterogeneity in VacA levels between strains also 
exists, and different strains produce different amounts: this is due to differences in 
vacA transcription and differences in protein secretion between strains. A vacA 
promoter and a transcriptional start point (TSP) have been identified. Sequence 
analysis revealed that -35 and -10 motifs are well conserved. Mutagenesis of this 
region resulted in a decrease in vacA transcription in vitro. However, investigation of 
vacA expression between 8 different H. pylori strains using real-time PCR revealed 
that differences in vacA transcription observed between different strains were 
unrelated to the putative -35 and -10 motifs. VacA type s1 and s2 signal sequences 
differ in the cleavage recognition site at key positions. In type s1 the more favourable 
serine and proline residues are at positions -3 and -6 respectively, whereas type s2 
strains have leucine present at -3 and glycine at -6.  In addition to VacA type, the 
determinants of VacA production are of importance in H. pylori pathogenesis: It has 
been shown that larger amounts of toxin produce greater damage in animal models. 
However there is limited information on the level of vacA expression in vivo and 
disease.  
Aims: To analyse the cysS ± vacA intergenic regions of a large number of strains to 
identify motifs and natural polymorphic differences that contribute to different vacA 
mRNA levels between strains in vivo and in vitro using sequencing and real-time 
PCR. Then to investigate these regions of interest using site directed mutagenesis. 
Next, to determine whether naturally occurring differences in the signal peptide 
cleavage recognition sites between type s1 and s2 strains affect the secreted VacA 
levels between the two strains using isogenic mutants and ELISA and Western 
blotting. Finally, to determine whether there is an association between the level of 
vacA mRNA in vivo and pre-cancerous changes, infection density and disease 
outcome in infected patients. 
 Results and Conclusions: Analysis of the cysS ± vacA intergenic region revealed that 
differences between strains in the -35 and -10 regions were not significantly associated 
with levels of vacA transcription, but that other regions were associated with 
differences in vacA production between strains. These regions differed in vitro and in 
vivo, which may imply in vivo regulation of vacA transcription. Strains with a fully 
palindromic inverted repeat upstream of the -35 motif expressed more vacA than other 
strains in vitro (P=0.01). Analysis of vacA transcription from the same strains in vivo 
UHYHDOHGWKDWVWUDLQVZLWKDQ$ZLWKLQDVHFRQGVWHPORRSORFDWHGLQWKH¶875RIWKH
vacA transcript expressed more vacA than those with a G at this position (P=0.006). 
Site directed mutagenesis confirmed that replacing the G with an A in an isogenic 
mutant strain resulted in an increase in vacA transcript levels. As found for other 
bacterial secreted proteins, these results show that positions -6 and -3 are important in 
the VacA signal sequence and may affect signal sequence processing efficiency. The 
level of vacA mRNA in vivo was significantly positively associated with the severity 
of chronic inflammation, neutrophilic activity, glandular atrophy and infection density 
in the infected patient. Differences in toxin production between H. pylori strains could 
help explain why only some infections result in disease.  
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1 Introduction 
1.1 Helicobacter pylori  
1.1.1 Introduction and history 
The presence of spiral shaped bacteria in the human stomach was first observed 
by Konjetzny in 1923. However proof for an infectious origin of diseases of the 
upper gastrointestinal tract was not provided until the early 1980s when 
Warren and Marshall isolated H. pylori from gastric biopsies and established 
WKHEDFWHULXP¶V DVVRFLDWLRQZLWKJDVWULWLV DQGSHSWLFXOFHUDWLRQ (Marshall and 
Warren, 1984). Following this discovery a large amount of research has been 
carried out over the last 2 decades, leading to the development of diagnostic 
tests and antibiotic treatment strategies for H. pylori infection. However, 
despite this intense investigation, H. pylori colonisation is still widespread in 
developing countries. Its route of transmission is poorly understood and 
emerging antibiotic resistance has consequences for the efficacy of treatment. 
Research into H. pylori transmission and disease is therefore important in 
developing novel prevention and treatment strategies. 
 
1.1.2 Microbiology  
 H. pylori is a microaerophilic Gram negative bacterium which is able to 
colonise and persist in the mucus layer of the human stomach (Atherton, 2006). 
Cells are between 0.5 and 5 µm in length and are usually curved or spiral 
shaped with 5 ± 7 unipolar sheathed flagella of approximately 3 µm in length 
which allow rapid motility through the viscous mucus layer (Goodwin et al., 
1985).  Morphological changes to a viable but non culturable coccoid form 
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occur after prolonged culture or antibiotic treatment (Enroth et al., 1999, 
Kusters et al., 1997, Monstein and Jonasson, 2001).  
 
Sequenced H. pylori genomes are approximately 1.7 Mbp in size and have a 
G+C content of 35-40% and contain two copies of the 16S, 23S and 5S rRNA 
genes (Tomb et al., 1997). H. pylori is genetically heterogeneous, which results 
in every infected individual carrying a distinct strain (Kansau et al., 1996) 
genetic heterogeneity is thought to occur mainly via DNA rearrangement and 
the introduction and deletion of foreign sequences (Falush et al., 2001, 
Achtman and Suerbaum, 2000). It is thought that generation of heterogeneity 
may be an adaptation of H. pylori to the immune response and the gastric 
environment (Kuipers and Meijer, 2000). 
 
1.2 H. pylori and disease 
1.2.1 Epidemiology, sources of infection and transmission  
H. pylori colonises the gastric mucosa which leads to chronic active gastritis, 
and generally persists for the life-time of the infected individual unless 
eradicated. The prevalence of H. pylori varies greatly between developed and 
developing countries. In developing countries approximately 80% of the 
population are H. pylori positive, but the prevalence of infection is relatively 
constant. In developed countries H. pylori prevalence generally remains under 
40% and is rapidly declining. The exact mechanisms of transmission of H. 
pylori are largely unknown, but transmission is thought to occur via direct 
human to human contact via either oral to oral or fecal to oral route or both. 
1-4 
 
Several studies by PCR have reported presence of H. pylori DNA in water, but 
this may be due to contamination of water with naked DNA or non-viable H. 
pylori.  
 
1.2.2 Clinical aspects of H. pylori associated disease 
Colonisation with H. pylori is a risk factor for development of peptic ulcer 
disease (Kuipers et al., 1995b) and distal gastric cancer (Parsonnet et al., 
1991a, Parsonnet et al., 1991b). Infected individuals have a 10-20% greater 
risk of developing peptic ulcer disease and a 1-2% greater risk of developing 
distal gastric cancer during their lifetime (Ernst and Gold, 2000, Kuipers et al., 
1999, Kuipers et al., 1995b, Kuipers et al., 1995d, Kuipers et al., 1995e, 
Kuipers et al., 1995f). Almost all individuals infected with H. pylori develop 
gastritis, however only a small proportion of infected individuals progress to 
symptomatic disease (Moss and Blaser, 2005). 
 
The pattern of gastritis plays an important role in the disease outcome in H. 
pylori infection. Antral predominant gastritis usually occurs in individuals with 
increased acid secretion resulting in H. pylori colonisation predominantly in 
the antrum where few acid secreting parietal cells are present. Antral 
predominant gastritis is associated with duodenal ulcer disease and is also 
characterised by increased polymorphonuclear cell activity and active chronic 
inflammation and gastric metaplasia in the duodenum. Individuals with antral 
predominant gastritis have limited inflammation and low numbers of bacteria 
colonising the corpus. Pan-gastritis usually occurs in individuals with impaired 
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acid secretion who have a more even distribution of H. pylori cells, with 
bacteria present in both the antrum and the corpus. Reduction in acid secretion 
can be due to a loss of parietal cells as a result of atrophic gastritis and can also 
occur when parietal cell function is inhibited by PPIs (Kuipers et al., 1995a). 
Pangastritis is associated with gastric ulcer disease and gastric adenocarcinoma 
and is characterised by chronic inflammation, more rapid progression towards 
atrophy (Kuipers et al., 1996), and intestinal metaplasia.  
 
Inflammation caused by chronic H. pylori infection can eventually lead to the 
loss of the normal gastric mucosal architecture, with destruction of gastric 
glands and replacement by fibrosis and intestinal type epithelium. Atrophic 
gastritis and intestinal metaplasia occurs in approximately half of the H. pylori 
positive population and increases the risk of gastric cancer by 5 to 10 fold 
depending on the extent and severity of atrophy (Sipponen et al., 1985). The 
risk for atrophic gastritis depends on the distribution and pattern of chronic 
active inflammation. Areas of gland loss and intestinal metaplasia extend with 
time, although they do not give rise to specific symptoms. 
  
Two histologically distinct types of gastric adenocarcinoma exist: the diffuse 
type which is characterised by gastritis throughout the stomach but not 
necessarily with gastric atrophy and the intestinal type which is characterised 
by a corpal predominant gastritis with gastric atrophy and intestinal metaplasia. 
The intestinal type of adenocarcinoma progresses through a cascade of 
histological steps which are initiated by chronic superficial gastritis which 
persists in the host for life unless specifically treated. Whether chronic active 
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gastritis then leads to atrophic gastritis is in part dependent on the host 
genetics, immune response, diet and levels of gastrin. Intestinal metaplasia 
follows leading to dysplasia and gastric adenocarcinoma (Peek and Blaser, 
2002, Sipponen and Correa, 2002, Correa, 1996, Correa et al., 1975).  
 
1.2.2.1 Gastric MALT lymphoma 
H. pylori infection is a risk factor for the development of gastric MALT 
lymphoma (Parsonnet and Isaacson, 2004, Parsonnet, 1994, Parsonnet et al., 
1994). However MALT lymphoma is relatively rare with less that 1% of H. 
pylori positive individuals affected (Parsonnet and Isaacson, 2004). 
 
1.2.2.2 Gastro-oesophageal reflux disease (GERD). 
GERD was considered to occur independently of H. pylori colonisation. 
However, further studies have found that colonisation with H. pylori may 
protect against the development of GERD. This protective effect is thought to 
be due to the acid suppressive effect of H. pylori induced corpus predominant 
gastritis.  
1.2.3 Immune response to H. pylori colonisation 
H. pylori colonization activates both the innate and acquired immune 
responses. This immune response to H. pylori infection persists for life and 
plays a central role in pathogenesis. Recognition of microorganisms by the 
innate immune system are largely reliant on the recognition of semi conserved 
bacterial products or pathogen associated molecular patterns (PAMPs) both on 
the surface of the bacteria and within the products shed as a results of bacterial 
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lysis (Nurnberger et al., 2004). Pattern recognition receptors (PRRs) expressed 
by cells of the mucosal epithelium and immune system, recognise a wide range 
of PAMPs including peptidoglycan, LPS, CpG motifs and flagellar (Hornef 
and Bogdan, 2005). Two main families of PRRs are known to be involved in 
H. pylori infection, the Toll-like receptor family (TLR) and the family of 
intracellular nucleotide-binding oligomerisation domain (NOD) PRRs (Ferrero, 
2005). Stimulation of these pattern recognition receptors results in NF-ț%
activation and pro-inflammatory gene expression (Jung et al., 1997, George et 
al., 2003).  
 
H. pylori infection has been reported to stimulate pro-inflammatory gene 
expression via TLR2, TLR4, TLR5 and TLR9 (Torok et al., 2005, Ding et al., 
2005, Ishihara et al., 2004, Gewirtz et al., 2004). However H. pylori has 
evolved mechanisms to avoid global activation of this system. For example 
TLR4, recognizes bacterial LPS, yet due to lipid A core modifications H. 
pylori LPS is relatively anergic compared to that of other gram negative 
bacteria (Backhed et al., 2003). Furthermore, TLR5 recognizes and responds to 
bacterial flagellins expressed by E. coli but is not stimulated by H. pylori 
flagellin (Smith et al., 2003).  
 
The intracellular pattern recognition receptor NOD1 recognizes soluble 
components of bacterial peptidoglycan (Viala et al., 2004). Bacterial 
peptidoglycan is delivered to the epithelial cell cytoplasm via the type IV 
secretion system which is encoded by the cag pathogenicity island (cagPAI) in 
cagPAI+ H. pylori strains which leads to NF-ț%DFWLYDWLRQ LQHSLWKHOLDO FHOOV
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and the expression of pro-inflammatory and anti-apoptotic genes such as IL-8 
and cyclooxygenase-2 (Karin, 2006, Woo et al., 2002, Hirata et al., 2006, Kim 
et al., 2001, Viala et al., 2004, Naumann and Crabtree, 2004). NOD1 
represents a crucial mechanism for the induction of H. pylori associated 
inflammation and its NF-ț%DFWLYDWLRQYLD12' is important for the induction 
of H. pylori associated inflammation and thus pathogenesis (Boughan et al., 
2006). 
 
The cytokines produced following PRR stimulation which include IL-6, IL-8, 
IL-10, IL-12, IL-ȕDQG71)Įare involved in the migration of granulocytes, 
monocytes and lymphocytes into the mucosa. High densities of infiltrating 
cells are associated with more severe inflammatory pathology (Ernst; et al 
2000). The influx of new immune cells results, with their own array of PRRs 
which are also then exposed to bacterial components, which leads to further 
pro-inflammatory gene expression. 
 
H. pylori also activates a specific acquired immune response including 
generation of antibodies and effector T cells (Bamford et al., 1998). Although 
this involves a Th1 and Th2 cell component, H. pylori infection in humans is 
Th1 poliarized (Bamford et al., 1998). Th1 cells secrete IL-2 and IFN-Ȗ DQG
promote cell-mediated immune responses, whereas Th2 cells produce IL-4, IL-
10, IL-5 and IL-6 and induce B-cell activation and differentiation. The majority 
of intracellular bacteria induce a Th1 response, whereas extracellular toxin 
producing bacteria usually stimulate a Th2 response. However studies in 
mouse models have shown that a Th1 response results in a reduced H. pylori 
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colonization density suggesting that a Th1 response is appropriate to control H. 
pylori infection (Mohammadi et al., 1997).  
 
A Th1 predominant response is a major factor in H. pylori pathogenesis: mice 
with a Th1 predominant response show more severe gastric inflammation than 
those with a Th2 predominant response (Mohammadi et al., 1997) (Smythies et 
al., 2000). T cell transfer experiments in a mouse model have shown that these 
effects are dependent on Th1 cells (Mohammadi et al., 1997). Furthermore it 
has been shown that IFNJ secreted by Th1 cells is key in the development of 
H. pylori associated disease; the number of IFNJ producing cells in the infected 
human gastric mucosa has been shown to correlate with the severity of gastritis 
(Lehmann et al., 2002) and it was found that mice infused with IFNJ developed 
pre-cancerous gastric atrophy, metaplasia and dysplasia even in the absence of 
infection (Garhart et al., 2002).  
 
1.2.4 Factors determining the outcome of H. pylori infection 
Although almost all individuals infected with H. pylori develop gastritis only a 
small minority go on to develop gastric cancer and several other risk factors are 
important in determining disease outcome. These include host genetics and 
inflammatory response, environmental factors such as diet and smoking and 
bacterial strain specific virulence factors which are discussed below. 
  
Host genetic polymorphisms can affect the level of expression of IL-1 and 
other cytokines affecting the immune response to H. pylori infection. It has 
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been shown that individuals with proinflammatory genotypes have a higher 
risk of corpus predominant pangastritis which predisposes them to atrophic 
gastritis, intestinal metaplasia and gastric cancer (El-Omar et al., 2000). 
 
Environmental factors, such as diet and smoking play an important part in 
determining the course of H. pylori associated disease. Smoking has been 
shown to be associated with an increased risk of peptic ulcer disease 
(Shimoyama et al., 2001, Atherton, 2006). Individuals whose diets are high in 
red meat and salt have been shown to be at an increased risk of developing 
gastric cancer (Atherton, 2006). As with other cancers, a diet rich in fruit, 
vegetables and cereals has been suggested to have mild to moderate 
prophylactic potential for gastric cancer although the specific food components 
acting as protective factors for gastric cancer still remain to be fully defined 
(Rocco and Nardone, 2007).  
 
H. pylori uses an extensive repertoire of virulence and colonisation factors to 
overcome host defence mechanisms. These factors have been shown to play an 
important role in determining H. pylori pathogenesis. H. pylori colonisation 
and virulence factors and their role in H. pylori associated disease are 
discussed in detail below. 
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1.3 H. pylori virulence and colonisation factors 
1.3.1 Acid resistance 
Urease is essential for the survival of H. pylori in the acidic gastric 
environment (Eaton and Krakowka, 1994, Tsuda et al., 1994, Andrutis et al., 
1995). It allows H. pylori to maintain a constant periplasmic and internal pH 
which is required for transmembrane potential difference. Urease is produced 
by all H. pylori strains although the level of urease activity differs significantly 
between H. pylori isolates (Contreras et al., 2003). Urease has been proposed 
to participate in tissue damage by producing ammonia which is thought to be 
cytotoxic to epithelial cells (Smoot et al., 1990).  
 
1.3.2 Motility 
Motility is essential for H. pylori colonization (Eaton et al., 1996, Ottemann 
and Lowenthal, 2002). Flagellar motility is thought to be required for the initial 
stages of infection allowing the bacterium to move from the acidic 
environment of the gastric lumen into the less acidic mucus layer (Schreiber et 
al., 2004). Mutants defective in the synthesis in either one of the two flagellins 
have impaired colonization efficiency. Non-motile double mutants are 
completely avirulent (Eaton et al., 1996).  
 
1.3.3 Adherence and outer membrane proteins  
Adherence to the gastric mucosa is thought to be important in the initial 
colonization and the long term persistence of H. pylori in the gastric mucosa. 
Five major outer membrane families that act as adhesins have been identified 
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and include the blood group antigen adhesin (BabA), sialic acid binding 
adhesion (SabA), outer inflammatory protein (OipA), adherence±associated 
lipoprotein (AlpAB) and HopZ. BabA recognises Lewis b antigen and related 
fucosylated ABO blood group antigens (Ilver et al., 1998) and mediates its 
attachment to surface mucus cells and cells in the gastric pit (Falk, 1995). It is 
thought to be the primary adhesin for human colonisation. babA2, the gene that 
encodes BabA is only present in some strains, but those that possess babA2 are 
more common in patients with peptic ulcer disease or gastric cancer. BabA has 
been shown to be associated with increased gastric inflammation and may play 
a role in pathogenesis by promoting colonisation and inflammation (Petersson 
et al., 2006). SabA recognises sialyl-Lewis x and sialyl-Lewis a antigens 
(Mahdavi et al., 2002) and has been shown to be  associated with increased 
gastric inflammation (Petersson et al., 2006). OipA is a 34 kD outer membrane 
protein which has been reported to promote gastric inflammation by inducing 
IL-8 production in gastric epithelial cells (Yamaoka et al., 2002).  OipA 
producing strains are associated with duodenal ulceration (Yamaoka et al., 
2002) and gastric cancer (Yamaoka et al., 2005). 
 
1.3.4 LPS 
Like other Gram negative bacteria, the outer membrane of H. pylori contains 
lipopolysaccharides (LPS) which are composed of a core oligosaccharide, a 
lipid moiety (lipid A) and an O-chain polysaccharide. The O-chain 
polysaccharide of the majority of H. pylori strains mimic Lewis and other 
human blood group antigens. These bacterial Lewis antigens display antigenic 
1-13 
 
variation and are thought to contribute to immune evasion by H. pylori 
(Appelmelk et al., 1997, Monteiro et al., 1998). Lewis antigens appear to play 
a limited role in adhesion (Mahdavi et al., 2003) and colonisation (Takata et 
al., 2002). 
 
1.3.5 CagA and the cag pathogenicity island (PAI) 
An important H. pylori virulence factor is the cytotoxin associated gene cagA. 
The CagA protein is encoded by the cagA gene, which is located within the cag 
pathogenicity island (cag PAI). The cag PAI encodes a type IV secretion 
system that facilitates CagA translocation into epithelial cells (Bourzac and 
Guillemin, 2005). The cag pathogenicity island (cag PAI) is present in 
approximately 60% of Western strains (Tomb et al., 1997, Alm et al., 1999, 
Censini et al., 1996, Akopyants et al., 1998). Nearly all East Asian H. pylori 
strains contain the cag PAI (van Doorn et al., 1999, Maeda et al., 1998, Maeda 
et al., 1999).  
 
Although all H. pylori strains induce gastritis to varying degrees, cagA positive 
strains are significantly associated with an increased risk of more severe 
gastritis, atrophic gastritis, peptic ulcer disease and distal gastric 
adenocarcinoma (Crabtree et al., 1993, Crabtree et al., 1991, Peek et al., 1995, 
Kuipers et al., 1995c, Beales et al., 1996, Blaser, 1995, Parsonnet et al., 1997, 
Rudi et al., 1997, Queiroz et al., 1998).  
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Upon translocation into the epithelial, cell CagA becomes phosphorylated at 
tyrosine residues within specific phosphorylation motifs by the Src family of 
kinases (Selbach et al., 2002, Stein et al., 2002). Phosphorylated CagA 
activates the eukaryotic SHP-2 phosphatase that stimulates cytoskeletal 
changes, abnormal cell proliferation and cell signalling pathways (Tsutsumi et 
al., 2003, Higashi et al., 2004). 
 
The number of CagA tyrosine phosphorylation motifs have been found to vary 
between strains. Both Eastern and Western strains have A and B 
phosphorylation motifs, Western strains have additional C motifs, which vary 
in number between different H. pylori isolates (Akopyants et al., 1998, Arents 
et al., 2001, Argent et al., 2007). In contrast East Asian strains do not possess 
C motifs but do possess a D motif. CagA proteins from East Asian strains 
possess stronger SHP-2 binding and cell scattering activities than CagA 
proteins from Western strains. There is a significant positive association 
between the numbers of type C phosphorylation motifs and gastric 
carcinogenesis in Western strains (Azuma et al., 2002).    
 
1.3.6 Duodenal ulcer promoting gene (dupA) 
The recently identified dupA gene encodes a VirB4 ATPase homologue which 
comprises both jhp0917 and jhp0918 (Lu et al., 2005). DupA has been found to 
increase IL-8 expression in epithelial cells (Lu et al., 2005). The presence of 
dupA in an infecting strain is associated with duodenal ulceration and increased 
mucosal neutrophil infiltration but appears to be a protective factor against 
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gastric cancer in some, but not all studies (Lu et al., 2005; Argent et al., 2007; 
Arachchi et al., 2007).  
 
1.3.7 Induced by contact with epithelium A (IceA) 
IceA was highlighted by the isolation of mRNA transcripts from strains 
associated with PUD (Peek et al., 1998). Two polymorphisms were identified: 
iceA1 for which transcription is up regulated following contact with epithelial 
cells and the inactive iceA2 which is not. The biological significance of these 
genes is unclear; iceA1 has been associated with peptic ulcer disease, but this 
association is not universal (Yamaoka et al., 2002). 
 
1.3.8 Vacuolating cytotoxin VacA 
In 1988, Leunk and colleagues discovered that cell free supernatants from 
broth cultures of H. pylori induced vacuolar degeneration of various cultured 
epithelial cell lines (Leunk et al., 1988). This effect was subsequently shown to 
be caused by a secreted protein toxin, designated VacA (Cover et al., 1992). 
vacA, the gene encoding the vacuolating cytotoxin was cloned from several 
strains of H. pylori. In each it has been estimated that the gene encodes a 
protein of 139-140 kDa (Telford et al., 1994b, Phadnis et al., 1994, Schmitt 
and Haas, 1994, Cover et al., 1994). VacA is translated into a pre-protoxin of 
approximately 1200 amino acids. The pre-pro toxin is composed of a 33 amino 
acid N-terminal signal peptide, a central passenger domain and a 50 kDa C-
terminal domain. The N-terminal signal peptide and the C-terminal domain are 
both cleaved during secretion of the toxin from the cell. Once secreted the 
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central passenger domain forms the mature toxin and consists of the p37 
subunit which is associated with the toxicity of VacA, and the larger p58 
subunit which mediates toxin-epithelial cell binding. The p37 and p58 subunits 
are linked by a protease sensitive surface exposed hydrophilic loop region 
(Figure 1.1.). Both the p37 and the p58 subunits are required for toxin activity 
(Ye et al., 1999). 
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Figure 1.1 VacA polymorphism and function. VacA is polymorphic with two possible 
signal regions, s1 and s2, two possible intermediate regions i1 and i2 and two possible 
mid-regions, m1 and m2. The translated protein is an autotransporter with N- and C-
terminal processing during bacterial secretion. The s1 signal region is fully active, but the 
s2 region encodes a protein with a different signal-peptide cleavage site, resulting in a 
short N-terminal extension to the mature toxin that blocks vacuolating activity and 
attenuates pore-forming activity. The mid-region encodes a cell-binding site, but the m2 
type binds to and vacuolates fewer cell lines in vitro. (Adapted from Rhead et al., 2007). 
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The vacA gene encodes a protoxin approximately 140kDa in mass. VacA 
possesses features typical of an autotransporter protein including a 33 amino 
acid N-terminal signal sequence, a ca.90kDa N-terminal passenger domain, and 
a 33kDa C-WHUPLQDO ȕ GRPDLQ (Phadnis et al., 1994). Autotransporters are a 
distinct family of secreted proteins which contain all the necessary elements for 
translocation across the outer membrane within their own polypeptide 
sequences (Henderson et al., 1998). The N-terminal signal sequence directs 
secretion via the sec apparatus and is cleaved at the inner membrane by a signal 
peptidase releasing the remaining portion of the VacA protoxin into the 
periplasm. It is unclear what happens in the periplasmic space, but it is thought 
that the protein may exist as an intermediate before the final stage of export. 
The amphipathic C-WHUPLQDO GRPDLQ IRUPV D ȕ EDUUHO ZKLFK LQVHUWV LQWR WKH
outer membrane to form a pore through which the rest of the protein passes. 
The C-terminal sequence is also cleaved by an unknown protease and the 
mature protein of approximately 90-95kDa is released as a soluble protein into 
the extracellular milieu (Reyrat et al., 1999; Schmitt et al., 1994; Henderson et 
al., 1998). An alternative model of autotransport secretion has been proposed 
by Veiga et al., 2004 (Veiga et al., 2004) who suggest WKDWDPLQLPXPRIVL[ȕ
domains assemble as a ring shaped oligomeric complex in the bacterial outer 
membrane. The protein is translocated from the periplasm to the external 
medium by passing through the central hydrophilic pore formed by an 
autotransporter oligomeric complex. VacA may remain localised on the surface 
of the bacterium in toxin-rich patches (Ilver et al., 2004). These VacA rich 
patches can be transferred directly from the surface of H. pylori to the host 
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cells upon direct contact (Ilver et al., 2004). VacA has also been shown to be 
released from the bacterial cell in the form of membrane blebs (Fiocca et al., 
1999, Keenan et al., 2000, Keenan and Allardyce, 2000).  
 
1.3.8.1 Oligomeric structure of VacA 
Once secreted into the extracellular environment, VacA exists as a 90-95kDa 
molecule that is composed of two domains separated by a surface exposed 
hydrophilic loop which is sensitive to proteolytic cleavage (Telford et al., 
1994b). Cleavage in this region yields two subunits, p37 and p58 (named 
according to their molecular weight, sometimes also designated p33 and p55) 
that remain non-covalently associated. Using deep etch electron microscopy 
the p37 and p58 subunits have been shown to aggregate into large flower 
shaped or flat form complexes. The round form flower shaped complexes are 
approximately 30nm in diameter and appear to consist of a central ring 
VXUURXQGHG E\ VL[ RU VHYHQ ³SHWDOV´ (Lupetti et al., 1996). The flat form 
complexes also consist of six or seven petals which radiate from the centre of 
the complex with a distinctive clockwise chirality but with no central ring 
(Figure 1.2.). In another model, the flower-like forms are suggested to be 
dodecamers or tetradecamers of VacA monomers of approximately 90kDa, and 
flat forms are suggested to be hexamers or heptamers (Cover et al., 1997). 
Atomic force microscopy imaging of purified VacA supports the deep-etch 
electron microscopy data and suggests that VacA is arranged in hexagonal 
central rings attached by connectors to peripheral domains (Figure 1.3.) 
(Czajkowsky et al., 1999).  
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Mutant forms of VacA that are unable to form oligomers also lack vacuolating 
activity (Vinion-Dubiel et al., 1999), which suggests that oligomerization is an 
important feature of purified VacA. Following exposure to acidic or alkaline 
conditions, these oligomeric forms become activated by dissociation into 
monomers (Cover et al., 1997, Molinari et al., 1998a, Yahiro et al., 1999), and 
thus results in enhanced internalisation of the toxin and a marked increase in its 
cytotoxin activity (Cover et al., 1997, de Bernard et al., 2000, McClain et al., 
2000, Molinari et al., 1998a, Yahiro et al., 1999). However, culture 
supernatants and VacA associated with the bacteria do not seem to require 
activation (Leunk et al., 1988, Reyrat et al., 1999), suggesting that active VacA 
may be monomeric in vivo, and oligomerization, which requires acid activation 
for its function, might be an artefact of protein purification (Gebert et al., 
2004). 
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Figure 1.2 Image of the top surface of a soluble VacA oligomer which has a diameter of 
approximately 30nm. This is a three dimensional reconstruction from electron 
micrographs of quick-freeze deep-etch metal replicas of VacA. (Taken from 
(Lanzavecchia et al., 1998)). 
 
 
 
 
 
 
 
 
 
Figure 1.3 Atomic force microscopy image of membrane associated VacA showing a 
lattice of pore-like structures. The line diagram in the top right hand corner shows a 
VacA hexamer with an overall diameter of 28nm. (Taken from (Czajkowsky et al., 1999).) 
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1.3.8.2 vacA polymorphism 
vacA is present in all strains of H. pylori and is transcribed in a monocistronic 
form (Cover et al., 1994, Phadnis et al., 1994, Schmitt and Haas, 1994, Telford 
et al., 1994b). The gene is generally well conserved between strains but there is 
significant diversity in three distinct regions of the gene: the signal (s) region 
and the mid (m) region and the recently identified intermediate (i) region 
(Atherton et al., 1995). Characterisation of these regions has revealed that 
allelic variation exists (Atherton et al., 1995, van Doorn et al., 1998).  Allelic 
diversity in vacA has allowed strains to be genotyped s1 or s2 for the signal 
region and m1 or m2 for the mid region and i1 or i2 for the intermediate region 
(van Doorn et al., 1998, Atherton et al., 1995). The vacA genotype is an 
important determinant of toxicity. 
 
Among the type s1 strains, subtypes s1a, s1b and s1c have been identified; 
although type s1c is restricted to Asia.  Type s2 VacA is cleaved at a different 
site in the signal peptide sequence to type s1 resulting in a form of VacA which 
has a 12 amino acid hydrophilic N-terminal extension whereas mature type s1 
VacA has a hydrophobic N-terminus (Atherton et al., 1995, Letley and 
Atherton, 2000). This 12 residue extension to VacA has been shown to be 
responsible for the loss of vacuolation induction by s2 strains. This was further 
demonstrated by the addition of the 12 amino acid extension to type s1 VacA 
resulted in vacuolating cytotoxin that could no longer vacuolate eukaryotic 
cells (Letley and Atherton, 2000, Letley et al., 2003, McClain et al., 2001)  
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Conversely, removing the s2 extension from type s2 VacA to make the strain 
s1-like confers vacuolating activity (Letley et al., 2003).  
 
The vacA mid region which encodes part of the p58 region has been shown to 
be associated with cell specificity (Atherton et al., 1995, Pagliaccia et al., 
1998, Letley et al., 2003, Ji et al., 2000). m1 forms vacuolate a variety of cell 
types but m2 forms are more limited in the cells they vacuolate (e.g. RK13 and 
primary gastric cells.). Within the m-region, two main types (m1 and m2) have 
been identified (Atherton et al., 1995). Among East Asian isolates, a novel m2 
subtype (m2b) was designated to distinguish it from the original m2 subtype, 
which is now designated m2a (van Doorn et al., 1998). Subtype m2b was only 
observed in strains that were of signal region type s1c.  
 
The recently identified intermediate region can also be divided into two types 
(i1 and i2) (Rhead et al., 2007). This region is located between the signal and 
mid regions of vacA. Rhead et al., (2007) observed that vacA s1/m1 type 
strains were nearly always type-i1 and that type s2/m2 strains were always 
type-i2. The s1/m2 strains varied in their intermediate region type however, 
they found that strains that were s1/i1/m2 had vacuolating activity whereas 
type s1/i2/m2 strains were non-vacuolating. Using mutagenesis experiments 
they confirmed that the i region type determines vacuolating activity in s1/m2 
strains and that the i region influenced cell specificity in s1/m1 strains. Thus, 
the i region is thought to be involved in cytotoxin binding (Rhead et al., 2007).  
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The vacA gene may comprise any combination of signal intermediate and mid 
region types. Most of the vacA combinations have been detected in strains 
isolated from infected individuals, although the s2/m1 form of vacA is rarely 
found. The reasons why allelic variants of vacA persist are not fully 
understood, but the natural persistence of distinct polymorphic forms of vacA 
in diverse human populations implies that each may offer differing selective 
advantages. 
 
1.3.8.3 Disease associations and animal models 
The clinical significance of VacA has been assessed from studies in animal 
models, and from several observations in humans infected with H. pylori. 
Firstly, large quantities of purified VacA can induce ulcer-like erosions when 
administered into the mouse stomach (Marchetti et al., 1995). In addition to 
this, VacA increases the risk of gastric ulcer formation in experimentally 
infected gerbils (Ogura et al., 2000) and also enhances the bacterial 
colonization rate in a mouse model of infection (Salama et al., 2001). Orally 
administered toxigenic H. pylori sonicates and purified VacA also induce 
epithelial vacuolation, loss of gastric gland architecture (Ghiara et al., 1995, 
Telford et al., 1994a, Supajatura et al., 2002) and infiltration of mononuclear 
cells into the lamina propria (Telford et al., 1994a, Supajatura et al., 2002).  
 
Several studies have investigated the association of vacA type and disease 
outcome. In Western populations such as the USA and Western Europe where 
vacA allelic diversity is common, vacA s1 genotypes are more frequently 
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associated with higher levels of inflammation in the gastric mucosa than s2 
types (Atherton et al., 1995, Atherton et al., 1997, Evans et al., 1998, Kidd et 
al., 1999, van Doorn et al., 1998). vacA s1/m1 and s1/m2 strains have been 
shown to be associated with peptic ulceration and s1/m1 type strains have been 
associated with gastric carcinoma (Atherton et al., 1995, Atherton et al., 1997, 
Rhead et al., 2007, Basso et al., 2008). Corpus neutrophil infiltration was 
found to be more severe in patients infected with an m1 type strain than those 
infected with an m2 type strain (Umit et al., 2009). The vacA i1 type is a risk 
factor for peptic ulcer disease and has been shown to be associated with 
duodenal ulcer disease as well as gastric cancer (Basso et al., 2008, Rhead et 
al., 2007). Importantly Rhead et al., 2007 found that although vacA s1, i1 and 
m1 alleles, along with cagA positive status were all associated with gastric 
adenocarcinoma in an Iranian population, the association was most pronounced 
with i1-type strains. Furthermore, only the i region status was independent of 
all other alleles studied. They concluded that the vacA i region is the best 
independent marker of toxicity and pathogenicity of a strain, and that the i1 i 
region type may be sufficient for identifying all pathogenic forms of vacA.  
 
In East Asian and Southeast Asian countries the association between vacA 
allelic diversity and clinical outcome is not well established as the vacA allelic 
type is quite homogeneous with the majority of the population being infected 
with type s1/i1 strains (Maeda et al., 1998, Yamaoka et al., 1998). However, it 
is possible that a high prevalence of the more virulent vacA s1/i1 type strains 
may contribute to the high incidence of gastric cancer in this region of the 
world (Rhead et al,. 2007).  
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1.3.8.4 Effect of VacA on epithelial cells 
In the past, VacA has mainly been regarded as a cytotoxin of the gastric 
epithelial cell layer. However, in addition to its well known vacuolating 
activity, VacA has been reported to induce apoptosis in epithelial cells (Cover 
et al., 2003; Galmiche et al., 2000; Kuck et al., 2001), to affect B lymphocyte 
antigen presentation (Molinari et al., 1998b), to inhibit the activation and 
proliferation of T lymphocytes (Fan et al., 1994; Shirai et al., 1998), and to 
modulate the T cell mediated cytokine response (Gebert et al., 2003), all of 
which may contribute to H. pylori persistence in the gastric niche. 
 
1.3.8.4.1 Alteration of permeability 
VacA has been shown to alter trans-epithelial resistance (TER). This appears to 
be due to modulation of the resistance of cell-cell junctions (Papini et al., 
1998). This effect appears to be independent of vacuolation as the reduction in 
TER following VacA treatment is not accompanied by vacuolation, and TER 
decrease is not influenced by weak bases, which do affect vacuolation. 
Furthermore it is only partially affected by inhibitors of the VacA anion 
channel (Szabo et al., 1999). In addition to ions, small neutral molecules such 
as mannitol and sucrose also exhibit increased trans-epithelial diffusion upon 
VacA treatment. This has led to the suggestion that VacA is involved in the 
release of essential nutrients necessary for the growth of H. pylori in the gastric 
mucosa (Papini et al., 1998).  
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1.3.8.4.2 Pore formation in the cell membrane 
VacA has been shown to form pores in epithelial cell membranes, allowing 
egress of anions and urea (Iwamoto et al., 1999, Tombola et al., 2001, Szabo et 
al., 1999, Tombola et al., 1999). This is important since urea hydrolysis 
catalyzed by H. pylori urease protects against gastric acidity allowing the 
bacterium to survive within the acidic environment of the stomach (Scott et al., 
1998). Ammonia and bicarbonate, products of urea hydrolysis are also 
metabolic substrates for H. pylori (Burns et al., 1995). 
 
1.3.8.4.3 Vacuolation 
Vacuolation is the most apparent effect of VacA (Figure 1.4). It has been 
shown by McClain et al., (2000) that acid activation of purified VacA is 
required prior to internalisation, after which VacA localises in late endosomal 
vesicles and causes their expansion (Ricci et al., 1997). Vacuolation also 
requires vacuolar-ATPase and the presence of permanent weak bases, such as 
ammonia in the extracellular medium (Cover et al., 1993, Papini et al., 1993a, 
Papini et al., 1993b, Cover et al., 1992, Ricci et al., 1997). The requirement of 
vacuolar ATPase activity suggests that the intralumenal pH in vacuole 
precursors must be acidic in order for VacA to induce cell vacuolation. It 
seems likely that ammonium ions accumulate within the acidic lumen of these 
compartments, and cause their osmotically driven swelling (Papini et al., 
2001). In addition to these, the cellular enzymes Rab7 (Papini et al., 1997), 
Rac1 (Hotchin et al., 2000) and dynamine (a high molecular mass G protein 
involved in the early stages of vesicle creation) are also required for vacuole 
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development and maintenance. The membrane trafficking protein Rab7 is a 
small GTPase, that is thought to be required to support membrane deposition 
and homotypic fusion between late endosomes, thus causing vacuole formation 
(Papini et al., 1997, Papini et al., 1994, Molinari et al., 1997). Rac1 is another 
GTP binding protein that is involved in the regulation of actin cytoskeleton 
rearrangements and intracellular signal transduction pathways (Hotchin et al., 
2000). Both Rab7 and Rac1 have been shown to be essential for vacuolation as 
dominant negative mutants of Rab7 and Rac1 inhibit vacuolation. 
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1.4 HeLa cells left untreated (A) or treated with H. pylori strain 60190 (s1/m1) water 
extract (B). Extensive vacuolation is observed in treated cells, highlighted by arrows. 
(Taken from (Narayanan, 2005).) 
 
HeLa treated with 60190HeLa - untreated
A B
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1.3.8.4.4 Apoptosis 
Several studies have shown a correlation between H. pylori infection and an 
increased level of apoptosis in the human gastric mucosa (Moss et al., 1996, 
Mannick et al., 1996, Rudi et al., 1998). It has been shown by several groups 
that VacA induces apoptosis via a mitochondrial dependent pathway, which 
leads to cytochrome c release, and subsequent activation of the caspase-3-
dependent cell death signalling cascade (Galmiche et al., 2000, Willhite and 
Blanke, 2004). 
 
Investigation into the mechanism of VacA mediated cytochrome c release has 
revealed that VacA intoxication of cells leads to a breakdown of the 
mitochondrial transmembrane potential (Willhite and Blanke, 2004), which 
may be associated with changes in the permeability of the mitochondrial 
membrane, allowing release of cytochrome c from the mitochondrion. 
Experiments performed with VacA-P9A and VacA-G14A (well characterized 
mutant forms of VacA which are unable to form membrane channels), clearly 
showed that VacA membrane channel formation is essential for reduction of 
the mitochondrial membrane potential and subsequent cytochrome c release.  
 
The mechanism by which VacA permeabilizes the mitochondrial membrane is 
still unknown. One model suggests that VacA directly permeabilizes the 
mitochondrial inner membrane by inserting and forming pores, which could 
result in a reduction in mitochondrial transmembrane potential leading to 
further changes in the outer membrane and release of cytochrome c into the 
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cytosol. Alternatively, it has been suggested that VacA could activate 
endogenous channels of the mitochondria such as the voltage dependent anion 
channel (VDAC), an abundant protein located in the outer membrane of 
mitochondria, which is thought to facilitate cytochrome c release (Tsujimoto et 
al., 2002). 
 
Interestingly it has been observed that the ability of VacA to induce apoptosis 
seems to be cell-type dependent, since no apoptosis could be detected in VacA-
treated activated T cells (Gebert et al., 2003, Boncristiano et al., 2003) but 
VacA induces apoptosis in parietal cells (Neu et al., 2002). This latter effect 
might facilitate H. pylori colonization of the gastric mucosa. 
 
1.3.8.5 Effects of VacA on cells of the immune system 
The vacuolating cytotoxin displays a diverse repertoire of novel activities for 
combating the immune defence mechanisms of the host. VacA has been shown 
to inhibit antigen presentation in B cells. This is thought to occur by blocking 
the maturation of endosomes to MHC class II compartments, where antigen 
loading takes place (Molinari et al., 1998b). Vaccination studies in animal 
models, (Ermak et al., 1998) and adoptive transfer experiments of T cells, 
(Lucas et al., 2001) have suggested that CD4+ T cells are a putative target of 
manipulation by H. pylori during infection. VacA, when added to T cells has 
been shown to completely inhibit the ability of human peripheral blood 
lymphocytic cells (PBLC) to proliferate (Gebert et al., 2003). In addition to 
inhibition of proliferation, VacA has also been found to inhibit secretion of 
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interleukin-2 (IL-2), which is essential for T cell proliferation and viability 
(Gebert et al., 2003). Furthermore VacA has been observed to down regulate 
expression of IL-5Į D KLJK DIILQLW\ UHFHSWRU H[SUHVVHG E\ 7 FHOOV
(Boncristiano et al., 2003). Most of these effects of VacA on T cells are 
expected to result in localized immune suppression. It has been suggested that 
VacA enters the lamina propria via disruptions in the epithelial cell layer 
leading to intoxication of immune cells. 
 
In epithelial cells, H. pylori seems to enter large cytoplasmic vacuoles, where 
the bacteria remain viable and motile. In professional phagocytes, such as 
macrophage cell lines THP-1 (human) and RAW 264.7 (murine), H. pylori 
displays an enhanced survival, as compared to a vacA-negative mutant strain 
(Zheng and Jones, 2003). VacA producing strains appear to reside in a 
compartment that has properties of an early endosome and avoids fusion with 
lysosomes. VacA is thought to arrest phagosome maturation by recruiting and 
retaining tryptophane aspartate-containing coat protein (TACO). This is a 
mechanism also used by Mycobacterium bovis to prevent phagosome 
trafficking and maturation (Ferrari et al., 1999). However, the role of VacA in 
phagosome fusion is uncertain (Rittig et al., 2003). VacA has also been 
reported to stimulate apoptosis in macrophages (Menaker et al., 2004). VacA 
has been shown to upregulate the expression of chemokines in eosinophils 
(Kim et al., 2007). VacA has also been shown to increase COX-2 expression 
and activates p38 MAP kinase in neutrophils (Boncristiano et al., 2003, Brest 
et al., 2006). Incubation of VacA with mast cells has been shown to stimulate 
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proinflammatory cytokine production and induce mast cell chemotaxis 
(Supajatura et al., 2002, de Bernard et al., 2005). 
 
1.4 Regulation of gene expression 
In general, protein production is regulated in a number of ways; these are 
discussed in detail generally and with respect to H. pylori below.  
    
1.4.1 Regulation of transcription Initiation 
Bacteria are highly versatile and responsive organisms that are able to respond 
to environmental changes such as heat shock, cold shock, acid shock, 
starvation and nutrient depletion by altering gene expression. This regulation 
aids the survival of the organism under these altered and stressful conditions. 
 
Gene expression is the combined process of the transcription of a gene into 
mRNA, the processing of that mRNA, and its translation into protein. It is 
generally observed that most regulation of bacterial protein expression occurs 
at the transcriptional level as it is most energetically economical for an 
organism to terminate expression of that gene and therefore block production at 
the earliest possible stage if demand for a protein decreases. However, other 
stages of transcription are also targets for regulation in some cases.  
 
One of the most striking features of the H. pylori genome is the relatively low 
abundance of predicted regulatory proteins. Only 32 gene products classified as 
having a possible regulatory function have been identified. Further analysis of 
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the genome has revealed that only 17 loci are predicted to have a role in the 
regulation of transcription in H. pylori (Scarlato et al., 2001). 
 
1.4.1.1 Sigma factors 
6LJPD ı IDFWRUV DUH NH\ WUDQVFULSWLRQDO DFWLYDWRUV ZKLFK IRUP SDUW RI WKH
RNA polymerase holoenzyme. Generally, a sigma subunit is required for the 
bacterial RNA polymerase to recognise a given promoter. Many bacteria make 
several different sigma subunits each of which can interact with the RNA 
polymerase core to form the holoenzyme and direct it to a specific set of 
promoters. This scheme permits large sets of genes to be differentially 
regulated by simply replacing one sigma subunit with another. The principle 
sigma factor in E. coli LVıVRFDOOHGEHFDXVHWKHSURWHLQLVN'DLQVL]H. It 
LVXVHGIRUQRUPDOPHWDEROLF³KRXVHNHHSLQJ´IXQFWLRQV 
 
When exposed to stressful conditions, alternative sigma factors are used to 
allow the expression of genes which allow the bacterium to survive under these 
QHZ VWUHVVIXO FRQGLWLRQV ı LV UHTXLUHG IRU WKH SURGXFWLRQ RI KHDW VKRFN
proteins (HSPs) which act as chaperones to protect cells against heat damage 
and other stress situations as well as preventing mis-folding of proteins 
(Hesterkamp and Bukau, 1998) 6RPH SDUWV RI WKH VHTXHQFH RI ı FDQ EH
recognized in otKHUEDFWHULDOVLJPDIDFWRUVıLVSUHVHQWDOOWKHWLPHDQGLWLV
required for the expression of many genes that are involved for nitrogen 
PHWDEROLVP ı KDV D YHU\ GLIIHUHQW VHTXHQFH DQG VWUXFWXUH WKDQ WKH RWKHU
sigma factors in E. coli and most bacteria; thus there are at least two different 
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IDPLOLHV RI VLJPD IDFWRU SURWHLQV LQ EDFWHULD ı RU ıV LV NQRZQ WR EH
associated with a variety of stress responses upon entry into stationary phase 
including osmotic stress (Hengge-Aronis, 2002b, Hengge-Aronis, 2002a). The 
LPSRUWDQFHRIıKDVEHHQLQFUHDVLQJO\UHFRJQLVHGLQUHFHQW\HDUV7KLVVLJPD
factor appears only as cells enter the stationary phase of growth. It is 
responsible for transcription of all of the genes whose products are required 
during stationary phase.  
 
H. pylori SRVVHVVHV RQO\ WKUHH VLJPD IDFWRUV ı ı DQG ı ı LV WKH
³normal´KRXVHNHHSLQJVLJPDIDFWRr in H. pylori. Because of the resemblance 
to the E. coli SURWHLQWKLVIDFWRUZDVGHVLJQDWHGıE\VRPHDXWKRUV(Tomb et 
al., 1997, Solnick et al., 1997), while based on the predicted molecular mass ±
ıE\RWKHUV(Beier et al., 1998). Recombinant H. pylori ıH[SUHVVHGLQE. 
coli is fully functional but H. pylori promoters have higher specificity for E. 
coli RNA polymerases utilising H. pylori ıDERYHE. coli ı(Beier et al., 
1998, Spohn and Scarlato, 1999a). The specificLW\ RI ı WR H. pylori 
promoters has been attributed to the spacer region between two domains in the 
H. pylori ıH. pylori ıPXWDQWVFRXOGQRWEHLVRODWHGDQGVRLWLVDVVXPHG
WKDWDQLQWDFWıLVQHFHVVDU\IRUWKHYLDELOLW\RIH. pyloriıDQGı28, the 
alternative sigma factors both seem to be dedicated exclusively to the 
transcriptional regulation of flagellar genes (Spohn and Scarlato, 1999a, 
Suerbaum et al., 1993, Kim et al., 1999). 
 
Mapping of the transcriptional start sites and identification of promoter 
sequences of H. pylori genes has implicated the role of these factors in 
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transcriptional regulation of different sets of genes (Akada et al., 2000, Beier et 
al., 1997, Bereswill et al., 1998, Burns et al., 2000, Dundon et al., 1999, 
Heuermann and Haas, 1995, Leying et al., 1992, Lundstrom and Bolin, 2000, 
Odenbreit et al., 1999, Pesci et al., 1994, Porwollik et al., 1999, Schmitz et al., 
1997, Spohn and Scarlato, 1999b, Spohn and Scarlato, 1999a, Suerbaum et al., 
1993). H. pylori does not possess homologues of either the stationary phase 
VLJPDIDFWRUıRUWKHKHDW-VKRFNVLJPDIDFWRUı7KHDEVHQFHRIWKHVH
factors suggests that H. pylori has a different mechanism to stress response 
than other bacteria.  
  
Analysis of consensus promoter sequences and RpoD in H. pylori revealed that 
there were no obvious -35 consensus sequence in H. pylori genes vacA, katA, 
cagB p2, cheY, ureA, cagA, hspA, cagB P3, copA, repA, sodB. The absence of 
a consensus H. pylori -35 sequence led to the speculation that there may be 
structural differences between H. pylori RpoD (Solnick et al., 1997). The DNA 
binding domains of RpoD from H. pylori 26695 (Tomb et al., 1997) were 
aligned with the corresponding domains of RpoD from 10 other bacterial 
genera. Alignment of the domains responsible for binding to the -10 motif 
indicates H. pylori differs from the RpoD consensus sequence at 4 positions. A 
more striking degree of divergence occurred in the 4.2 domain of the H. pylori 
RpoD, which typically mediates binding to -35 promoter elements. This is 
consistent with the finding that -35 promoter elements in H. pylori that are 
quite different to those found in E. coli. 
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Lack of conservation between H. pylori promoters outside the -10 hexamer 
suggest that there may be considerable variation in the avidity of RpoD binding 
to different promoters and may represent a mechanism for determining the 
levels at which individual genes are constitutively expressed. 
 
1.4.1.2 Transcription factors 
Analysis of the H. pylori genomes of strains 26695 (Tomb et al., 1997) and J99 
(Alm et al., 1999) indicates that only two proteins with homology to known 
and characterised repressors have been identified. These include the 
homologues of the ferric uptake regulatory protein (Fur), and the heat shock 
regulator (HspR). Further analysis led to the identification of the carbon 
storage regulator (CsrA) and the nickel uptake regulator (NikR). There are 
three additional possible transcriptional repressors: one is a homologue of the 
BirA repressor of the E. coli biotin operon; another is a homologue of the 
Bacillus subtilis chromosome partitioning protein Soj, which has been shown 
to exert a direct responsive action on promoters of different sporulation genes 
(Quisel et al., 1999). The most recently described is a homologue of the HrcA 
repressor of B. subtilis, which controls chaperone gene expression (Spohn and 
Scarlato, 1999a, Homuth et al., 2000). 
 
The ferric uptake regulator (Fur) of E. coli is a 17kDa polypeptide which acts 
as a transcriptional repressor of iron-uptake and metabolism genes by means of 
its iron-dependent DNA-binding activity. When high concentrations of iron are 
present, Fur binds ferrous iron and undergoes a conformational change which 
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enables it to bind its target sequences on the DNA (Fur boxes), and repress 
transcription. Low iron concentrations lead to release of ferrous iron from the 
protein, and the resulting decreased DNA-binding affinity leads to derepression 
of transcription, and hence protein expression.  
 
Iron acts as a corepressor of H. pylori Fur proteins. Several Fur boxes have 
been found in the promoter regions of different iron-uptake and iron±
detoxification genes (Tomb et al., 1997, Odenbreit et al., 1996). Iron-mediated 
repression has been shown for fecA2 (Bereswill et al., 2000) and ribBA (Worst 
et al., 1998) and has been investigated for the vacA and fur genes (Szczebara et 
al., 1999). Fur has also been shown to be necessary for iron-dependent 
regulation of transcription of the pfr gene which codes for a ferritin-like protein 
involved in intracellular iron storage (Bereswill et al., 1998, Bereswill et al., 
2000). Expression of pfr is repressed under low iron conditions in wild-type H. 
pylori but not in an isogenic fur- mutant, which indicated that Fur acts as a 
transcriptional repressor of this gene in the response to iron deprivation 
(Bereswill et al., 2000). 
 
In addition to regulation of iron acquisition, Fur also plays a central role in the 
acid tolerance response (Audia et al., 2001). H. pylori Fur protein was found to 
be directly or indirectly involved in the acid induction of urease, amidase and 
formidase (Bury-Mone et al., 2004; Heimer et al., 2002). Furthermore, the 
presence of active Fur protein in H. pylori is essential for resistance to acidity 
in vitro (Bijlsma et al., 2002). Moreover, Fur is required for efficient 
colonization of the Mongolian gerbil (Gancz et al., 2006). 
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Using assays of DNA binding activity, it has been shown that Fur can 
specifically bind to a number of promoters. However, promoters bound by Fur 
appear to be regulated differently. While the fur promoter is activated by the 
Fur protein, other promoters are repressed under low-iron conditions and others 
appear to be iron-independent (Delany et al., 2001a, Delany et al., 2002b, 
Delany et al., 2001b, Delany et al., 2002a, Spohn et al., 2002). Therefore Fur 
protein acts as a transcriptional activator on its own promoter, and as a 
repressor on other promoters. 
 
The global transcriptional regulatory repressors like the HspR repressor in 
Streptomyces species allows the bacterium to respond to heat shock (Bucca et 
al., 1995, Bucca et al., 1997). HspR binds to HspR-associated inverted repeat 
(HAIR) motifs found in the upstream promoter regions of chaperone genes. At 
physiological temperature this binding appears to be stable, leading to 
repression of transcription. An increase in temperature destabilises the protein 
and/or the protein-DNA interaction, which results in derepression of 
transcription of the chaperone genes (Grandvalet et al., 1999). 
 
The H. pylori genome contains homologues to common heat shock proteins 
such as groEL, groES, dnaK and cbpA (Tomb et al., 1997, Spohn and Scarlato, 
1999b). GroEL, GroES and DnaK have been implicated in regulating urease 
activity and adhesion to epithelial cells (Suerbaum et al., 1994; Yamaguchi et 
al, 1997). H. pylori GRHV QRW SRVVHVV D ı KRPRORJXH EXW KRPRORJXHV RI
repressors such as HspR and HrcA have been identified (Tomb et al., 1997, 
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Spohn and Scarlato, 1999a). The hspR gene of H. pylori is the second gene in 
an operon which contains cbpA (encoding a DnaJ homologous protein) and a 
gene coding for a putative helicase-like protein. HspR has been shown to 
repress transcription of this operon as well as groES and dnaK (Spohn and 
Scarlato, 1999a), by binding to large DNA regions of approximately 75bp in 
the respective promoter regions. All three binding sites were found to contain 
sequences with similarities to the HAIR consensus sequence established for 
Streptomyces, indicating similar DNA binding specificities of both proteins. 
Transcriptional analysis of the major heat-shock genes of H. pylori using 
Northern blot analysis has detected increased amounts of both groESL and 
dnaK- associated RNAs after 30 minutes of temperature up VKLIW WR Û&
(Homuth et al., 2000). Transcription of the cbp-hspR-orf and groESL operons 
has been demonstrated in response to osmotic shock (Spohn and Scarlato 
1999a). In addition Barnard et al (Barnard et al., 2004) demonstrated that 
transcription of groESL and hspR were up regulated in response to a 
temperature up shift. A HrcA homologue has also been identified in H. pylori 
and is encoded by the first gene of the dnaK operon. It has been speculated that 
the HrcA homologue could function as a corepressor of the groESL and dnaK 
promoters together with the HspR protein. In support of this hypothesis it has 
been found that the groESL and dnaK promoters contain sequences with 
similarities to the controlling inverted repeat of chaperone expression 
consensus sequence, which has been established as the binding site for the 
HrcA protein of Bacillus subtilis. As H. pylori GRHV QRW SRVVHVV D ı
homologue it has been speculated that HspR and HrcA may act in co-
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ordination with each other to regulate gene expression of H. pylori chaperone 
genes. 
 
NikR is a nickel responsive transcription factor, which has been found to 
control the activation and repression of several genes including urease, the 
outer membrane proteins FecA3 and FrpB4 (van Vliet et al., 2004a, van Vliet 
et al., 2002, van Vliet et al., 2004b, Bury-Mone et al., 2004, Ernst et al., 
2005b, Wolfram et al., 2006, Contreras et al., 2003). NikR has also been 
shown to be involved in the control of expression of several genes in response 
to acidic conditions in H. pylori (Bury-Mone et al., 2004, van Vliet et al., 
2004a, van Vliet et al., 2004b). The NikR acid-responsive regulatory circuit 
has been found to functionally overlap with the Fur regulator (Bury-Mone et 
al., 2004, van Vliet et al., 2004a, van Vliet et al., 2004b). 
 
The Carbon storage regulator A (CsrA) is a post-transcriptional regulator 
(Romeo, 1998, Romeo and Gong, 1993) that appears to be involved in 
influencing the processing and translation of target transcripts in H. pylori but 
has minimal effects on the stability of transcripts (Barnard et al., 2004). CsrA 
has been shown to be involved in modulating motility and plays a role in 
controlling gene expression in response to environmental stress (Barnard et al., 
2004) and has been shown to affect Fur and HspR expression. Mutagenesis of 
csrA in H. pylori resulted in the deregulation of the acid induction of vacA 
(Barnard et al., 2004). Furthermore, CsrA appears to play a role in H. pylori 
colonisation as deletion of CsrA inhibited the strains ability to colonise a 
mouse model of infection (Barnard et al., 2004).  
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Transcription profiling studies have revealed that there is considerable overlap 
between regulatory responses to growth phase-regulated genes, regulatory 
responses to acid, nickel and iron restriction in H. pylori (Bury-Mone et al., 
2004, Ernst et al., 2005a, Merrell et al., 2003a, Merrell et al., 2003b, van Vliet 
et al., 2004a, van Vliet et al., 2004b, Wen et al., 2003).  
 
1.4.2 Two-component systems 
Two-component systems are a method by which bacteria regulate their cellular 
functions in response to changing environmental conditions. They are 
composed of a sensor protein, also referred to as histidine kinase which detects 
environmental stimuli by its N-terminal input domain, and a cognate response 
regulator, which elicits a cellular response via its C-terminal output domain, 
frequently by acting as a transcriptional activator. The response regulator is 
activated by a phosphotransfer reaction from the histidine kinase, which 
autophosphorylates in the presence of the appropriate environmental stimulus, 
to an aspartic acid residue in the N-terminal receiver domain of the regulator 
protein. Phosphorylation of the receiver domain then triggers a conformational 
change in the response regulator which activates its C-terminal output domain. 
H. pylori has a relatively small array of these two-component systems (Tomb 
et al., 1997). Besides the CheA/CheY (HP0392/HP1067) system that regulates 
the chemotactic response, there are only three histidine kinases and five 
response regulators putatively involved in transcriptional regulation (Joseph 
and Beier, 2007). There are relatively few two-component systems found in H. 
1-43 
 
pylori (E. coli encodes approximately 30 two-component systems (Inui et al., 
2003) and Campylobacter jejuni, a close relative of H. pylori encodes seven 
two-component systems, as well as three orphan response regulators (Parkhill 
et al., 2000).) This small number of regulatory proteins may be due to a lesser 
need for H. pylori to be able to adapt to environmental changes because of the 
restricted niche it inhabits and the lack of competition from other organisms. 
 
Motility and urease dependent acid resistance required for colonisation of the 
stomach are regulated by 2 component systems. In H. pylori. HP0703-HP0244 
(FlgRS) is a two component system protein and is part of the regulatory 
cascade involved in the regulation of class II flagellar gene expression (Niehus 
et al 2004). HP0392-HP1067 (CheAY2-CheY) is a two component system 
protein and a bifunctional histidine kinase and is involved in chemotaxis and 
regulation of flagellar motion. HP0019 (CheV1), HP0616 (CheV2), HP0393 
(CheV3) are response regulators that are thought to be involved in chemotaxis 
but their precise function is unknown. HP0166-HP0165 (ArsRS) is a two 
component system protein and an essential response regulator and is involved 
in the pH-responsive regulation of the urease gene cluster and other genes 
involved in acid resistance (Pflock et al., 2005, Pflock et al., 2006, Wen et al., 
2006). HP1365-HP1364 (CrdRS) is a two component system protein and is 
possibly involved in the regulation of genes encoding Cu2+ resistance 
determinant regulation of acid resistance genes. Waidner et al., 2005 
demonstrated that CrdRS positively regulates the expression of the copper 
resistance determinant CrdAB-CzcAB in response to increasing concentrations 
of copper ions (Waidner et al., 2005). 
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1.4.3 Transcriptional termination 
Once RNA polymerase has initiated transcription at a promoter, it will continue 
along the DNA, polymerizing ribonucleotides, until it encounters a 
transcription termination site in the DNA at the end of the cluster of genes 
being transcribed. Bacterial DNA has two basic types of transcription 
termination sites: factor-independent and factor-dependent. As their names 
suggest, these types are distinguished by whether they work with just RNA 
polymerase and DNA alone or need other factors before they can terminate 
transcription. 
 
1.4.3.1 Factor-independent termination 
Factor-independent terminator sequences are characterized by the presence of 
self-FRPSOHPHQWDU\VHTXHQFHVDWWKH¶HQGRIJHQHVFDXVLQJKDLUSLQVWUXFWXUHV
in the RNA which act as terminators. The stem of the hairpin often has a high 
content of G-C base pairs giving it high stability, causing the polymerase to 
pause. The hairpin is often followed by four or more uracil residues which 
result in weak RNA-antisense DNA strand binding. This favours dissociation 
of the RNA strand, causing transcription termination.   
 
1.4.3.2 Factor-dependent termination 
While RNA polymerase can self-terminate at a hairpin structure followed by a 
stretch of U residues, other known terminator sites may not form strong 
hairpins, so require an accessory factor for efficient transcription termination. 
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7KHWUDQVFULSWLRQWHUPLQDWLRQIDFWRU5KRȡ LV WKRXJKW WRH[LVW LQDOO W\SHVRI
bacteria, and is the most widely understood of the transcription factors. Rho is 
a hexameric protein that binds to specific sites in single stranded RNA. It 
hydrolyzes ATP and moves along the nascent RNA towards the transcription 
complex, where it enables the polymerase to terminate transcription at Rho-
dependent transcriptional terminators. Like the factor independent terminators, 
these signals are recognized in the newly synthesized RNA rather than in the 
template DNA.  
 
Genome sequence analysis comparisons have revealed that H. pylori has very 
few stem loop structures; therefore it is presumed that transcription termination 
occurs primarily via a Rho- dependent mechanism (Washio et al., 1998). This 
is supported by the discovery of H. pylori orthologues to known E. coli 
transcription termination factors (rho, nusA, nusB and nusG) (Bandyopadhyay 
et al., 2001).  
 
1.4.3.3 Attenuation and antitermination 
Bacteria use mechanisms known as attenuation and antitermination to regulate 
transcription elongation in order to control gene expression in response to 
changes in their environment. Both involve controlling the formation of a 
transcription terminator structure in the RNA transcript prior to a structural 
gene or operon. Transcription attenuation is a mechanism that utilizes 
transcription pausing to regulate the expression of downstream genes in 
response to environmental changes. Antitermination is generally distinguished 
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from attenuation in that the action of the regulatory molecule results in 
transcription read through, with the default pathway being premature 
termination; whereas in attenuation, the regulatory molecule induces 
transcription termination and the default pathway is read through. Several 
different mechanisms of attenuation and antitermination have been identified, 
but the best known mechanism is that used in E. coli for attenuation at the trp 
RSHURQ7KH¶HQGRIWKH trp operon mRNA is rich in tryptophan codons. At 
high tryptophan levels, normal translation of this sequence occurs. As this 
happens, the trp mRNA forms a terminator hairpin structure that does not 
allow RNA polymerase to continue the transcription of the rest of the trp 
operon. Therefore under normal conditions, most trp operon transcripts are 
attenuated. When the tryptophan level drops the ribosome stalls when trying to 
WUDQVODWH WKH ¶ HQG RI WKH trp operon, and results in the formation of an 
antiterminator hairpin structure in the next segment of trp mRNA, which 
allows the RNA polymerase to continue with the transcription of the trp operon 
(Kuroda and Yanofsky, 1984). Other mechanisms of antitermination rely on 
RNA binding proteins that bind and stabilise an antiterminator hairpin structure 
which prevents early termination of transcription e.g. the blg operon in E.coli 
(Amster-Choder et al, 2005). Other mechanisms of antitermination have also 
been described that rely on regulatory proteins that bind to RNA and interact 
with RNA polymerase to prevent the RNA polymerase from recognising RNA 
terminators e.g N protein-PHGLDWHGDQWLWHUPLQDWLRQLQEDFWHULRSKDJHȜ(DeVito 
et al., 1994). No mechanisms of attenuation or antitermination have yet been 
described in H. pylori. 
1-47 
 
 
1.4.3.4 mRNA stability 
The wide variation in mRNA stability in both prokaryotes and eukaryotes 
suggests that the decay rate of mRNA is involved in the control of gene 
expression. The complex mechanisms of degredation that determine the 
stability of mRNA in bacteria have been investigated extensively in the last 
decade and are beginning to be understood. The vast majority of mRNAs in a 
bacterial cell are very unstable, having a half-life of about 3 minutes. 
Endoribonucleases are usually responsible for the initial cleavage of the 
transcript allowing exonucleases to degrade the cleavage products in the 3¶ to 
5¶ direction. Because its mRNAs are both rapidly synthesized and rapidly 
degraded, a bacterial cell can adapt quickly to environmental changes. 
 
H. pylori encodes at least three genes involved in RNA processing (papS 
(polyadenylate polymerase), rnc (RNase III), rnpA (RNase P)) and one 
involved in RNA degradation ((pnp) polynucleotide phosphorylase) (Tomb et 
al., 1997). The products of these genes are likely to be part of the degradosome 
of H. pylori. Therefore, turnover of RNA is expected to be a mechanism 
regulating gene expression in H. pylori. The first evidence that mRNA stability 
regulates gene expression in response to changes in environmental conditions 
came from studies of the urease operon of H. pylori (Akada et al., 2000). It was 
demonstrated that the urease gene cluster of H. pylori consists of two operons, 
ureAB and ureIEFGH, and that primary transcripts of ureIEFGH as well as of 
the read-through transcript, ureABIEFGH, are cleaved to produce several 
species of mRNA. The finding that mRNA from this operon was found to be 
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less stable at pH 7 than at pH 5.5, suggests that the ureIEFGH operon is 
regulated post-transcriptionally by mRNA decay in response to environmental 
pH (Akada et al., 2000). 
 
In E. coli, WKH¶XQWUDQVODWHG UHJLRQRI WKH ompA transcript contains a stem-
ORRS VWUXFWXUH DW WKH H[WUHPH HQG RI WKH ¶ WHUPLQXV WKDW KDV EHHQ VKRZQ WR
stabilise mRNA transcripts, and protects mRNA from degradation (Emory et 
al., 1992) 7KH SRWHQWLDO WR IRUP D KDLUSLQ VWUXFWXUH FORVH WR WKH ¶ HQG LV D
feature common to a number of stable prokaryotic messages. Sequence 
alignments of a collection of H. pylori strains has revealed a potential stem-
loop structure at the +4 site of the vacA ¶-untranslated region. It is not clear if 
this potential stem loop structure has an effect on transcription or transcript 
stability; although deletion caused a reduction in transcript level (Narayanan, 
2005). The role of mRNA stability in the regulation of VacA production will 
be discussed in detail in chapter 5. 
 
1.4.4 Translational regulation 
As previously mentioned most regulation of protein production takes place at 
the transcriptional level, a point at which it is most economic to terminate 
protein production if a given protein is no longer required. However, there are 
additional mechanisms of regulation that occur at the translational level. 
 
Efficient initiation of translation depends on the existence of a ribosome 
binding site (a purine rich group of six to eight nucleotides also known as the 
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Shine-Dalgarno sequence) just upstream of the AUG start codon. The ribosome 
ELQGLQJ VLWH KDV FORVH FRPSOHPHQWDULW\ LQ VHTXHQFH WR WKH ¶ HQG RI WKH 16S 
rRNA molecules found in bacterial ribosomes. Initial positioning of mRNA 
upon the smaller ribosomal subunit requires base pairing between the 16S 
rRNA chain and the ribosome-binding (Shine-Dalgarno) sequences. Mutations 
in the ribosome binding sequence including mutations that cause this sequence 
to be nearer or further away from the AUG codon can greatly reduce 
translational efficiency, compared to those mRNAs that have their ribosome-
binding sequences centred eight nucleotides upstream from the AUG start 
codon, which are translated efficiently.  
 
The efficiency with which Shine-Dalgarno sequences work can be mediated by 
proteins that bind to them and block their availability. The best understood 
example of this involves the ribosomal (r-proteins) of E.coli. When the rate of 
r-protein synthesis exceeds the rate of rRNA synthesis, free r-proteins 
accumulate. Some of them bind to the Shine-Dalgarno sequences on the r-
protein mRNAs and prevent further translation, so that the rate synthesis of 
ribosomal proteins does not exceed the rate at which they can be used in 
making ribosomes. When r-protein mRNAs are rendered untranslatable by the 
binding of r-proteins, they are degraded more rapidly than usual. Once 
translation is underway, its rate is determined by the availability of the various 
tRNA species that correspond to the specific codons in use in the mRNA 
molecules. Different tRNA molecules are present in different amounts; more 
commonly used codons generally have larger quantities of the corresponding 
tRNA molecules. mRNA with a high proportion of codons recognised by rare 
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tRNA molecules are therefore translated more slowly than codons recognised 
by abundant tRNAs. In addition to regulation by r-proteins, regulation of 
translation initiation can also be regulated by the formation of an RNA hairpin 
that sequesters the ribosomal binding site (RBS) of the mRNA and prevents 
translation initiation. A good example of this mechanism is the expression of 
the cobalamin (cbl) biosynthetic cob operon in Salmonella typhimurium 
(Ravnum and Andersson, 2001). In the absence of cobalamin a cis-acting 
translational enhancer element, located 83 nucleotides upstream of the Shine-
'DOJDUQRVHTXHQFHLQWKH¶-untranslated region of the cob mRNA, is required 
to unfold the inhibitory RBS hairpin. In the absence of cobalamin the 
translational enhancer element, which consists of 5 nucleotides, functions as an 
enhancer by interacting with nucleotides in the stem of the RBS hairpin. This 
interaction destabilizes the RNA hairpin and allows ribosome binding. In the 
presence of cobalamin, the enhancer function is inhibited. As a result, the RBS 
hairpin forms and prevents translation initiation (Ravnum and Andersson, 
2001). 
 
From genome analysis of the H. pylori strain 26695, the translational 
machinery appears similar to that of the well characterised E. coli system. 
There are three genes associated with initiation factors of translation, four 
genes involved with elongation and three genes coding for release factors.  
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1.4.5 Phase-variation 
In contrast to transcriptional regulation, Phase-variation allows the continuous 
generation of alternative phenotypes within a population, which facilitates 
adaptation to changing environmental conditions and allows the organism to 
evade detection by the host immune system by creating antigenic variation of 
surface exposed epitopes of flagella, adhesins and lipopolysaccharide (LPS). 
Phase variation allows reversible switching between phenotypes, by a genetic 
re-organisation, mutation or modification, which is not associated with a loss 
of coding potential. A well known mechanism is slipped strand mispairing of 
DNA, which occurs in short sequence repeat (SSR) regions of DNA present in 
the target genes (van Belkum, 1999).  These repetitive sequences can consist of 
single or multi-nucleotide repeat sequences and are positioned upstream of a 
gene which affects transcription or within a gene which affects translation 
(Henderson et al, 1999).  The number of repeats keeps the gene in frame and if 
the number of repeats increases or decreases during cell replication, the 
translation of the gene will be out of frame leading to a phenotypic change.  
The repetitive sequences usually consist of poly-purines or pyrimidines which 
form a triple stranded form of DNA along with a single stranded form of DNA 
which may be more likely to form under conditions of stress.  This form of 
DNA may stimulate gene expression if located near a 5c end of a promoter 
region and the single stranded region may promote slipped strand mispairing 
(Henderson et al, 1999). 
 
The LPS of most H. pylori strains contain complex carbohydrates known as 
Lewis antigens that are structurally related to the human blood group antigens. 
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H. pylori fucosyltransferases (FUCTs) are responsible for expression of 
alternative Lewis antigens in a given strain. The presence of some cis-elements 
in the FUCT encoding genes, including the polyA-polyC tract, mediate slipped 
strand mispairing and the signature sequences regulating the -1 translation 
frameshifting allow H. pylori to produce interchangeable Lewis antigens. 
Genome sequencing has revealed that H. pylori possesses many sequence 
repeat regions (Alm et al., 1999, Tomb et al., 1997). Forty six putative phase 
variable genes have been identified which have the potential to act by altering 
the translational frame of the coding regions. These putative phase variable 
genes include genes involved in LPS biosynthesis, production of cell surface 
proteins, and DNA restriction modification systems (Salaun et al., 2004, de 
Vries et al., 2001) (Henderson and Owen, 1999). As the H. pylori genome is 
relatively small, the abundance of repetitive DNA suggests that phase-variation 
may offer an efficient way of altering gene expression (de Vries et al., 2001). 
  
1.4.6 Protein secretion 
Many secreted bacterial proteins possess a signal sequence in their N-terminus, 
which directs secretion by the general secretion pathway. The signal peptidase 
then cleaves the signal sequence from the N-terminus of membrane and 
secreted proteins after they have been translocated across the cytoplasmic 
membrane. Bacterial signal sequences possess a positively charged N-terminus 
that orientates the signal in the inner membrane, a hydrophobic core that forms 
a membrane spanning helix, and a cleavage recognition site that acts as a 
substrate for the leader peptidase. Analysis of a large number of signal 
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sequences has shown there is a characteristic pattern of small apolar residues at 
positions -1 and -3 (with respect to the cleavage site) and a helix breaking 
residue in the region -4 to -6. It has been observed that these positions are the 
most important with respect to processing, with positions -2, -4, -5 and +1 
being of secondary importance (von Heijne, 1983, Perlman and Halvorson, 
1983). Such structural regularity in the -3 and -1 region is considered to be 
necessary for recognition of the signal peptide cleavage site by leader 
peptidase. As mentioned previously VacA type s1 and VacA type s2 not only 
differ in the position of their signal cleavage site (with type s2 possessing a 12-
amino acid hydrophilic N-terminal extension (Letley et al., 2003, Letley and 
Atherton, 2000), but also in the amino acids present at various positions within 
the signal sequence (Figure 1.5.). Both VacA type s1 and s2 have alanine 
present at the -1 position. Studies on the processing of E. coli alkaline 
phosphatase, show that the presence of alanine, glycine and serine at -1 
position allows processing, with alanine providing the highest rate of 
processing (Karamyshev et al., 1998). Serine is present at position -3 in type s1 
VacA, whereas type s2 VacA has leucine present at this position. Studies on 
the effect of sequence variation on the processing of the M13 procoat protein 
revealed that, only procoat proteins with small amino acids (serine and glycine) 
at the -3 position were efficiently cleaved in vivo, whereas presence of leucine 
at the -3 position retarded cleavage (Shen et al., 1991). However it has been 
suggested that the effect of some amino acid substitutions at position -3 on 
processing may vary from protein to protein, as mutant maltose-binding 
proteins with leucine, threonine or valine at the -3 position were processed 
efficiently (Fikes et al., 1990).  
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A characteristic feature of bacterial signal sequences is the presence of a helix-
destabilizing residue such as a proline or glycine between the -4 and the -6 
position of the peptide. In type s1 VacA, proline is present at -6, whereas in 
type s2 glycine is present at this position. Although proline and glycine are 
both effective helix breakers, procoat substituted with a glycine at the -6 
position was not processed in vivo, and had reduced processing in vitro, 
compared to the wild type with proline at -6 (Shen et al., 1991). It is thought 
that proline helps alter the conformation of the polypeptide chain surrounding 
the cleavage site, allowing efficient cleavage of the signal peptide. In addition 
to the differences between VacA type s1 and s2 at the -1, -3, and -6 positions, it 
has also been observed that there are differences in the signal sequences 
between VacA type s1a strains that possess a glutamine at the -4 position and, 
type s1b VacA that has glutamate at -4. However a study of the processing of 
mutant alkaline phosphatases showed that only lysine when present at the -4 
position affects processing (Karamyshev et al., 1998). The effect of differences 
in signal peptide processing on VacA production will be discussed in detail in 
chapter 6. 
1-55 
 
 
Figure 1.5 Signal sequences of VacA type s1a, s1b and s2. The cleavage site of each 
sequence is indicated by an arrow. Type s2 VacA possesses a 12-amino acid N-terminal 
extension and so differs in its cleavage site to s1 type vacA. All three signal sequences 
possess an alanine at the -1 position. Type s1a and s1b, VacA have a serine at position -3 
and a proline at the -6 position, whereas type s2 VacA has leucine at position -3 and a 
glycine at position -6. 
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1.5 Determinants of VacA production 
1.5.1 Genetic determinants of vacA expression 
Heterogeneity in VacA levels are known to exist between strains. Forsyth et 
al., (1998) first described key findings focussing on the heterogeneity of vacA 
levels amongst different H. pylori strains. It was observed that yields of VacA 
were higher among s1/m1 strains than s2/m2 strains. Using primer extension 
analysis it was concluded that differences in VacA levels between strains could 
be attributed to differences in vacA transcription (Forsyth et al., 1998).  
 
Previous studies have shown that vacA transcription is initiated by a single 
promoter which is located in the 285bp intergenic region between the upstream 
housekeeping gene, cysteinyl-tRNA synthase (cysS) and the start of vacA 
(Forsyth et al., 1998). Sequence analysis of this region from 12 strains (Forsyth 
et al., 1998) revealed that vacA has a single TSP which is located 119 
nucleotides upstream of the AUG start codon, a conserved -35 region 
(TTTATG), a conserved -10 region (TAAAAA) and a TGN motif adjacent to 
the -10 motif (Davies et al., 2002) similar to the extended -10 boxes found in 
E. coli (Forsyth et al., 1998). Site directed mutagenesis indicated that -35 and 
extended -10 sequences along with promoter element spacing are important in 
determining vacA transcript levels. Differences in vacA expression between 8 
strains in vitro were shown to be unrelated to -10 and -35 sequences (Ayala et 
al., 2004). G. L. Narayanan (2005) analysed the vacA promoter sequences of a 
collection of published strains and found, in agreement with Forsyth et al 
(1999) that there appears to be an extended ± 10 region. She also found that in 
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4 out of 8 clinical strains there was a substitution from a G to an A at position -
14 that makes up part of the extended -10 region. In addition the final base 
within the -35 motif has a frequent substitution from a G to an A residue. An 
inverted repeat upstream of the -35 motif was found to be present in 4 out of 8 
clinical strains (Ayala et al., 2004). Inverted repeats are a common feature of 
regulator binding sites, however the role of the inverted repeat in the cysS ± 
vacA intergenic region in transcriptional regulation of vacA is yet to be 
determined.  
 
In order to determine whether different promoter strengths between strains was 
the reason for differing transcriptional levels between s1/m1 and s2/m2 strains, 
comparison of promoter regions and promoter exchange experiments were 
performed between an s1/m1 strain (60190) and an s2/m2 strain (86-313). 
These suggested that there is a difference in promoter strength between s1/m1 
strains and s2/m2 strains, but that factors which govern this difference in 
promoter strength must be located outside the promoter region. As vacA from 
an s2/m2 strain was capable of yielding higher levels of transcription in an 
s1/m1 background, this suggested that either s1/m1 strains produce an activator 
of transcription, or s2/m2 strains produce a repressor of transcription (Forsyth 
et al., 1998, Forsyth and Cover, 1999).  
 
An alternative suggestion put forward by Forsyth et al. is that vacA mRNA 
transcript stability differs between the two strains, but experimental data was 
QRWREWDLQHG&RPSDULVRQRIWKH¶HQGVRIvacA transcripts revealed that both 
s1/m1 and s2/m2 strains possessed prominent stem-ORRSVWUXFWXUHVDWWKH¶HQd, 
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thus indicating that there were no differences in transcript structures that could 
account for differences in vacA levels. Furthermore, in the promoter exchange 
H[SHULPHQWV WKHHQWLUH¶XQWUDQVODWHGUHJLRQVZHUHVZDSSHGIURPWKHVP
strain to the s2/m2 strain, yet there was no significant increase in vacA mRNA 
levels (Forsyth et al., 1998). A sequence alignment of the published promoter 
regions of 19 H. pylori strains revealed a conserved stem loop structure at the 
+4 position of the mRNA transcript. Deletion of this stem loop resulted in a 
reduction in vacA mRNA levels compared to the control. The alignment also 
revealed that this stem loop was reasonably well conserved except for 
differences at the +11 and +28 positions within the stem loop. However, the 
importance of these polymorphisms in determining vacA transcript level was 
not determined G. L Narayanan (2005).  
 
1.5.2 Environmental determinants of vacA expression 
Several studies have shown that VacA levels are also influenced by 
environmental stimuli. Microarray analysis has demonstrated that vacA 
expression is repressed after acid exposure at pH 5.0 (Merrell et al., 2003a). 
This was in contrast to non-array based work which demonstrated that vacA 
was induced under acidic conditions (Barnard et al., 2004). Moreover, two 
other studies found no difference in vacA expression in response to acid 
exposure (Allan et al., 2001, Ang et al., 2001). RNA dot blot analysis revealed 
a significant increase in the accumulation of vacA transcripts under iron-
restricted conditions (Szczebara et al., 1999). However transcriptional 
regulation of vacA is Fur independent (Szczebara et al., 1999).  
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vacA expression has been found to be growth phase dependent. Microarray 
studies and RNA dot blots have shown that vacA transcription appears to peak 
at late log to early stationary phase when strains are cultured in vitro 
(Thompson et al., 2003, Narayanan, 2005, Boonjakuakul et al., 2004). An 
increase in vacA transcript levels has also been observed during infection of 
PMNs (Gieseler et al., 2005). These expression patterns were also dependent 
on time (Gieseler et al., 2005). In a study by Boonjakuakul et al., (2005) vacA 
levels during H. pylori infection of rhesus macaques were higher one week 
after infection than 4-6 weeks after infection (Boonjakuakul et al., 2005) 
indicating that VacA may play a role in the early stages of colonisation. 
 
Several studies have shown that vacA transcript levels are increased by 
attachment to epithelial cells (van Amsterdam et al., 2003, Bach et al., 2002, 
Graham et al., 2002, Salama et al., 2000, Gieseler et al., 2005). Similar results 
were also obtained during infection of polymorphonuclear leukocytes in which 
2 out of 8 strains produced higher levels of vacA mRNA. vacA was also found 
to be one of the most highly expressed putative virulence factors in H. pylori 
positive human gastric biopsy specimens out of a total of 18 virulence factors 
assessed (Boonjakuakul et al., 2004). 
 
1.5.3 Other genetic factors potentially affecting VacA levels 
In addition to differences in transcription, heterogeneity of VacA levels could 
be attributed to differences between strains in signal peptide cleavage between 
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vacA type s1 and s2 strains, although the effect of these differences in 
determining VacA levels is yet to be determined.  
 
The passenger domains of many autotransporter proteins contain a pair of 
cysteine residues. These are usually found in the same location and have the 
same spacing. Letley et al., 2006 showed that these paired cysteine residues are 
required for high levels of VacA production. 
 
As protein stability will influence the steady-state levels of VacA observed, the 
stability of VacA is important when investigating differences in the amount of 
VacA produced between strains, as stability may affect the quantification of 
VacA produced. Although there is no published data on the stability of VacA, 
preliminary results show that VacA is stable in broth culture supernatant over a 
period of 72 hours and is not degraded by bacterial cell factors (Narayanan, 
2005). 
 
1.6 Aims and objectives 
The aim of this study was to investigate the effect of naturally occurring 
differences between H. pylori VWUDLQV LQ WKH SURPRWHU WKH ¶ XQWUDQVODWHG
region and the signal peptide processing site of VacA on VacA production. The 
association between the level of VacA production and disease in humans was 
also assessed. These aims will be discussed in further detail at the beginning of 
each of the results chapters. 
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2 Materials and Methods 
2.1 Media 
2.1.1 Luria-Bertani medium 
Luria-Bertani (LB) medium was prepared using 10g of tryptone (Oxoid, UK), 
10g of sodium chloride (Sigma-Aldrich, UK) and 5g of Yeast extract (Oxoid, 
UK), made up to 1L in distilled water. The medium was adjusted to pH 7.5 
with NaOH. All media sterilised by autoclaving was heated to Û& DW D
pressure of 15psi for 15 minutes.  
 
2.1.2 Luria-Bertani agar 
Agar (Oxoid, UK) was added to LB medium to a final concentration of 1.5% 
w/v; then sterilised by autoclaving.  
 
2.1.3 Brain heart infusion medium 
Brain heart infusion (BHI) medium (Oxoid, UK) was prepared according to the 
PDQXIDFWXUHU¶VJXLGHOLQHV(37g/L in dH2O).  BHI was sterilised by autoclaving. 
BHI broth was supplemented with eiWKHU  ZY ȕ F\FORGH[WULQ 6LJPD-
Aldrich, UK) added prior to autoclaving, or 5% (v/v) filter sterilised foetal 
bovine serum (FBS) (Invitrogen, UK) added after sterilisation. 
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2.1.4 Sulphite free brucella broth 
Sulphite free brucella broth (SFBB) comprised 1% (w/v) tryptone (Oxoid, 
UK), 1% (w/v) Protease peptone (BD, France), 0.1% (w/v) Glucose (Sigma-
Aldrich, UK), 0.2% (w/v) Yeast extract (Oxoid, UK), 0.5% (w/v) NaCl 
(Sigma-Aldrich, UK) in distilled water. SFBB was sterilised by autoclaving. 
6)%%ZDVVXSSOHPHQWHGZLWKHLWKHUZYȕ-cyclodextrin added prior to 
autoclaving, or 5% (v/v) filter sterilised FBS, added after sterilisation. 
 
2.1.5 Iso-Sensitest medium 
Iso-Sensitest broth (Oxoid, UK) was prepared using 23.4g of Iso-Sensitest 
media per 1L of distilled water. Iso-Sensitest broth was sterilised by 
autoclaving.  
 
2.1.6 Terrific broth 
12g Tryptone (Oxoid, UK), 24g yeast extract and 4ml glycerol were added to 
800ml of dH2O and sterilized by autoclaving. When cool the volume was 
adjusted to a final volume of 1L with 100ml of filter sterilized 0.17M KH2PO4 
and 0.72M K2HPO4 solution. 
 
2.1.7 Blood agar 
H. pylori were maintained on Columbia blood agar plates containing (Oxoid, 
UK).  Alternatively blood agar plates were prepared using blood agar base # 2 
2-64 
 
(Oxoid, UK) to a final concentration of 4% (w/v) in distilled water, then 
sterilised by autoclaving. When cooled to less than 50 qC, 7 % (v/v) of lysed 
horse blood (Oxoid, UK) was added.   
 
2.1.8 Antibiotics 
If required appropriate antibiotics were then added to a final concentration of 
30Pg/ml for ampicillin and chloramphenicol (All Sigma-Aldrich, UK). 
 
2.2 Culture conditions 
2.2.1 E. coli culture on LB agar plates 
E. coli strains were maintained on LB agar plates, supplemented with 
antibiotics as required, and incubated at 37 qC overnight.   
 
2.2.2 E. coli liquid culture  
Broth cultures of E. coli were grown in LB or Terrific broth, supplemented 
with antibiotics if required at a concentration of 30µg/ml, at 37qC with 
agitation at 200 rpm. Profiles of E. coli growth were monitored by optical 
density at 600 nm (OD600).  
 
2.2.3 H. pylori culture on blood agar plates 
H. pylori strains were cultured on Columbia blood agar plates containing 5% 
horse blood (Oxoid, UK). Strains were incubated for 48h in a Microaerophilic 
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ZRUNVWDWLRQ0$&69$':6FLHQWLILFDWÛ&LQDQDWPRVSKHUHRI
carbon dioxide in a humidified atmosphere.  
 
2.2.4 Isolation of clinical strains from gastric biopsies 
Gastric biopsies from the corpus taken at endoscopy were immediately 
transferred to 200µl of Iso-Sensitest broth (Oxoid, UK) containing 15% (v/v) 
sterile glycerol. Biopsies were then swabbed over H. pylori strains were 
isolated from gastric biopsies on Columbia blood agar plates containing DENT 
H. pylori selective supplement (Oxoid, UK) and incubated for 3 days in a 
Microaerophilic workstation (MACS VA500 (DW Scientific)) at a temperature 
RIÛ& LQ DQ DWPRVSKHUHRIFDUERQGLR[LGH in a humidified atmosphere. 
After 3 days single colony isolates were passaged onto fresh Columbia blood 
agar plates containing 5% horse blood and grown in a Microaerophilic 
workstation for 48 hours. Frozen stocks of H. pylori strains were made by 
harvesting the growth from blood agar plates in ȝORI,VR-Sensitest medium 
and 15% (v/v) sterile glycerol (Courtin and Warner Ltd). Frozen stocks were 
stored at -Û&  
 
2.2.5 H. pylori Broth cultures 
H. pylori strains were grown on Columbia blood agar plates for 24 hours at 
Û&in a humidified atmosphere containing 5% CO2. Growth from two plates 
was resuspended in 5ml SFBB containing 5% (v/v) fetal bovine serum 
(Invitrogen, UK) added after sterilisation. 200µl of this inoculum was added to 
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800 µl of sterile SFBB. The amount of this suspension required to give a 
starting OD600 of 0.1 in a final volume of 30ml was determined. The cultures 
were grown in a 75cm3 WLVVXHFXOWXUHIODVN1XQF'HQPDUNwith shaking on 
a mini orbital shaker (Stuart Scientific) at 100 rpm in a Microaerophilic 
workstation (MACS VA500 (DW Scientific)). Samples were routinely grown 
on Columbia blood agar plates and Gram stained to confirm the presence of H. 
pylori and the absence of contamination by morphology. 
 
2.2.6 Culture of H. pylori in tissue culture medium 
H. pylori cells were grown on blood agar plates (Oxoid, UK) in a 
microaerophilic workstation and were harvested using a sterile swab and 
resuspended in 10 ml F-12 Ham medium (Sigma-Aldrich, UK) was 
supplemented with 1% L-glutamine (Sigma-Aldrich, UK) and 10% FBS 
(Invitrogen). The cell suspension was adjusted to a starting OD600 of 0.1 then 
incubated in a Microaerophilic workstation DWÛ&.  
 
2.2.7 Co-culture of H. pylori and AGS cells 
AGS cells derived from human gastric carcinoma were cultured in 25ml of F12 
Ham medium with 1% L-glutamine and 10% FBS at Û&LQDQDWPRVSKHUHRI
5% carbon dioxide. Confluent T75 flasks of cells were trypsinised, washed and 
resuspended in 10ml F12 medium with l-glutamine and 10% FBS. 24-well 
plates were seeded with ȝOof the cell suspension added to 1ml of medium 
per well and incubated for 24 hours DW Û& LQ DQ DWPRVSKHUHRI FDUERQ
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dioxide and 80% humidity. The medium was then removed from the wells and 
replaced with 300µl pre warmed fresh medium. Three plates of 24h H. pylori 
growth was resuspended in 5ml sterile PBS. This bacterial suspension was 
adjusted to a final OD600 of 0.01, (2.5 x 106 bacteria) and added to each well of 
a 24 well plate. H. pylori cells were layered onto AGS cells at 1000 x G for 20 
PLQXWHVDWÛ& in a bench top centrifuge. H. pylori cells that had not bound to 
the surface of the AGS cells were removed by washing twice with fresh media. 
The media was replaced and the plates incubated DWÛ&LQDQDWPRVSKHUHRI
5% carbon dioxide and 80% humidity. Cells were removed from wells by 
manual agitation and the cells resuspended by pipetting. In addition wells 
containing only H. pylori were used as a negative control and set up in the 
same way. Samples were taken and stabilized using RNA protect Bacteria 
Reagent (Qiagen, UK) prior to extraction. 
 
2.3 Collection of gastric biopsies 
Consenting patients attending upper gastrointestinal endoscopy at the Queens 
Medical Centre, Nottingham donated two gastric biopsies from the corpus; one 
of which was immediately stored in RNA later (Qiagen, UK) and the other in 
200µl of sterile Iso-Sensitest broth (Oxoid, UK) containing 15% (v/v) sterile 
glycerol. Additional corpal and antral biopsies were taken for routine 
diagnostic testing, histopathology, H. pylori culture and isolation. CLO 
(Camplyobacter-like organism test) (Kimberly-Clark, USA) were carried out at 
the time of the endoscopy using an antral biopsy according to the 
PDQXIDFWXUHU¶V GLUHFWLRQV The result was used in conjunction with H. pylori 
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culture and histology to determine the H. pylori infection and disease status of 
the patient.  
 
2.4 Strains and plasmids 
H. pylori and E. coli strains used in this study, and their relevant characteristics 
are shown in Table 2.1.  H. pylori was identified by morphology, Gram 
staining and urease testing. The strains used in this study were isolated and 
typed by myself, J. Hale, J. Rhead, S. Patel and A. Memon. Table 2.2 shows 
the details of the plasmids used in this study and their relevant 
characteristics.  
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Table 2.1 Bacterial strains  
Strain 
 
Relevant characteristics Reference/Source 
EŽǀĂy'ĂƉƉĞƌƐ ?
Electrocompetent 
cells 
F
- 
mcrA ȴ ?mrr-hsdRMS-mcrBC) ĞŶĚ ?ƌĞĐ ?ˇ ? ?ĚůĂĐȴD ? ?
ȴůĂĐy ? ?ĂƌĂ ? ? ?ȴ ?ĂƌĂ-ůĞƵ ) ? ? ? ?ŐĂůhŐĂů<ƌƉƐ>ŶƵƉ'ʄ- tonA 
Novagen 
 
60190 Wild-type, VacA type s1/m1, Tox+ Leunk et al. (1988) 
60190/A130 As 60190. except vacA::km  Cover et al, 1994 
60190 pCTB2::cat 
 
pBluescript containing 3c cysS to vacA nt 274 from strain 
60190. cat inserted into Hind III site immediately 3c to cysS ; 
Amp
R
; Cm
R 
Letley et al. (2003) 
60190 P(-6)G  
 
As 60190 pCTB2::cat except proline replaced with glycine at 
position -6 of the signal sequence. 
D.P. Letley 
60190 S(-3)L 
 
As 60190 pCTB2::cat except serine replaced with leucine at 
position -3 of the signal sequence. 
D.P. Letley 
60190 P(-6)GS(-3)L  As 60190 pCTB2::cat except proline replaced with glycine at 
position -6, and serine replaced with leucine at position -3 of 
the signal sequence. 
D.P. Letley 
Tx30a Wild-type, VacA type s2/m2, Tox- Leunk et al. (1988) 
Tx30a pA153::cat  As Tx30a but cat ŝŶƐĞƌƚĞĚŝŵŵĞĚŝĂƚĞůǇ ? ?ƚŽcysS; CmR Letley et al. (2003) 
Tx30a G(-6)P As Tx30a pA153::cat except glycine replaced with proline at 
position -6 of the signal sequence. 
D.P. Letley 
Tx30a L(-3)S As Tx30a pA153::cat except leucine replaced with serine at 
position -6 of the signal sequence. 
D.P. Letley 
Tx30a G(-6)PL(-3)S As Tx30a pA153::cat except glycine replaced with proline at 
position -6, and leucine replaced with serine at position -3 of 
the signal sequence. 
D.P. Letley 
60190 G(-6)PL(-3)S As Tx30a G(-6)PL(-3)S but with plasmid transformed into a 
60190 strain background.  
D.P. Letley and C.G. 
Masters (This study). 
Tx30a P(-6)GS(-3)L  As 60190 P(-6)GS(-3)L but  with plasmid transformed into a 
Tx30a strain background. 
D.P. Letley and C.G. 
Masters (This study). 
60190/ȴSL 
 
As pCTB2::cat except stem loop deleted from vacA nt 608 to 
704 and replaced with a Bgl II site; Amp
R
; Cm
R
 
G.L. Narayanan 
60190/SL GtoA 
 
As 60190 pCTB2::cat except with G at position +28 within 
the vacA  ? ?hdZŽĨ ? ? ? ? ?ǁĂƐƌĞƉůĂĐĞĚǁŝƚŚ ? 
This study 
60190/IRDIS As 60190 pCTB2::cat except with a 6bp disruption  in an 
ŝŶǀĞƌƚĞĚƌĞƉĞĂƚůŽĐĂƚĞĚ ?ďĂƐĞƐƵƉƐƚƌĞĂŵĨƌŽŵƚŚĞ-35 
motif of the vacA promoter. 
This study 
45B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
46B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA -. 
This study 
72B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
73B Clinical strain isolated from corpus. vacA type s1/m2/i2, 
cagA +. 
This study 
77B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
83B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
86B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
93B Clinical strain isolated from corpus. vacA type s1/m2/i1, 
cagA  
This study 
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120B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
121B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
122B Clinical strain isolated from corpus. vacA type s1/m1/i2, 
cagA +. 
This study 
124B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
126B Clinical strain isolated from corpus. vacA type s1/m2/i1, 
cagA +. 
This study 
173B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
181B Clinical strain isolated from corpus. vacA type s1/m1/m2/i2, 
cagA -. 
This study 
182B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA -. 
This study  
187B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
192B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
194B Clinical strain isolated from corpus. vacA type s1/m2/i1, 
cagA -. 
This study 
201B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
206B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
215B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
218B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
221B Clinical strain isolated from corpus. vacA type s1/m2/i2, 
cagA -. 
This study 
223B Clinical strain isolated from corpus. vacA type s2/m2/i2, 
cagA -. 
This study 
233B Clinical strain isolated from corpus. vacA type s2/m2/i2, 
cagA +. 
This study 
240B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
242B Clinical strain isolated from corpus. vacA type s2/m2/i2, 
cagA -. 
This study 
247B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
249B Clinical strain isolated from corpus. vacA type s1/m2/i1/i2, 
cagA +. 
This study 
253B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
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255B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study  
256B Clinical strain isolated from corpus. vacA type s2/m2/i2, 
cagA +. 
This study 
265B Clinical strain isolated from corpus. vacA type s1/m2/i2, 
cagA +. 
This study 
271B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA -. 
This study 
274B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
308B Clinical strain isolated from corpus. vacA type s1/m2/i2, 
cagA -. 
This study 
320B Clinical strain isolated from corpus. vacA type s1/m2/i2, 
cagA -. 
This study 
322B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
326B Clinical strain isolated from corpus. vacA type  s1/i2/m2, 
cagA -. 
This study 
335B Clinical strain isolated from corpus. vacA type s1/m1/i1, 
cagA +. 
This study 
350B Clinical strain isolated from corpus. vacA type s1/m2/i1, 
cagA +. 
This study 
 
Table 2.2 Plasmids 
Name Construct Resistance Reference/Source 
pCTB2::cat pBluescript containing 3c 
cysS to vacA nt 274 from 
strain 60190. cat inserted 
into Hind III site 
immediately 3c to cysS ; 
Amp
R
; Cm
R
 
Ampicillin, 
chloramphenicol 
Letley et al, 2000 
pCTB2::cat P(-6)GS(-3)L As 60190 pCTB2::cat 
except proline replaced 
with glycine at position -6, 
and serine replaced with 
leucine at position -3 of 
the signal sequence. 
Ampicillin, 
chloramphenicol 
Letley et al, 2000 
pCTB2::cat 'SL As pCTB2::cat except stem 
loop deleted from vacA nt 
608 to 704 and replaced 
with a Bgl II site; AmpR; 
CmR. 
Ampicillin, 
chloramphenicol 
G.L. Narayanan 
2005 
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2.5 Isolation, manipulation and analysis of DNA 
2.5.1 Preparation of H. pylori genomic DNA 
H. pylori was harvested from blood agar plates or broth cultures, and 
resuspended into 1ml of phosphate buffered saline (PBS) (Oxoid, UK) then 
FHQWULIXJHGDWUSPIRUPLQXWHV&HOOSHOOHWVZHUHUHVXVSHQGHGLQȝO
of TE buffer (10mM Tris-Cl, 1 mM EDTA, pH 8.0).  50ȝORI*(6EXIIHU0
guanidine thiocyanate, 0.1M EDTA, 0.5% (w/v) sarkosyl) was added and left 
WRLQFXEDWHDWURRPWHPSHUDWXUHIRUPLQXWHVWKHQSODFHGRQLFHȝORILFH
cold ammonium acetate (7.5M) (Sigma-Aldrich, UK) was added, gently mixed 
and incXEDWHGRQ LFHIRUD IXUWKHUPLQXWHVȝORIFKORURIRUPZas added 
and mixed gently. Samples were then centrifuged at 13000 rpm for 5 minutes. 
The upper DTXHRXVOD\HUZDVWUDQVIHUUHGWRDIUHVKWXEHDQGDQRWKHUȝORI
chloroform was added and centrifuged as before. The aqueous layer was again 
transferred to a fresh tube and 0.54 x volume of 100% isopropanol was added. 
The samples were mixed gently by inversion to allow precipitation of DNA 
and then centrifuged at 13000 rpm for 5 minutes. The DNA pellet was washed 
WZLFH ZLWK ȝO RI  HWKDQRO DQG DOORZHG WR GU\ The pellet was 
UHVXVSHQGHGLQȝORI7(EXIIHU 
 
2.5.2 Natural transformation of H. pylori 
H. pylori strains were grown on blood agar plates for 24hrs (2 plates for each 
transformation). Growth IURP  SODWHV ZDV UHVXVSHQGHG LQ ȝO RI LVR-
sensitest medium ZLWK ȝO IRHWDO ERYLQH VHUXP WKHQ centrifuged for 1 
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minute at 13000rpm . The supernatant was discarded and the cells were 
UHVXVSHQGHG LQ ȝO RI WKH LVR-sensitest FBS solution. The resulting cell 
suspension was then placed as a small dot on the centre of a blood agar plate 
DQG LQFXEDWHG DW Û& IRU  hours to allow the cells to adhere to the plate. 
3XULILHG SODVPLG '1$ ZDV KHDWHG DW Û& IRU  PLQXWHV WR VWHULOLVH DQG
DOORZHGWRFRROȝORI3ODVPLG'1$at a concentration of 50 ng/µl was added 
WRWKHFHOOVDQGLQFXEDWHGDWÛ&RYHUQLJKW7KHFHOOPDVVZDs spread over the 
VXUIDFHRI WKHVDPHSODWHZLWKDVWHULOHVZDEDQGLQFXEDWHGIRUKUVDWÛ&
the passaged on to blood agar plates containing the appropriate antibiotic to 
select for positive transformants.  
 
2.5.3 Plasmid DNA extraction 
Plasmids were extracted from E. coli liquid culture (section 2.2.2) using the 
QIAprep® Miniprep kit (Qiagen, UK DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
recommendations. 
 
2.5.4 Polymerase chain reaction (PCR) 
5HDFWLRQVZHUHFDUULHGRXWLQDWRWDOYROXPHRIȝOFRQVLVWLQJRIȝORI[
PCR reaction buffer (100 mM Tris-HCl, 15mM MgCl2, 500mM KCl, pH 8.3 
Û&5RFKH8.ȝORIGHR[\QXFOHRWLGHWULSKRVSKDWHVG173Vȝ0
(ProPHJD86$ȝORIeach of the forward and reverse primers ȝ0VHH
Table 2)ȝORI7DTSRO\PHUDVH5RFKH*HUPDQ\DQGȝORIQXFOHDVH
free water. PCR conditions were as shown in Table 2.3. The annealing 
2-74 
 
temperatures for the primers were calculated based on the number of purine 
and pyrimidine bases present, using the formula: Tm = (2 x (A+T)) + (4 x 
(G+C) (Wallace rule)). The extension time was based on the expected length of 
the product. For Taq polymerase (Roche, UK) 1 minute of extension time was 
allotted per kb of product. 
 
Table 2.3 PCR conditions 
Step Number of cycles Temperature Length of time 
1 1  ? ?ȗ 1 min 30 secs 
 
2 
 
 
35 
 ? ?ȗ 30 secs 
Variable annealing 
temperature 
1 min 
 ? ?ȗ Variable extension time 
3 1  ? ?ȗ 5 min 
2.5.4.1 Primers 
Details of the primers used in this study are shown in Table 2.4 
Table 2.4 Primers 
Primer Name WƌŝŵĞƌ^ĞƋƵĞŶĐĞ ? ?ƚŽ ? ? Reference 
A1043 ATTTTACCTTTTTACACACATTCTAGCC Atherton et al 1999 
VacR10 TTATAAGTCCCTACAGCGTC D. L. Letley (Unpublished) 
C1226 CTGCTTGAATGCGCCAAAC Cover et al 1994 
A3436 ATGGAAATACAACAAACACAC Cover et al 1994 
DL1 GCTTTGATGGACACCCCACAAGG Avilez-Jimenez et al 2004 
C0374 CTCCAGAACCCACACGATT D. L. Letley (Unpublished) 
Cys2F GGATCAAAACCCTAAAAACA D. L. Letley (Unpublished) 
VagF CAATCTGTCCAATCAAGCGAG Cover et al 1994 
VagR CTAGCGTCAAAAATAATTCCAAGG Cover et al 1994 
VacF1 GTTGGGATTGGGGGAATGCCG Avilez-Jimenez et al 2004 
C1R TTAATTTAACGCTGTTTGAAG Rhead et al 2007 
C2R GATCAACGCTCTGATTTGA Rhead et al 2007 
16s rRNA F CGATGAAGCTTCTAGCTTGC Narayanan 2005 
16s rRNA R ATAGGACATAGGCTGATCTC Narayanan 2005 
Cag2 GGAACCCTAGTCGGTAATG Rudi et al 1998 
Cag4 ATCTTTGAGCTTGTCTATCG Rudi et al 1998 
VacR5 CATGCTTTGATTGCCGATAGC Avilez-Jimenez et al 2004 
LepB forward TTTTATCACCCCTGTGCCT N. C. Doherty (Unpublished) 
LepB reverse GGATTTTCATTAAGGTGG N. C. Doherty (Unpublished) 
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2.5.5 Analysis of DNA by agarose gel electrophoresis 
DNA fragments were separated by electrophoresis using 0.8% or 2% agarose 
(Seakem, UK) gels prepared in 1 x Tris-acetate ± EDTA (TAE) buffer (40 mM 
Tris-DFHWDWH P0 ('7$ S+  FRQWDLQLQJ HWKLGLXP EURPLGH ȝJPO
Samples were loaded in 1 x loading buffer (6 x 0.25% bromophenol blue, 20% 
JO\FHURO LQ 7(  6'6 ȝO RI D .E '1$ ODGGHU ZDV XVHG DW D
FRQFHQWUDWLRQRIȝJȝO ,QYLWURJHQ8.*HOVZHUHUXQDW9LQ[7$(
buffer.  DNA was visualised under ultra-violet light (Uvidoc). 
 
2.5.6 Purification of DNA fragments 
PCR fragments were purified using Promega Wizard SV Gel and PCR clean-
XSV\VWHP3URPHJD8.DFFRUGLQJWRWKHPDQXIDFWXUHU¶VUHFRPPHQGDWLRQV 
 
2.5.7 DNA sequencing and analysis 
DNA sequencing was performed using purified PCR fragments at the 
BiRSRO\PHU 6\QWKHVLV DQG $QDO\VLV XQLW %6$8 4XHHQ¶V 0HGLFDO &HQWUH
University of Nottingham). DNA sequence analysis was carried out using 
SeqMan and MegAlign software (DNAstar Inc).  
 
2-76 
 
2.5.8 Site directed mutagenesis 
Reactions were carried out in a total volume of 50ȝOFRQVLVWLQJRIȝORI[ 
PFU buffer (Stratagene 8. ȝO RI GHR[\QXFOHRWLGH WULSKRVSKDWHV G173V
ȝ0 3URPHJD 86$ ȝO RI each of the forward and reverse primers 
ȝ0 ( 
Table 2.5), 1ȝORIPFU polymerase (Stratagene, UKDQGȝORIQXFOHDVHIUHH
ZDWHU )LQDOO\ ȝO RI pCTB2::cat plasmid DNA was added at a final 
concentration of 1ng/ ȝO PCR conditions were as shown in Table 2.6ȝORI
Dpn1 enzyme (Stratagene) to each PCR reaction and incubated for 1.5 hours at 
Û&WRGLJHVWPHWK\ODWHG'1$ 
 
Table 2.5 Primers used for site directed mutagenesis 
Primer Name Sequence ( ? ?ƚŽ ? ?) Reference 
IRDIS Forward TCTAGCCAAAAATTCTCATAGAATTGCTTTTTAATCT This study 
IRDIS Reverse AGATTAAAAAGCAATTCTATGAGAATTTTTGGCTAGA This study 
SL GtoA Forward TACTGCATATTTATAACCTTAATCGTAAATG This study 
SL GtoA Reverse CATTTACGATTAAGGTTATAAATATGCAGTA This study 
 
Table 2.6 PCR conditions for site directed mutagenesis 
Step Number of cycles Temperature Length of time 
1 1  ? ?ȗ 1 min 30 secs 
 
2 
 
 
18 
 ? ?ȗ 1 min 
 ? ?ȗ 1 min 
 ? ?ȗ 15min 
3 1  ? ?ȗ 7 min 
 
2.5.9 Transformation of E. coli by electroporation  
For each reaction ȝO RI GLDO\VHG '1$ VROXWLRQ (as highly concentrated as 
possible) was added to a pre chilled electroporation cuvette (0.1-FPJDSȝO
of 1RYD;* =DSSHUV (OHFWURFRPSHWHQW FHOOV were added to the 
electroporation cuvette without introducing bubbles. Cells were electroporated 
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at 1.8 kV. Within 10 seconds of the pulVHȝl of room temperature Terrific 
broth medium was added to the cuvette, then transferred to a 5ml universal and 
incubated at 37°C with shaking at 225±250 rpm for 60 min prior to plating. 100 
ȝORIFHOOVZHUHSODWHGGLUHFWO\RQWR/%DJDUSODWHVFRQWDLQLQJ the appropriate 
antibiotics DQGLQFXEDWHGDWÛ&RYHUQLJKWAntibiotic resistant colonies were 
isolated and grown in 5ml of LB supplemented with the appropriate antibiotics, 
at 37qC with shaking at 200 rpm overnight. 
 
2.6 Isolation and Analysis of RNA 
2.6.1 Preparation of RNA from bacterial cultures and AGS 
cell co-culture 
Broth culture and tissue culture samples were grown as described in sections 
2.4.5 and 2.4.7. The RNA Mini kit is optimized to extract RNA from no more 
than 2.5x108 cells. 1ml of H. pylori culture of an OD600 of 1 contains 
approximately 1x109 cells. Thus the volume of culture containing 2.5x108 cells 
was calculated and 2 x volumes of RNA protect Bacteria Reagent (Qiagen, 
UK) were added to this volume of culture, then vortexed for 5 seconds. The 
stabilized broth culture was left to incubate at room temperature for 5 minutes 
then centrifuged at 5000g for 10 minutes. The supernatant was then decanted 
and any residual supernatant was removed by gently dabbing the inverted tube 
onto a paper towel. Cell pellets were stored at ± Û&WRPLQLPLVHGHJUDGDWLRQ
of RNA. Total RNA was prepared using the RNeasy® Mini Kit (QIAGEN, 
8.7R O\VH WKHFHOOVȝORI4LDJHQSURWHLQDVH.PJPOZDVDGGHG WR
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ȝO '3(& WUHDWHG 7( EXIIHU FRQWDLQLQJ PJPO O\VR]\PH This mixture 
was then added to the pellet and vortexed for 10 seconds and incubated for 10 
minutes, vortexing for 10 seconds every 2 minutes during incubation. The 
VXEVHTXHQW 51$ H[WUDFWLRQ ZDV SHUIRUPHG DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
protocol. RNA was elXWHGLQȝORI51DVH-free water was added directly to 
the spin column membrane, and centrifuged for 1 min at 10000 rpm to elute the 
RNA. This elution step was repeated with the original eluate to obtain a higher 
final concentration of RNA. The resulting RNA samples were stored at -Û&
in order to minimise RNA degradation. The resulting RNA samples were 
stored at -Û&WRPLQLPLVH51$GHJUDGDWLRQ 
 
2.6.2 Preparation of RNA from gastric biopsies 
At endoscopy, gastric biopsies for RNA extraction were transferred 
LPPHGLDWHO\ WR ȝO RI 51$ ODWHU VWDELOL]DWLRQ UHDJHQW Qiagen, UK) and 
stored at -Û& DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V UHFRPPHQGHG SURWRFRO
%LRSVLHV WKDW KDG EHHQ EULHIO\ WKDZHG RQ LFH ZHUH WUDQVIHUUHG WR ȝO RI
%XIIHU5/7DQGȕ-mercaptoethanol (Qiagen, UK), and homogenized for 20-40 
seconds using a T8 ultra Turrax rotor-stator homogeniser (IKA, Werke & Co., 
Freiburg, Germany). The homogenized samples were added to QIAshredder 
columns (Qiagen, UK)  and centrifuged for 2 minutes at maximum speed. The 
lysate was spun for 3 minutes at full speed, and the supernatant transferred to a 
new microfuge tube. Total RNA was prepared using the RNeasy® Mini Kit 
4LDJHQ8.DFFRUGLQJWKHPDQXIDFWXUHUVSURWRFRO51$ZDVHOXWHGLQȝO
of RNase-free water was added directly to the spin column membrane, and 
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centrifuged for 1 min at 10000 rpm to elute the RNA. This elution step was 
repeated with the original eluate to obtain a higher final concentration of RNA. 
The resulting RNA samples were stored at -Û& LQ RUGHU Wo minimise RNA 
degradation. 
 
2.6.3 Quantitation of total RNA 
Once the total RNA was extracted from the biopsy and the broth culture 
samples, the yield of total RNA obtained was assessed using the Nanodrop 
spectrophotometer (Nanodrop ND-1000, Nanodrop Technologies Inc., 
Wilmington, USA). The concentration of total RNA (exSUHVVHGDVQJȝODQG
both the 260:280 and 260:230 ratios were measured and recorded.  
 
2.6.4 DNA-free treatment of RNA 
ȝORI['1DVH,EXIIHU$PELRQ/WGDQGȝOU'1DVH,$PELRQ/WGZDV
DGGHGWRWKH51$ZKLFKZDVDGMXVWHGWRDFRQFHQWUDWLRQRIQJȝO in the 
total DNA-IUHHUHDFWLRQPL[ZLWK51DVHIUHHZDWHUDQGLQFXEDWHGDWÛ&IRU
PLQXWHVȝORIWKHUHVXVSHQGHG'1DVH,QDFWLYDWLRQ5HDJHQW$PELRQ/WG
was then added, mixed well, and incubated at room temperature for 2 minutes 
vortexing the mixture 3 times during the incubation period to redisperse the 
DNase Inactivation Reagent. The mixture was then centrifuged at 10,000 x g 
for 1.5 minutes to pellet the DNase Inactivation Reagent. The supernatant 
containing the DNA-free treated RNA was transferred to a fresh tube and 
stored at -Û& 
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2.6.5 cDNA synthesis 
RNA was transcribed using a QIAGEN Omniscriptreverse transcriptase kit. 
5HDFWLRQVZHUHFDUULHGRXWLQDWRWDOYROXPHRIȝOFRQVLVWLQJRIȝO%XIIHU
57 ȝO RI G173 PL[ ȝO RI SG16 ¶-Phosphate, Sodium salt random 
KH[DPHU SULPHU $PHUVKDP 8. ȝO RI 51DVH LQKLELWRU 8ȝ ȝO RI
ZDWHU ȝO RI 2PQLVFULSW UHYHUVH WUDQVFULSWDVH DQG ȝO RI 51$ DW D
FRQFHQWUDWLRQRIQJȝO5HYHUVH WUDQVFULSWLRQZDVSHUIRUPHGDWÛ& IRU
hour. Negative controls for each RNA sample were prepared in the same 
manner but excluded reverse transcriptase. 
 
2.6.6 Quantitative real-time PCR 
Primers were specific to H. pylori and checked using a Basic Local Alignment 
Search Tool (BLAST) search (www.ncbi.nlm.nih.gov/BLAST/) and can be 
found in Table 2.7. Any predicted secondary structures and dimer formation of 
WKH SULPHUV ZHUH DVVHVVHG XVLQJ SUHPLHU ELRVRIW¶V 1HWSULPHU DOJRULWKP
(http://www.premierbiosoft.com/netprimer/index.html). Real time PCR was 
performed using the Rotor-Gene 3000 real-time PCR system (Corbett 
Research, Australia), using the QuantiWHFW6<%5*UHHQ3&5NLW4,$*(1, 
UK). Amplification was carried out in a reDFWLRQYROXPHRIȝODQGZDVVHW
XS DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V UHFRPPHQGDWLRQV XVLQJ ȝO RI WHPSODWH
F'1$GLOXWHGWRQJȝOIRUELRSV\VDPSOHVHFWLRQDQG QJȝOIRU
broth culture samples (section 2.6.1). Cycling conditions are outlined below in 
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Table 2.8. No template controls (NTCs) were included in each run, and melt 
curve analyses were performed to ensure primer specificity and the absence of 
contamination. Negative cDNA samples, produced in the absence of reverse 
transcriptase from each RNA sample were tested in parallel to ensure that 
products were not amplified from contaminating genomic DNA. Samples were 
run in triplicate and the results were analysed using the Pfaffl method of 
analysis (Pfaffl, 2001). Efficiencies of each PCR were calculated by serial 
dilution as described in the appropriate results chapters.  
Table 2.7 Real-time PCR primers 
Primer Name WƌŝŵĞƌ^ĞƋƵĞŶĐĞ ? ?ƚŽ ? ? Reference 
C1226 CTGCTTGAATGCGCCAAAC Cover et al 1994 
A3436 ATGGAAATACAACAAACACAC Cover et al 1994 
16s rRNA F CGATGAAGCTTCTAGCTTGC Narayanan 2005 
16s rRNA R ATAGGACATAGGCTGATCTC Narayanan 2005 
 
Table 2.8 Real-time PCR conditions 
Step Number of cycles Temperature Length of time 
1. 1  ? ?ȗ 2 min 
2. 1  ? ?ȗ 15 min 
 
3. Cycling 
 
 
35 
 ? ?ȗ 30 sec 
 ? ?ȗ 60 sec 
 ? ?ȗ 30 sec 
 ? ?ȗ 15 sec 
 ? ?ȗ 20 sec 
4. Melt 1  ? ?ȗƚŽ ? ?ȗƌŝƐŝŶŐ
ďǇ ?ȗĞĂĐŚƐƚĞƉ 
Wait for 45 sec on 1
st
 
step, then wait for 5 
seconds for each step 
afterwards 
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2.7 Isolation and Analysis of Protein 
2.7.1 Separation of secreted proteins by centrifugation 
ȝO VDPSOHV RI K EURWK FXOWXUHs were centrifuged at 13000 rpm for 1 
minute. The resulting supernatant was removed and transferred to a fresh 
eppendorf tube. The pellet and supernatant were stored at -Û&.  
 
2.7.2 Preparation of cellular proteins 
Cell pellets were corrected for OD600 by resuspending in variable volumes of 
1x SDS-sample loading buffer (50mM Tris-Cl, 100mM DTT, 2% SDS, 0.1% 
bromophenol blue, 10% glycerol). The pellets were then sonicated on ice with 
one, 10 second blast at an amplitude of 15 microns. 
 
2.7.3 SDS-PAGE analyses of H. pylori proteins 
Samples were boiled for 5min in 1x SDS-sample loading buffer (50mM Tris-
Cl, 100mM DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol) and 
centrifuged for 3 min at 13000 rpm prior to loading. Sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) gels were cast in Mini-
protein casting trays (BioRad, USA) and comprised of a 9% polyacrylamide 
resolving  gel ( For 1 gel: 1.25ml separating buffer ( 1.5 M Tris-HCl pH 8.8, 
0.4% (w/v) SDS), 1.5ml 30% Bis-acrylamide solution (37.5:1) (Geneflow, 
8. PO ZDWHU ȝO $36 10% (w/v) 6,*0$ 86$ ȝO 7(0('
(SIGMA, USA)) and a 3% stacking gel ( For 1 gel: 1ml stacking gel buffer ( 
0.5 M Tris-HCl pH 6.8, 0.4% (w/v) SDS), ȝO DFU\ODPLGH VROXWLRQ 
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ZY  ZY $36 ȝO 7(0(' and water ȝO RI HDFK VDPSOH ZDV
loaded per well, in addition to ȝO RI 6HH%OXH 3OXV SUHVWDLQed standard 
marker (Invitrogen). Proteins were separated at 20mA through the stacking gel 
and 40mA through the resolving gel in SDS-PAGE electrode buffer (5x stock: 
0.125M Tris, 0.95M glycine, 0.4% SDS, pH 8.3). 
 
2.7.4 Coomassie blue staining 
Gels were stained with Coomassie Brilliant Blue solution (0.1% (w/v) 
Coomassie brilliant blue (BIO-RAD, USA), 45% (v/v) methanol, 9% (v/v) 
glacial acetic acid) for 1 hour and destained with 20% (v/v) methanol and 7% 
(v/v) glacial acetic acid overnight or until the protein bands were clearly 
visible. Gels were dried using DryEase Mini Gel Drying System (Novex, 
USA) and Gel-Dry drying solution (Invitrogen, USA).  
 
2.7.5 Western blotting 
Proteins separated by SDS-PAGE as described above were transferred to 
BioTrace®NT Pure nitrocellulose blotting membrane (pre-soaked in transfer 
buffer - 10mM Tris, 100mM glycine, 20% (v/v) methanol), using western 
blotting transfer apparatus (BIO-RAD, USA). The transfer was performed at 
100mA for 90 minutes.  After transfer, the nitrocellulose membrane was 
removed, and blocked in PBST-milk (PBS (Oxoid, UK), 0.5% (v/v) Tween-20 
(Sigma, UK), and 5% skimmed milk powder (Oxoid, UK)) overnight, with 
JHQWOHVKDNLQJDWÛ&7KH3%67-milk was then discarded and the membrane 
was incubated in PBST-milk with primary antibody (rabbit polyclonal anti- 
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VacA p58 diluted to1:10,000) for 1 hour, shaking at room temperature. The 
membrane was washed 3 x 5 minutes in PBST (PBS containing 0.5% (v/v) 
Tween-20), shaking at room temperature. The membrane was incubated in a 
secondary antibody solution of goat anti-rabbit IgG peroxidise conjugate 
(Sigma, UK) in PBST (1:20,000) for 1 hour, shaking at room temperature. The 
secondary antibody solution was discarded and the membrane was washed in 
PBST as follows: 3x 5 min, 2x 15 min, 3x 5min. The blot was developed using 
the ECL detection system (Amersham Pharmacia Biotech, UK) according to 
WKHPDQXIDFWXUHU¶VUHFRPPHQGDWLRQVDQGYLVXDOLVHGE\H[SRVXUHWR;-ray film 
(HyperfilmTM, Amersham, UK).  
 
2.7.6 Quantitation of immunoreactive protein concentrations 
Protein levels detected on the western blots were quantified using a GS800 
densitometer (BioRad, USA) using the comparative Quantity One densitometry 
software (BioRad, USA). Immunoreactive bands were selected and the peak 
density measured within each band. In order to account for the background 
level of the blot the rolling disk option was selected. 
 
2.7.7 N-terminal protein sequencing 
Proteins were separated by SDS-PAGE as described above. The gel was then 
soaked in [cyclohexylamino]±1propanesulphonic acid buffer (CAPS) for 20 
minutes with shaking at room temperature. PVDF membrane (Amersham 
biosciences) was activated in 100% methanol for 10 seconds, washed in 
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distilled water for 5 minutes and equilibrated in CAPS buffer for 10 minutes. 
Proteins were transferred to the PVDF membrane for 1 hour at 100V with 
cooling using western blotting transfer apparatus (BIO-RAD, USA). All 
blotting equipment was washed thoroughly to remove all traces of glycine prior 
to the transfer. After transfer, the membrane was removed, rinsed with dH2O 
and stained with Coomassie blue, then destained, washed, air dried and sent to 
Alta Biosciences, Edgbaston, UK for N-terminal sequencing.  
 
2.7.8 VacA enzyme linked immuno-sorbent assay (ELISA) 
Equal volumes of supernatant samples were added to 2x carbonate buffer 
(100mM Na2CO3, 100mM NaHCO3, pH 9.8). ȝO aliquots were dispensed 
into 96 well micro-titre plate (Nunc-IPPXQR 0RGXOHV 1XQF 'HQPDUN
which were LQFXEDWHGDWÛ&RYHUQLJKW WRDOORZ WR[LQ WRELQG7KHFDUERQDWH
EXIIHUZDVUHPRYHGDQGHDFKZHOOZDVEORFNHGZLWKȝO3%67-BSA (PBS 
with 0.1% (v/v) Tween-20, 3% (w/v) BSA (SIGMA, USA)). Plates were 
LQFXEDWHGDWÛ&IRUKRXU7KHZHOOVZHUHWKHQZDVKHGWLPHVZLWKȝO
PBST (PBS with 0.1% (v/v) Tween-ȝORISULPDU\DQWLERG\LQ3%67-
0.1% BSA (1:5000) was added to each wHOODQGLQFXEDWHGDWÛ&IRUKRXU
The polyclonal primary antibody used was anti-VacA p58, as used for the 
ZHVWHUQEORWV7KHZHOOVZHUHZDVKHGWLPHVLQ3%67ȝORIWKHVHFRQGDU\
antibody solution (goat anti-rabbit IgG, peroxidise conjugate secondary 
antibody (Sigma, UK) in PBST-0.1% BSA (1:1000).) was added to each well 
DQG WKHSODWH LQFXEDWHGDWÛ& IRUKRXU7KHSODWHZDVZDVKHG WLPHV LQ
3%67 ȝO RI IUHVKO\ SUHSDUHG 6LJPD )DVW 23' GHYHORSHU 6LJPD 86$
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was added to each well and incubateGIRUPLQXWHVLQWKHGDUNȝORI0
H2SO4 was added to stop the reaction. Dual optical densities for each well were 
determined immediately using a microplate reader (Labsystems MF) set to 
492nm and 540nm. Readings at 540nm were subtracted from the 492nm 
readings to correct for optical imperfections in the plate.  
 
2.8 Histopathology 
Two antral and two corpal biopsies samples were taken from each patient and 
immediately fixed in 6 ± 10% formalin in 0.9% NaCl (provided by 
histopathology). The biopsies were embedded in SDUDIILQ ZD[ DQG ȝ0
sections cut for histological slide preparation. Slides were stained with 
Hematoxylin and eosin (H&E) for quantitative assessment of inflammatory 
cells and Giemsa for H. pylori quantification. All preparation work was carried 
out by technicians within the Division of Histopathology, University Hospital, 
Nottingham. The histopathological parameters were assessed using the Sydney 
scoring system, (Dixon et al., 1996) a visual analogue scale. Biopsies were 
evaluated for the presence, number and distribution of mononuclear cells 
(lymphocytes and plasma cells) (chronic inflammation), the density of H. 
pylori colonization, the presence number and distribution of neutrophils and 
eosinophils (neutrophilic activity). Glandular atrophy was recorded when the 
gastric glands were atrophic and reduced in number and the mucosa thinned. 
Intestinal metaplasia was recorded when gastric epithelium appeared to have an 
intestinal pattern or goblet cells were detected. The criteria for normal gastric 
histology were: no cells to a few mononuclear cells per high-power field (HPF; 
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400x magnification) and none to occasional scattered neutrophils and 
eosinophils without tissue changes which include loss of glandular tissue and 
the presence of metaplastic epithelium. Sparse lymphocyte aggregates without 
an increase in inflammatory cells were considered normal. The Sydney system 
measures chronic inflammation, polymorphonuclear activity, glandular 
atrophy, intestinal metaplasia and H. pylori colonisation density on a scale 
ranging from 0 ± normal, to 1 ± mild, 2 ± moderate, and 3 ± severe; evaluating 
one feature at a time. In cases where intensity varied considerably within the 
same biopsy sample the different areas were averaged and the specimen scored 
accordingly. (See figure 3.5 for a schematic visual analogue scale for 
evaluating and scoring histopathological parameters and figure 3.6 to 3.16. for 
photographic examples (photographs prepared by Dr Abed Zaitoun)). Other 
parameters such as presence of lymphoid follicles, loss of mucus layer, 
follicular hyperplasia and whether H. pylori colonisation was predominantly on 
the surface of epithelial cells or in the lumen were also noted. Scoring was 
blinded to vacA mRNA and strain typing results and was carried out 
simultaneously by me, Sapna Patel and Dr Abed Zaitoun (Division of 
Histopathology, University Hospital, Nottingham). Two sections from 2 
corporal biopsies were examined and a score was given when all parties were 
in agreement. 
 
2.9 Statistical analysis 
Statistical analyses were carried out using MINITAB Release 14 and Microsoft 
Excel. In all cases, a significant difference or correlation was taken at P 
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Specific statistical analyses are described in more detail in each of the results 
chapters where appropriate. 
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Chapter 3 
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3 Investigation into associations between levels 
of vacA transcription in vivo and disease.  
3.1 Introduction 
H. pylori infection is a known risk factor for distal adenocarcinoma which is 
known to be induced by chronic gastric inflammation. Two histologically 
distinct types of gastric adenocarcinoma exist (Lauren, 1965): the diffuse type 
which is preceded by gastritis throughout the stomach but not necessarily with 
gastric atrophy, and the intestinal type which is preceded by a corporal 
predominant gastritis with gastric atrophy and intestinal metaplasia (Reviewed 
in (Atherton et al., 1997). The intestinal type of adenocarcinoma progresses 
through a cascade of histological steps which are initiated by chronic 
superficial gastritis leading to atrophic gastritis and intestinal metaplasia 
followed by dysplasia and gastric adenocarcinoma (Sipponen and Correa, 
2002, Correa, 1996). Although almost all individuals infected with H. pylori 
develop gastritis only a small minority go on to develop gastric cancer. Several 
other risk factors are important in determining disease outcome, including host 
genetics, inflammatory response; environmental factors such as diet and 
smoking and bacterial strain specific virulence factors.  
 
An important H. pylori virulence factor linked with gastric cancer is the 
vacuolating cytotoxin. The gene vacA that encodes the vacuolating cytotoxin is 
present in all H. pylori strains, but an active toxin is not produced in all cases 
(Cover et al., 1994). The vacA gene is generally well conserved but there is 
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significant allelic diversity in three regions of the gene: the signal region (s), 
the mid region (m) and the intermediate region (i). Characterisation of these 
regions has revealed that different specific forms of these regions exist 
(Atherton et al., 1995, van Doorn et al., 1998). This allelic diversity has 
allowed strains to be genotypically differentiated. 
 
The signal region can be one of two main types; s1 or s2. Among the type s1 
strain subtypes, s1a, s1b and s1c have been identified (although type s1c is 
restricted to Asia). Type s2 VacA is cleaved at a different site in the signal 
peptide sequence to type s1 resulting in a form of VacA which has a 12 amino 
acid hydrophilic N-terminal extension whereas mature type s1 VacA has a 
hydrophobic N-terminus (Atherton et al., 1995, Letley and Atherton, 2000).  
This 12 residue extension to VacA has been shown to be responsible for the 
loss of vacuolation induction by s2 strains (Letley et al., 2003, Letley and 
Atherton, 2000, McClain et al., 2001). 
 
Within the vacA mid region, two main types (m1 and m2) have been identified 
(Atherton et al., 1995). The mid region has been shown to be associated with 
cell specificity (Atherton et al., 1995, Pagliaccia et al., 1998, Letley et al., 
2003, Ji et al., 2000). m1 forms of VacA vacuolate a variety of cell types but 
m2 forms are more limited in the cells they vacuolate (e.g. RK13 and primary 
gastric cells.). Natural mosiacism occurs so that all combinations of signal and 
mid region types exist (Atherton et al., 1995). However strains with the vacA 
type s2/m1 are rarely found (Letley et al., 1999).  
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The recently identified intermediate region can also be divided into two types 
(i1 and i2) (Rhead et al., 2007). This region is located between the signal and 
mid regions of vacA. Rhead et al (2007) observed that vacA s1/m1 type strains 
were nearly always type-i1 and that type s2/m2 strains were always type-i2. 
The s1/m2 strains varied in their intermediate region type however: strains that 
were s1/i1/m2 showed vacuolating activity whereas type s1/i2/m2 strains were 
non-vacuolating. Using site directed mutagenesis they confirmed that i region 
type determines vacuolating activity in s1/m2 strains and that the i region 
influenced cell specificity in s1/m1 strains. Thus, the i region may be involved 
in cytotoxin binding (Rhead et al., 2007).  
 
The particular vacA genotype of an infecting strain determines toxin production 
(Israel et al., 2001), and is a marker for the pathogenicity of an individual 
strain (Atherton et al., 1995, Rhead et al., 2007). Several studies have 
investigated the association of vacA type with disease outcome. In Western 
populations such as the USA and Western Europe, where vacA allelic diversity 
is common, vacA s1 genotypes are more frequently associated with higher 
levels of inflammation in the gastric mucosa than s2 types (Atherton et al., 
1995, Atherton et al., 1997, Evans et al., 1998, Kidd et al., 1999, van Doorn et 
al., 1998). vacA s1/m1 and s1/m2 strains have been shown to be associated 
with peptic ulceration and s1/m1 type strains have been associated with gastric 
carcinoma (Atherton et al., 1995, Atherton et al., 1997, Rhead et al., 2007, 
Basso et al., 2008). Corpus neutrophil infiltration was found to be more severe 
in patients infected with an m1 type strain than those infected with an m2 type 
strain (Umit et al., 2009). The vacA i1 type is a risk factor for peptic ulcer 
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disease and has been shown to be associated with duodenal ulcer disease as 
well as gastric cancer (Basso et al., 2008, Rhead et al., 2007). Importantly 
Rhead et al. 2007 found that although vacA s1, i1 and m1 alleles, along with 
cagA positive status were all associated with gastric adenocarcinoma in an 
Iranian population, the association was greatest with i1-type strains. 
Furthermore, only i region status was independent of all other alleles studied. 
They concluded that the vacA i region is the best independent marker of 
toxicity and pathogenicity of a strain, and that i region type may be sufficient 
for identifying all pathogenic forms of vacA (Rhead et al., 2007).  
 
In East Asian and Southeast Asian countries, the association between vacA 
allelic diversity and clinical outcome is not well established as the vacA allelic 
type is quite homogeneous, with the majority of the population being infected 
with type s1/i1 strains (Maeda et al., 1998, Yamaoaka et al., 1998). However, 
it is possible that a high prevalence of the more virulent vacA s1/i1 type strains 
may contribute to the high incidence of gastric cancer in this region of the 
world (Rhead et al., 2007). However, not all individuals infected with more 
virulent strains go on to develop disease. 
 
Heterogeneity in vacA transcription between strains is known to exist (Forsyth 
et al., 1998). In addition to differences in toxicity, production of the 
vacuolating cytotoxin is related to the mosaic structure of vacA, with type 
s1/m1 and s1/m2 strains producing on average higher levels of toxin than 
s2/m2 strains (Forsyth et al., 1998). VacA amount as well as the type and 
activity is thought to have important implications for disease; large amounts of 
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purified VacA induce ulcer-like erosions in mice, and VacA increases gastric 
ulcer formation in experimentally infected gerbils (Ghiara et al., 1995, Ogura 
et al., 2000). Orally administered toxigenic H. pylori sonicates and purified 
VacA also induce epithelial vacuolation, loss of gastric gland architecture 
(Ghiara et al., 1995, Telford et al., 1994a, Supajatura et al., 2002) and 
infiltration of mononuclear cells into the lamina propria (Telford et al., 1994, 
Supajatura et al., 2002). Furthermore, a small study carried out by G. L. 
Narayanan (2005) showed that there was an association between the 
occurrence of ulcers or erosions in the patient and a high level of vacA 
transcript produced by an infecting strain in vivo.  Heterogeneity in vacA 
transcription levels between H. pylori strains may be a factor that contributes to 
different vacuolating cytotoxin phenotypes. 
3.1.1 Aims 
The aims of this study were to:  
x Determine the level of vacA transcript produced per H. pylori cell in 
corporal gastric biopsies taken from H. pylori infected patients. 
x Assess the association between the level of vacA expression of an 
infecting strain in vivo and the level of chronic inflammation, 
neutrophilic activity, the level of H. pylori density and the presence of 
glandular atrophy, and intestinal metaplasia in the infected patient.  
x To determine whether the vacA transcript level of an infecting strain in 
vivo could explain the imperfect correlation between vacA type and 
disease.  
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3.2 Results 
3.2.1 Quantitative real-time PCR showed large differences in 
vacA transcription between strains 
Gastric biopsy samples were taken from 39 consenting H. pylori positive 
patients (determined by both culture and CLO test). Two gastric biopsies were 
taken from the corpus during routine upper GI endoscopy under informed 
consent. One of which was immediately placed in RNAlaterTM (QIAGEN) in 
the clinic to provide a snapshot of the mRNA present with limited interference 
IURPKDQGOLQJWKHQVWRUHGDFFRUGLQJWKHPDQXIDFWXUHU¶V LQVWUXFWLRQVDW -Û&
The other biopsy was stored in 200µl of sterile Iso-Sensitest broth (Oxoid, UK) 
with 15% (v/v) sterile glycerol for H. pylori culture. Additional corporal 
biopsies were taken for histological examination and were fixed in 10% 
buffered formalin solution. Patients were normally referred for endoscopy to 
investigate symptoms such as dyspepsia and chronic indigestion but were 
otherwise healthy. Disease severity and other observations from the endoscopy 
ZHUH QRWHG DORQJVLGH WKH SDWLHQWV¶ V\PSWRPV Samples were not taken from 
patients who had taken antibiotics or proton pump inhibitors two weeks prior to 
the endoscopy. Patients ranged in age from 29 to 81 years, 51% were male and 
49% were female. The male and female groups had median ages of 49 years 
and 62 years respectively.  
 
In order to quantify the amount of vacA transcript present per H. pylori cell, in 
corporal gastric biopsies, RNA was extracted from the gastric biopsies as 
described in section 2.6.2. The quality of the purified RNA is critical for 
accurate mRNA quantification by real-time PCR. Total RNA was quantified 
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using the Nanodrop to check for protein and organic contamination samples; 
260/280 and 260/230 ratios of less than 1.8 were not used for subsequent 
analysis. RNA samples were then adjusted to 33.3ng/µl to adjust for biopsy 
size and any DNA contamination was removed using a DNAfree kit (Ambion) 
as described in section 2.6.4. cDNA was synthesised using 1µg of total RNA 
using the Omniscript RT kit (Qiagen, UK) as described in section 2.6.5 which 
included an RNase inhibitor, as RNases carried over from the RNA isolation 
process can affect the apparent reverse transcription efficiency (Freeman et al., 
1999, Schwabe et al., 2000)$³PLQXV UHYHUVH WUDQVFULSWDVH´PL[FRQWDLQLQJ
the cDNA master mix and RNA sample without reverse transcriptase was also 
produced for each sample to confirm the absence of residual DNA in the RNA 
samples. A cDNA water blank was also produced which contained the cDNA 
master mix and water to confirm the absence of contamination in the master 
mix.  
 
Quantitative real-time PCR was performed on the Rotorgene 3000 using the 
methodology outlined in section 2.6.6 using the cycling conditions detailed in 
table 2.8. The specificity of the primers was checked using a BLAST search. 
The results show that the primers are specific to the genes of interest and would 
not amplify product from any other species residing in the gastric mucosa. 
Primers were chosen for their lack of predicted secondary structure and dimer 
formation. Predictions were carried out using Netprimer (Premier Biosoft) 
http://www.premierbiosoft.com/netprimer/index.html. 
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Differences in vacA mRNA levels between patients were assessed using 
relative quantitation which determines differences in mRNA levels across 
multiple samples and expresses it relative to that of a control sample which is 
included on every run. The level of expression of a gene is based on the distinct 
cycle that the fluorescence of a sample crosses a threshold level of fluorescence 
which is selected by the user at a level where amplification is exponential. For 
accuracy the threshold needs to be set as low as possible and needs to be the 
same on each real-time run. In this study the threshold was set at 0.01. 
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Figure 3.1Amplification plots produced by real-time PCR machines (diagram adapted 
from original in Narayanan 2005). The above diagram represents a typical example of an 
amplification plot produced as a result of a quantitative real-time PCR reaction. The 
graph shows that sample A has a higher concentration of starting template than sample 
B, as the level of fluorescence for this sample is detected after fewer cycles than sample B.  
The early part of the curves are represented by the baseline which represents noise at the 
start of the PCR.  There is no detectable increase in PCR products emitting fluorescence.  
The threshold is adjusted by the user and represents the amount of expression above 
which a sample is deemed to have reacted. When setting a threshold manually, it is set in 
the exponential phase of the experiment, significantly above the background level to 
avoid noise. The cycle threshold (CT) represents the cycle number at which an increase in 
fluorescence is crosses the threshold which is set at the lowest level of fluorescence when 
the amplification of the sample is exponential.  For ease of comparison the threshold was 
set to 0.01 in the experiments presented here.   
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The Pfaffl method of analysis was used which calculates the expression of a 
target in this case vacA based on the difference in CT value of the test sample 
(biopsy) versus the control sample (biopsy 173B) and takes into account the 
amplification efficiency of the gene of interest in a particular sample type. This 
is then adjusted to the level of expression of a housekeeping gene; in this study 
16S rRNA was used. 
 
To determine the amplification efficiency of both vacA and 16S rRNA, a 
sample of control cDNA was serially diluted (in triplicate) to produce a 
standard curve. The amplification efficiencies were calculated from the slopes 
of the standard curve according to the equation E = . The 
amplification efficiencies for vacA and 16S rRNA were 1.91 and 1.57, 
respectively, with R2 values of 0.98 and 0.99, respectively. 
 
The optimised real-time PCR was performed in triplicate for each biopsy 
tested. The mean CT value was used to calculate the relative expression. In this 
study, biopsy cDNA taken from patient 173B was used as the control and 
included in triplicate in each real-time PCR run to control for inter-
experimental variations. The level of vacA mRNA in a biopsy was expressed 
relative to sample 173B the vacA mRNA level in this sample was taken to be 
100. Blanks containing the real-time PCR master mix for both the vacA and 
16S rRNA. Primers were tested on each run to confirm the absence of 
contamination in the master mix. Melt curves for all samples tested, including 
the cDNA negative and blanks were checked on every run to confirm the 
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absence of contamination (see Figure 3.3). Melt curves are used to determine 
the melting temperature of the product at the end of the amplification reactions. 
The temperature is raised by a fraction of a degree and the change in 
fluorescence is measured. When the product reaches its melting temperature 
the two strands of DNA separate and the fluorescence rapidly decreases. The 
Rotorgene software plots the rate of change of the relative fluorescence units 
(RFU) with time (T) (d-(RFU)/dT) on the Y axis against the temperature on the 
x axis, which peaks at the melting temperature. All products for a particular 
primer pair should have similar melting temperatures unless there are 
contamination, mispriming or primer-dimer artefacts.     
  
3-101 
 
 
A 
 
B
 
Figure 3.2 Standard curve and amplification efficiency of  vacA (A) and 16S (B).  To 
determine the amplification efficiencies of 16S and vacA using templates extracted from 
gastric biopsies, a sample of control cDNA 173B was serially diluted to produce a 
standard curve. The amplification efficiencies were calculated from the slopes of the 
standard curve according to the equation E = . The amplification efficiencies 
for vacA and 16S rRNA were 1.91 and 1.57 respectively, with R2 values of 0.979 and 
0.994 respectively. 
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Figure 3.3 Melt curves of 16S and vacA PCR products synthesised from template 
extracted from a H. pylori positive biopsy (A) and a H. pylori negative biopsy (B). The 
melt curve shows the rate of change of relative fluorescence units (RFU) with time (T) (d-
(RFU)/dT) on the y axis against the temperature on the x axis. The melt curves are 
performed at the end of the amplification reactions to determine the melting temperature 
of the PCR product. The single peak in each melt curve in figure 3.3 (A) indicates that 
only one product is present for each primer pair. The lack of peak in the RT ± reactions 
also indicates that no contamination or primer dimer artefacts were present. The lack of 
peak in both the positive and negative RT reactions for primer pairs for 16S and vacA 
indicated that amplification of non-specific temples did not occur. It also indicates that no 
contamination or primer dimer artefacts were present. 
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The results show that there is a 468 fold difference in detectable vacA mRNA 
levels produced by a strain in the biopsy. The results indicate that there is a 
large variation in vacA expression amongst strains. 
 
vacA transcript was not detectable in some of the biopsies tested. To determine 
the limit of detection of vacA mRNA using the real-time qPCR, cDNA 
synthesised from sample 173B that was used as a control on every run was 
serially diluted. The lowest relative detectable level of vacA was calculated 
using the formula: vacA efficiency ǻ&T (CT 173B neat - CT 173B diluted). Where CT 173B 
neat is the CT value of the undiluted control cDNA and CT 173B diluted is the 
CT value of the lowest dilution of the control cDNA that could be detected 
when the threshold was set at 0.01. The amplification efficiency of vacA in the 
biopsy cDNA was determined using the vacA standard curve (see Figure 3.2) 
and was found to be 1.91. The lowest detectable level of vacA was 0.18, which 
is 8.2 times lower than that of sample 223 which had the lowest detectable 
level of vacA in this study. Samples that had no detectable level of vacA 
transcript were considered to be non transcribers in vivo and were given a value 
of zero (see Table 3.1).  
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Strain vacA per 16SrRNA Titre vacA Type cagA Status 
326 46.80 s1/m2/i2 Negative 
335 35.29 s1/m1/i1 Positive 
194 30.22 s1/m2/i1 Negative 
187 24.65 s1/m1/i1 Positive 
242 21.67 s2/m2/i2 Negative 
215 9.18 s1/m1/i1 Positive 
126 7.92 s1/m2/i1 Positive 
271 7.86 s1/m1/i1 Negative 
206 6.01 s1/m1/i1 Positive 
322 5.16 s1/m1/i1 Positive 
255 5.11 s1/m1/i1 Positive 
247 4.14 s1/m1/i1 Positive 
249 3.84 s1/m2/i1/i2 Positive 
274 3.34 s1/m1/i1 Positive 
265 3.26 s1/m2/i2 Positive 
350 3.21 s1/m2/i1 Positive 
256 1.90 s2/m2/i2 Positive 
320 1.82 s1/m2/i2 Negative 
253 1.52 s1/m1/i1 Positive 
240 0.93 s1/m1/i1 Positive 
223 0.10 s2/m2/i2 Negative 
83  0 s1/m1/i1 Positive 
233  0 s2/m2/i2 Positive 
73  0 s1/m2/i2 Positive 
121  0 s1/m1/i1 Positive 
218  0 s1/m1/i1 Positive 
192  0 s1/m1/i1 Positive 
201  0 s1/m1/i1 Positive 
221  0 s1/m2/i2 Negative 
124  0 s1/m1/i1 Positive 
181  0 s1/m1/m2/i2 Negative 
86  0 s1/m1/i1 Positive 
45  0 s1/m1/i1 Positive 
72  0 s1/m1/i1 Positive 
182  0 s1/m1/i1 Negative 
122  0 s1/m1/i2 Positive 
46  0 s1/m1/i1 Negative 
77  0 s1/m1/i1 Positive 
120  0 s1/m1/i1 Positive 
Table 3.1 Details of strain genotypes and transcript levels within the gastric biopsies. 
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3.2.2 vacA and cagA genotyping of the infecting strains 
To determine whether the vacA type and cagA status of the infecting strains 
were associated with the disease status of patients, all strains were vacA and 
cagA typed. To do this; strains were isolated and cultured from the second 
corporal biopsies as detailed in section 2.4.4 Genomic DNA was extracted 
from H. pylori strains using the methodology detailed in section 2.5.1. The 
vacA signal region was typed using A3436 and C1226 primers (Figure 3.4). 
The vacA mid region was typed using VAGF and VAGR primers (Figure 3.4). 
The intermediate region was typed using VacF1 and C1R for i1 type strains 
(Figure 3.4) and VacF1 and C2R for i2 type strains (Figure 3.4). The cagA 
status of the infecting strain was also determined using PCR typing using Cag2 
and Cag4 primers (Figure 3.4). All typing PCRs were carried out using the 
cycling conditions detailed in section 2.5.4 and run on a 2% agarose gel. 32 
strains were typed by me; the other 7 strains were typed by Sapna Patel and 
James Hale. Examples of the vacA and cagA typing gels are shown in Figure 
3.4 and the vacA type and cagA status of all of the infecting strains are shown 
in Table 3.1. 
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Figure 3.4 shows 2% agarose gels containing PCR products from vacA and cagA typing 
PCRs. Gel (A) contains PCR products amplified using primers A3436 and C1226 which 
amplify the vacA signal region, a product of 259 bp indicates the presence of vacA of the 
s1 type whereas a product of 286 bp indicates the presence of vacA of the s2 type. Gel (B) 
contains PCR products amplified using primers VAGF and VAGR which amplify the 
vacA mid region, a product of 570 bp indicates the presence of vacA of the m1 type 
whereas a product of 645 bp indicates the presence of vacA of the m2 type. Gel (C) 
contains PCR products amplified using primers VacF1 and C1R which amplify the vacA 
intermediate region of strains that possess the i1 allelic form of this toxin, a product of 
426 bp indicates the presence of vacA of the i1 type. Gel (D) contains PCR products 
amplified using primers VacF1 and C2R which amplify the vacA intermediate region of 
strains that possess the i2 allelic form of this toxin, a product of 432 bp indicates the 
presence of vacA of the i2 type. Gel (E) contains PCR products amplified using primers 
Cag2 and Cag4 which amplify the cagA variable region. A PCR product between 500 bp 
and 750 bp is visible for strains that posses the cagA pathogenicity island.  Lane M 
contains a 1kb DNA ladder in all 5 typing gels. 
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3.2.3 Relationships between vacA mRNA level and 
histological severity 
The relationship between the vacA mRNA level of an infecting strain and the 
histological severity in the corpus of the patient was investigated. To do this, 
corporal biopsies taken from thirty nine H. pylori positive patients were fixed 
in 6 ± 10% formalin in 0.9% NaCl. The biopsies were paraffin wax-embedded, 
FXW LQWR ȝP VHFWLRQV DQG VWDLQHG ZLWK KHPDWR[\OLQ DQG HRVLQ +	( IRU
quantitative assessment of inflammatory cells, Giemsa for H. pylori 
quantification and Alcian blue for confirmation of intestinal metaplasia. All 
preparation work was carried out by technicians under the supervision of Dr 
Abed Zaitoun (Division of Histopathology, University Hospital, Nottingham). 
The histopathological parameters were assessed using the Sydney scoring 
system, (Dixon et al., 1996) a visual analogue scale. Biopsies were evaluated 
for the presence, number and distribution of mononuclear cells (lymphocytes 
and plasma cells) (Chronic inflammation), the density of H. pylori 
colonization, the presence number and distribution of neutrophils and 
eosinophils (neutrophilic activity). Glandular atrophy was recorded when the 
gastric glands were atrophic and reduced in number and the mucosa thinned. 
Intestinal metaplasia was recorded when gastric epithelium appeared to have an 
intestinal pattern or goblet cells were detected. The criteria for normal gastric 
histology were: no cells to a few mononuclear cells per high-power field (HPF; 
400 x magnification) and none to occasional scattered neutrophils and 
eosinophils without tissue changes which include loss of glandular tissue and 
the presence of metaplastic epithelium. Sparse lymphocyte aggregates without 
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an increase in inflammatory cells were considered normal. The Sydney system 
measures chronic inflammation, polymorphonuclear activity, glandular 
atrophy, intestinal metaplasia and H. pylori colonisation density on a scale 
ranging from 0 ± normal, to 1 ± mild, 2 ± moderate, and 3 ± severe; evaluating 
one feature at a time. In cases where intensity varied considerably within the 
same biopsy sample the different areas were averaged and the specimen scored 
accordingly. (See Figure 3.5 for a schematic visual analogue scale for 
evaluating and scoring histopathological parameters and figures 3.6 to 3.16 for 
photographic examples (photographs prepared by Dr Abed Zaitoun)). Other 
parameters such as presence of lymphoid follicles, loss of mucus layer, 
follicular hyperplasia and whether H. pylori colonisation was predominantly on 
the surface of epithelial cells or in the lumen were also noted. Scoring was 
blinded to vacA mRNA and strain typing results and was carried out 
simultaneously by me, Sapna Patel and Dr Abed Zaitoun (division of 
histopathology, University Hospital, Nottingham). Two sections from 2 
corporal biopsies were examined and a score was given when all parties were 
in agreement. 
 
Any correlations between the histopathological findings and vacA transcript 
level were assessed using the real-time PCR data shown in Table 3.1. The vacA 
transcript level in the gastric biopsy was normalised to the 16S rRNA level in 
the same biopsy to give vacA mRNA level per bacterial cell.  
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To control for the difference in toxicity between strain types, the analysis was 
limited to i1-type strains only, as the i1-type has been shown to be the best 
independent marker of toxicity (Rhead et al., 2007).  
 
Data were analysed with Minitab 14 software. The Mann-Whitney U test was 
used to assess the association between transcript levels and histopathological 
parameters and disease. Differences were considered statistically significant for 
P values less than or equal to 0.05.  
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Figure 3.5 Sydney scoring system, using the visual analogue scales: The observer should 
attempt to evaluate one feature at the time. The most prevalent appearance on each side 
should be matched with the graded panel that resembles it most closely. Observers should 
keep in mind that these drawings are not intended to represent realistically the 
histopathological appearance of the gastric mucosa; rather, they provide a schematic 
representation of the magnitude of each feature and, as such, have certain limitations. 
Thus, for example, the decreasing thickness of the mucosa usually observed with 
increasing atrophy is not depicted realistically. Particularly with Helicobacter pylori and 
neutrophils, there may be a considerable variation of intensity within the same biopsy 
sample; in such cases, the observer should attempt to average the different areas and 
score the specimen accordingly (taken from (Dixon et al., 1996)). 
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Figure 3.6 Slide showing normal gastric mucosa, not colonized by H. pylori. Grade 0 
inflammation, activity, atrophy, intestinal metaplasia and H. pylori density. Slide stained 
with haematoxylin and eosine stain (H&E); x 10 magnification. 
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Figure 3.7 Slide showing active chronic H. pylori gastritis. The gastric mucosa contains 
low numbers of lymphocytes and plasma cells (grade 1 inflammation), no signs of 
polymorphonuclear activity (grade 0 activity), atrophy (grade 0 atrophy) or intestinal 
metaplasia (grade 0 intestinal metaplasia). Slide stained with H&E; magnification x 20. 
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Figure 3.8 Slide showing moderate chronic antral gastritis with lymphoid follicle. The low 
power view shows moderate chronic inflammation (grade 2) and glandular atrophy 
(grade 2). Slide stained with H&E; magnification x10. 
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Figure 3.9 Slide showing activity in chronic H. pylori antral gastritis. Neutrophils are 
marked with an arrow. Slide stained with H&E; magnification, x 20. 
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Figure 3.10 Slide showing mild chronic antral H. pylori gastritis. The low power view 
shows mild inflammation (grade 1) with low grade atrophy (grade1). Slide stained with 
H&E; magnification x 10. 
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Figure 3.11 Slide showing antral gastritis with marked atrophy (grade 3). Slide stained 
with H&E; magnification, x 20. 
 
 
Figure 3.12 Slide showing grade 2 H. pylori colonization density. H. pylori marked with an 
arrow. Slide stained with toludine blue; magnification, x 100. 
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Figure 3.13 Slide showing grade 2 H. pylori colonization density. H. pylori marked with an 
arrow. Slide stained with toludine blue; magnification, x 100. 
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Figure 3.14 Slide showing moderate chronic inflammation and atrophy (grade 2) and 
marked intestinal metaplasia (grade 3). Goblet cells (an indicator of the presence of 
intestinal metaplasia) are marked with arrows. Slide stained with (H&E); magnification, 
x 10. 
 
 
 
Figure 3.15 Slide showing antral gastritis with mild intestinal metaplasia (grade 1). 
Goblet cells are marked with arrows. Slide stained with alcian blue/PAS; maginification, 
x 40. 
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Figure 3.16 Slide showing antral gastritis with marked intestinal metaplasia (grade 3). 
Goblet cells are marked with arrows. Slide stained with alcian blue/PAS; maginification, 
x 40. 
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3.2.4 vacA transcript level is associated with the severity of 
inflammation, neutrophilic activity and atrophy and the 
density of H. pylori infection 
Among the 25 patients infected with an i1-type strain tested, 12 had mild 
inflammation, 8 had moderate inflammation and 5 had severe inflammation. 
There were no patients with grade 0 inflammation in the corpus. Comparing 
the degree of inflammation and the level of vacA transcription in the gastric 
biopsies, it was observed that vacA transcript levels were significantly higher in 
patients with moderate to severe inflammation (median relative vacA 5.11) titre 
compared to those with mild inflammation (median relative vacA titre 0.00 (P 
= 0.006)). vacA mRNA levels were significantly lower in patients with mild 
inflammation compared to those with moderate or severe inflammation (P = 
0.013 and  P = 0.008, respectively). The median levels of vacA were 3.74 and 
7.92 in patients with grade 2 and grade 3 inflammation, respectively. However, 
this difference was not statistically significant. 
 
Seventeen out of twenty five patients infected with i1-type strains had 
neuotrophilic activity in the corpus. Six of those had mild activity, and eleven 
showed moderate activity. No patients within the group had severe activity. 
Similarly to findings for inflammation, vacA transcript levels were significantly 
higher in patients with polymorphonuclear activity compared to those with no 
activity (P = 0.0016). vacA levels were significantly lower in patients with no 
polymorphonuclear activity compared to those with grade 1 or grade 2 activity 
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(P = 0.05 and  P = 0.0007, respectively). vacA transcript levels were not 
significantly different between individuals with mild versus moderate activity. 
 
Six out of the twenty five patients tested who were infected with an i1-type 
strain had grade 1 atrophy. The other 19 patients showed no signs of atrophy in 
the corpus. When the relationship between the level of vacA transcript and the 
presence of atrophy in the gastric biopsies was assessed, it was observed that 
vacA transcript levels were significantly higher in patients with atrophy than 
those with no atrophy P = 0.017 (median values 6.49 and 0.0 respectively). 
 
Fifteen out of twenty five patients infected with i1-type strains had grade 1 
infection density in the corpus. One had grade 2 infection density and nine had 
grade three infection density. As there was only one patient in the grade 2 
density group, patients with grade 2 and 3 infection density were combined. 
vacA transcript levels were significantly higher in patients with an infection 
density of grade 2 and 3 compared to those with a grade 1 infection density (P 
= 0.0056) (median values 5.16 and 0.0 respectively).  
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Figure 3.17 Box and whisker plot showing the vacA mRNA level of strains in gastric 
biopsies taken from patients with mild, moderate and severe inflammation (A) and mild 
versus moderate and severe inflammation (B). P values were assessed by the Mann-
Whitney U test. Data are expressed as median with interquatile ranges (box 25-75%; bars 
10-90%). 
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Figure 3.18 Box and whisker plot showing the vacA mRNA level of strains in gastric 
biopsies taken from patients with no, mild and moderate activity (A) and activity versus 
no activity (B).  P values were assessed by the Mann-Whitney U test. Data are expressed 
as median with interquatile ranges (box 25-75%; bars 10-90%). 
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Figure 3.19 Box and whisker plot showing the vacA mRNA level of strains in gastric 
biopsies taken from patients with atrophy and no atrophy. P values were assessed by the 
Mann-Whitney U test. Data are expressed as median with interquatile ranges (box 25-
75%; bars 10-90%). 
 
Figure 3.20 Box and whisker plot showing the vacA mRNA level of strains in gastric 
biopsies taken from patients with grade 1 infection density and grade 2 or 3 infection 
density. P values were assessed by the Mann-Whitney U test. Data are expressed as 
median with interquatile ranges (box 25-75%; bars 10-90%). 
3-125 
 
3.2.5 Association between vacA transcript levels and other 
histopathological parameters  
Only two patients in the study had intestinal metaplasia, so the numbers were 
not sufficient for statistical analysis. However, the two patients were infected 
with s1/i1/m1 type strains and the median relative vacA level in the group with 
intestinal metaplasia was 6.51 compared with a median value of 0.0 in the 
group of patients with no intestinal metaplasia. 
  
Using histopathology to assess the primary location of the H. pylori 
colonisation in the corpus, it was observed that the strains mainly colonised the 
surface of the epithelial cells in 11 out of 21 patients, the lumen in 7 patients; 
and in the other 3 patients the location of colonisation was mixed. There were 
no significant differences between vacA transcript levels of strains that 
predominantly colonised the epithelial cell surface compared to those that 
colonised the lumen.  
 
3.2.6 Association with disease 
During endoscopy, disease severity and other observations were noted 
DORQJVLGH WKH SDWLHQWV¶ V\PSWRPV Patients who showed no pathology were 
classified as normal and those with ulcers or erosions were categorised into the 
erosive disease group. Samples were not taken from patients who had taken 
antibiotics or proton pump inhibitors two weeks prior to the endoscopy. 
Sixteen out of twenty six patients infected with i1-type strains showed signs of 
disease, the other 10 patients showed no pathology. 
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When the relationship between the level of vacA transcript and the presence of 
erosive disease was assessed, it was observed that the median level of vacA 
transcript was 1.23 in the disease group and 0.00 in the normal group. 
However, the differences between the two medians were not found to be 
statistically significantly different (P = 0.5800). 
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Figure 3.21 Box and whisker plot showing the vacA mRNA level in gastric biopsies taken 
from patients with disease and no disease. P values were assessed by the Mann-Whitney 
U test. Data are expressed as median with interquartile ranges (box 25-75%; bars 10-
90%). 
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3.3 Discussion 
Infection with H. pylori results in chronic gastritis and can lead to diseases 
such as peptic ulcer disease, gastric cancer and gastric MALT lymphoma 
(Dunn et al., 1997, Spencer et al., 1997, Graham et al., 2000). Many studies 
have investigated the association with vacA type and disease outcome 
(Atherton et al., 1997). In Western populations, s1/i1/m1 type strains are 
associated with higher levels of inflammation, peptic ulcer disease and gastric 
cancer (Rhead et al., 2007). The association between vacA type and disease in 
East Asian and Southeast Asian populations is not as clear as strains are 
predominantly of the vacA s1/i1 type in these populations. However, it is 
thought that the high prevalence of these more virulent strain types in these 
populations may contribute to the high incidence of gastric cancer within this 
region. Although vacA type has been shown to be a good marker of toxicity, 
not all individuals infected with more virulent strains go on to develop disease. 
Heterogeneity in vacA levels is known to exist and is thought be a factor that 
contributes to toxicity; large amounts of purified VacA induce ulcer-like 
erosions in mice, and VacA increases gastric ulcer formation in experimentally 
infected gerbils (Marchetti et al., 1995, Ogura et al., 2000). This chapter 
investigates the heterogeneity in vacA mRNA levels between different strains 
in vivo and assesses the associations between vacA transcript level and the 
disease severity of the infected individual determined by histopathology. 
 
In this study a significant positive association was seen between the level of 
vacA transcript produced per H. pylori cell and the severity of inflammation, 
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activity and the presence of atrophy in the corpus of infected patients. VacA 
has been shown directly damage the gastric epithelium, a gastric mucosal 
inflammatory response may occur as a consequence of the VacA mediated 
damage. Additionally, the findings of several studies provide evidence that 
VacA may be directly involved in proinflammatory signalling. VacA induces 
p38 activation in gastric epithelial cells, T-cells, macrophages and neutrophils 
(Boncristiano et al., 2003). p38 activation has been shown to increase 
production of COX-2 which can lead to the generation of proinflammatory 
prostanoids (Hisatsune et al., 2007, Boncristiano et al., 2003). VacA has also 
been found to stimulate proinflammatory cytokines and chemokines production 
by mast cells and eosinophils contributing to inflammation (Supajatura et al., 
2002, Kim et al., 2007). Previous studies in animal models have found that 
gastric pathology resembles that of human gastric disease in infections with 
toxigenic strains but not with non toxigenic strains (Marchetti et al., 1995). In a 
mouse model of infection oral administration of H. pylori sonicate from 
toxigenic strains reproduced several aspects of the histological lesions 
observed in biopsies from patients with gastric ulcer disease. These included 
epithelial vacuolation, infiltration of mononuclear cells into the lamina propria, 
loss of gastric gland structure and ulceration (Telford et al., 1994b, Ghiara et 
al., 1995). Sonicate of a non-toxigenic strain did not induce histological 
lesions. Indicating that the cytotoxin is necessary to induce gastric damage 
(Telford et al., 1994b). Oral administration of purified VacA into the same 
mouse model induced the same histological lesions as those obtained with the 
crude extract, although inflammatory cell infiltration was not observed. A 
study by Supajatura et al (2002) confirmed the findings that purified VacA 
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induces histological lesions in the murine gastric mucosa, however no 
neutrophil infiltration was observed in this particular study (Supajatura et al., 
2002). Interestingly, significantly fewer gerbils suffered from gastric ulcers 
when infected with an isogenic vacA null mutant when compared to those 
infected with an isogenic wild type toxigenic strain (Ogura et al., 2000). 
However the severity of gastritis in the gerbils infected with a null mutant was 
not significantly different from that seen in gerbils infected with the wild type 
strain (Ogura et al., 2000). Superficially, this appears difficult to reconcile with 
my results, but the level of vacA transcription and production by the strains 
used in the study is not stated. The strain used may have been a low transcriber 
of vacA so deletion of the vacA gene may not have had a significant effect on 
the toxicity of the strain in vivo and could explain the inconsistency between 
the other studies on the importance of VacA in gastric disease in animal 
models. A difference in the inflammatory response between species may also 
be responsible.  
 
The differences in inflammation and activity observed between this study and 
previous animal studies on VacA may partly be explained by the fact that many 
studies in animal models routinely infect animals with high bacterial loads. 
Also histopathological changes were observed within hours of infection or 
exposure to the toxin (Ogura et al., 2000, Ghiara et al., 1995, Salama et al., 
2001, Supajatura et al., 2002). Furthermore, delivery of VacA to the gastric 
mucosa in an animal model of acute mucosal injury which consists of large 
pulse administrations of bacterial sonicates or purified cytotoxin is likely to be 
very different from the targeted slow release occurring during H. pylori 
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infection. Moreover, H. pylori infection in humans is a slow progression, 
gastric disease is manifested after prolonged infection, and the early 
inflammatory changes are difficult to recognise (Supajatura et al., 2002). 
Murine T-cells are resistant to the effects of VacA (Algood et al., 2007) 
indicating that there may be differences in the immune response to H. pylori 
infection between species.   
 
A positive correlation between the vacA level of an infecting strain and the 
density of infection in the corpus was observed. Several lines of evidence 
indicate that VacA may enable H. pylori colonization of the gastric mucosa. 
Competition experiments with an isogenic vacA null mutant and a wild type 
strain in a mouse model indicated that VacA may play a role in colonisation of 
the gastric mucosa (Salama et al., 2001). Salama et al. (2001) suggested that 
VacA causes tissue damage leading to alteration of the local pH and nutrient 
release allowing H. pylori to survive in the mucosa. Another suggestion was 
that cell damage caused by VacA plays a role in the local inhibition of acid 
secretion, which facilitates H. pylori colonisation (Salama et al., 2001). This is 
supported by a study by Boonjakuakul et al., (2005) during H. pylori infection 
of rhesus macaques vacA mRNA levels were higher one week after infection 
than 4-6 weeks after infection (Boonjakuakul et al., 2005). vacA was also 
found to be one of the most highly expressed putative virulence factors in H. 
pylori positive human gastric biopsy specimens out of a total of 18 virulence 
factors assessed (Boonjakuakul et al., 2004). 
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Several functions have been ascribed to VacA which include modulating the 
trans-epithelial resistance of cell-cell junctions to release essential nutrients 
from the epithelium (Papini et al., 1998). VacA has also been shown to form 
pores in the cell membrane, allowing egress of anions and urea which enables 
H. pylori to protect itself from the acidity of the gastric environment (Iwamoto 
et al., 1999, Szabo et al., 1999, Tombola et al., 1999, Tombola et al., 2001). 
Several studies have suggested that VacA may play an important role in 
modulating the immune response during infection by inhibiting the activation 
and proliferation of T lymphocytes (Akada et al., 2000, Fan et al., 1994) 
affecting B lymphocyte antigen presentation (Molinari et al., 1998b) and 
modulation of the T cell mediated cytokine response (Gebert et al., 2003). 
Collectively these findings indicate that VacA can induce physiological 
changes that may contribute to pathogenesis and the persistence of H. pylori in 
the gastric niche. However, the exact role of the cytotoxin in gastric 
pathogenesis in vivo remains to be determined.  
 
Only two patients in the study had intestinal metaplasia, consequently there 
were insufficient numbers for statistical analysis. However, the two individuals 
with intestinal metaplasia were both infected with strains of the toxigenic vacA 
type s1/i1/m1 and had relative vacA levels within the top 8 highest transcribers 
of vacA. 
 
No association was found between vacA transcript level and disease outcome 
as determined during the endoscopy. Observations of disease during endoscopy 
only show whether a patient has observable pathology on the day of the 
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endoscopy, it may be the case that the patient may present with disease at 
another point in time. Investigating histopathological changes enables 
quantification of different parameters of disease progression at earlier time 
points and although a patient does not show signs of ulcer disease at the present 
time, it may be that in time disease will develop. This may explain the seeming 
disparity between the histopathological observations and disease determined by 
endoscopy. Furthermore, it could be argued that the investigations of 
histopathological changes are a more accurate measure of disease progression. 
Other studies in mice and gerbils showed a positive association between VacA 
and ulcers, however it is likely that there are differences in the inflammatory 
response between humans and animal models. In the studies of acute mucosal 
injury using animal models, large bacterial loads, pulse administrations of 
bacterial sonicates or purified cytotoxin are used which are not representative 
of virulence factor release in the human stomach. Another explanation is a type 
two error, the study may not be big enough to show a statistically significant 
association. 
 
The vacA genotype of an infecting strain has been found to be a good marker 
of disease. This chapter showed that there is a relationship between vacA 
transcript levels produced by a strain and the severity of inflammation, activity 
and atrophy in the corpus. Several putative virulence factors including the cag 
pathogenicity island, BabA and in-frame OipA alleles are present in strains of 
the more toxic s1 vacA type more frequently than in strains of the non-toxic 
vacA s2 type (Atherton et al., 1995, van Doorn et al., 1998, Gerhard et al., 
1999, Cao and Cover, 2002, Yamaoaka et al., 2002, (Dossumbekova et al., 
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2006). It is therefore difficult to determine which of these putative virulence 
factors is the most important in the pathogenesis of gastroduodenal disease. 
However other factors such as variations in acid production, the immune 
response of the infected individual, environmental factors such as smoking and 
diet and other H. pylori virulence factors may also have an effect on 
histopathological severity and the disease status of the patient. It is likely that 
the development of disease in humans is not due to the action of one single 
factor and that a combination of these factors contribute to development of 
disease. More studies are required to assess the relative importance of these 
other factors in H. pylori associated disease. 
 
In conclusion this chapter has shown that the level of vacA transcript produced 
by a strain is positively associated with the severity of inflammation, atrophy 
and neutrophil activity, and with the density of infection in the corpus. 
Differences in vacA expression between H. pylori strains in vivo could explain 
the imperfect correlation between vacA type and disease. Host factors and other 
H. pylori virulence factors may also have an effect on histopathological 
severity and the disease status of the patient. However, more studies are 
required to assess the importance of these other factors in H. pylori associated 
disease. 
3.3.1 Limitations 
3.3.1.1 Sample size 
This study assessed the vacA mRNA level present in corporal biopsies taken 
from 39 patients, only 25 of those were of the vacA i1 type.  The analysis could 
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have been improved if more samples had been available for testing. 
Unfortunately, the number of gastric biopsies that could be taken for research 
was limited by ethical constraints. In some cases in this chapter, correlations 
that were not statistically significant showed trends which may reach 
significance, if additional data points were included. Gastric biopsies were 
sampled from the same sites in all patients involved in the study to control for 
differences in colonisation density between different areas of the corpus. It 
would be interesting to analyse samples taken from different sites in the corpus 
to determine whether vacA mRNA levels are similar in different sites within 
the corpus. Unfortunately, the limited sample size meant that this was not 
possible. 
 
This chapter investigated vacA mRNA levels using quantitative real-time PCR, 
ideally transcript levels would be backed up by another method such as 
Northern blotting. Similarly, it would be interesting to determine whether vacA 
transcript levels correlate with VacA protein levels by Western blotting or 
ELISA. However, the amount of gastric tissue available in this study meant 
that this was not possible.   
 
Patients regularly taking NSAIDs were excluded from this study. However, we 
could not control for intermittent use or for cases where patients had taken 
NSAIDs unwittingly (e.g. in cold remedies). NSAIDs are known to cause 
peptic ulcers. Thus, we cannot rule out the possibility that some disease 
conditions identified in this study were due to unrecorded NSAID use. The age 
and sex of the patient along with the cagA status of the strain were taken into 
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account, however other factors such as diet, host genetics and smoking all have 
an effect on severity of gastric disease, unfortunately this data was not 
available for these patients and so could not be controlled for in this study. 
 
3.3.1.2 Real-time PCR 
Reverse transcription followed by quantitative real-time PCR is the most 
sensitive and reliable method for quantifying low abundant transcripts in 
tissues (Freeman et al., 1999, Steuerwald et al., 1999). Several methods of 
analysis are available to quantify the mRNA content in a sample. The level of 
gene expression can be measured using an absolute or a relative quantification. 
Absolute quantification relates the level of fluorescence to an input copy 
number using a calibration curve which can be derived from dilutions of spiked 
tissue samples, recombinant DNA or RNA or PCR products (Bustin, 2000, 
Fronhoffs et al., 2002). In this chapter, differences in vacA mRNA levels 
between patients were assessed using relative quantitation which determines 
differences in mRNA levels across multiple samples and expresses it relative to 
that of a control sample which is included on every run. The Pfaffl method of 
analysis was used which also takes into account the amplification efficiency of 
a gene in the particular sample type. Target gene expression is adjusted to the 
expression of a house-keeping gene that is constitutively expressed. In this 
study 16S rRNA was used and is commonly used as the housekeeping gene of 
choice in gene expression studies in bacteria. 
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The level of expression of a gene is based on the distinct cycle that the 
fluorescence of a sample crosses a threshold level of fluorescence which is 
selected by the user at a level where amplification is exponential. For accuracy, 
the threshold needs to be set as low as possible and needs to be the same on 
each real-time run. In this study the threshold was set at 0.01. 
 
vacA transcript was not detectable in 18 of the biopsies tested. The limit of 
detection of vacA was found to be 0.18. This is 8.2 fold lower than that of 
sample 223 which had the lowest detectable level of vacA in this study. 
Samples that had no detectable vacA transcript were given a value of zero. The 
Mann Whitney U test which ranks the samples in order or transcript level was 
used to compare mRNA levels between disease groups so that designating a 
value of zero to samples with no detectable vacA transcript would not affect the 
analysis. 16S rRNA was detectable in all of the biopsies tested indicating that 
H. pylori was present in the biopsy and that the RNA had not degraded.  
 
3.3.2 Future work 
In Western populations such as the USA and Western Europe, strains of the 
vacA s1/m1 type have been shown to be associated with peptic ulceration, and 
gastric cancer (Atherton et al., 1995, Atherton et al., 1997, Rhead et al., 2007, 
Basso et al., 2008). The vacA i1 type is also a risk factor for peptic ulcer 
disease, duodenal ulcer disease and gastric cancer (Basso et al., 2008, Rhead et 
al., 2007). In East Asian and Southeast Asian countries the association between 
vacA allelic diversity and clinical outcome is not well established as the 
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population is predominantly infected with strains of the s1/i1 type (Maeda et 
al., 1998, Yamaoka et al., 1998). There is a high incidence of gastric cancer in 
this population which could be explained by the high prevalence of the more 
virulent vacA s1/i1 type strains (Rhead et al., 2007). However, not all 
individuals infected with more virulent strains go on to develop disease. It 
would be interesting to repeat the study carried out in this chapter on different 
populations to determine whether differences in vacA expression between H. 
pylori strains of the same vacA type in vivo could explain the imperfect 
correlation between vacA type and disease.  
 
Studies have shown that the pattern of gastritis is important in determining 
disease outcome with antral predominant gastritis being associated with 
duodenal ulceration and a pangastritis being epidemiologically linked with 
gastric ulcers and gastric adenocarcinoma. It would be interesting to look at 
whether there is a correlation between the level of vacA transcript in the antrum 
and in the corpus, and to investigate whether there is a relationship between 
vacA transcript level and the pattern of gastritis.   
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Chapter 4 
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4 Characterisation of the effect of natural 
polymorphisms in the cysS ± vacA intergenic 
region on vacA transcription levels in vitro and 
in vivo. 
4.1 Introduction 
Heterogeneity in vacA transcription between strains is known to exist; Ayala et 
al., (2004) observed 28 fold differences in vacA transcription between 8 
different H. pylori strains cultured in vitro using real-time PCR. Using 
quantitative primer extension analysis, Forsyth et al., (1998) found that vacA is 
transcribed in both type s1/m1 (Tox+) and s2/m2 (Tox-) strains, but type s1/m1 
(Tox+) strains produce significantly higher levels of toxin than s2/m2 (Tox-) 
strains (Forsyth et al., 1998). This difference in transcript level correlated with 
differences in VacA protein level (Forsyth et al., 1998). 
Prokaryotic gene transcription requires the RNA polymerase holoenzyme with 
a specific sigma subunit, which is required for making sequence specific 
contacts with the promoter DNA. Prokaryotic promoters are generally 
composed of 2 short conserved sequences (termed the -10 and -35 boxes which 
are located 10 nucleotides and 35 nucleotides upstream of the transcription 
start site, typically a single purine nucleotide (A or G)). Some promoters 
lacking a conserved -35 sequence depend on an extended -10 region for 
transcription initiation. The extended -10 region consists of 2 additional bases 
upstream of the -10 motif. Variations in both the promoter sequence and 
promoter element spacing influence the level of transcription. Some bacterial 
promoters contain sequences in addition to the -35 and -10 motifs that can 
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further modulate transcription by allowing binding of activators or repressors 
of transcription.  
Previous studies have shown that vacA transcription is initiated by a single 
promoter which is in the 285bp intergenic region located between the upstream 
housekeeping gene, cysteinyl-tRNA synthase (cysS) and the start of vacA 
(Forsyth et al., 1998). Sequence analysis of this region from 12 strains revealed 
that vacA has a single TSP which is located 119 nucleotides upstream of the 
AUG start codon, a conserved -35 region (TTTATG), a conserved -10 region 
(TAAAAA) and a TGN motif adjacent to the -10 motif (Davies et al., 2002) 
similar to the extended -10 boxes found in E. coli (Forsyth et al., 1998).  
Forsyth et al., (1999) created specific mutations in the cysS ± vacA intergenic 
region to assess the importance of specific promoter elements on vacA 
transcription using a xylE reporter system. Mutations in the -10 region, where 
the wild type sequence TAAAAG was changed to AGATCT resulted in a 15 
fold reduction in vacA level. Changing the -35 motif from the wild type 
sequence TTTATG to AGATCT resulted in a 4 fold reduction in expression. 
The specific sequence of the spacer region did not appear to be important in 
determining transcript levels as substituting CCTTA to GATCT from positions 
-23 to -19 did not affect expression levels. However spacing appeared to be 
important as introducing a 10bp insertion between -24 and -23 reduced 
expression. They concluded that -35 and -10 sequences along with promoter 
element spacing are important for binding.  
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Substituting G for T at the -14 position resulted in a 2 fold reduction in vacA 
transcript level, and changing the T to a G at the -12 position resulted in a 4 
fold reduction. Deletion of 6 nucleotides (TTTATG) from position -37 to -32 
in strain 60190 resulted in a 6 fold reduction in expression. Substitutions at the 
-13 and -15 positions had no effect on vacA transcript levels. This lead to the 
conclusion that positions -12 and -14 may be important for RNA polymerase 
binding. Forsyth et al., (1999) also found that 15 out of 17 strains all used the 
same transcriptional start point. They suggested that the conservation of the 
adenosine residue at the +1 position may be important as Liu et al., (1994) 
reported that the identity of the +1 site can affect transcriptional efficiency. 
 
Using promoter exchange experiments Forsyth et al., (1999) also found that 
Tox- strains under control of a Tox+ promoter showed no difference in vacA 
transcription. When reciprocal changes were made they found that a Tox+ 
strain under the control of a Tox- promoter resulted in a 65% decrease in vacA 
transcription in the reporter strain. However vacA transcription was still 10 fold 
higher than in the control Tox- reporter strain. They concluded that Tox+ and 
Tox- strains investigated differ in promoter strength but the differences must be 
due to changes outside the -35 and -10 motifs, as the two hexamers were 
identical in both strains studied. They suggested that the difference in vacA 
transcriptional levels between the two strains may be due to a trans-acting 
repressor in the Tox- strain or an activator present in the Tox+ strain which are 
absent or reduced in the other strain type. 
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Ayala et al., (2004) also found that the differences in vacA expression between 
8 strains in vitro were unrelated to -10 and -35 sequences. G. L. Narayanan 
(2005) analysed the vacA promoter sequences of a collection of published 
strains and found, in agreement with Forsyth et al., (1999) that there appears to 
be an extended ± 10 region. It was also observed that in 4 out of 8 clinical 
strains there was a substitution from a G to an A at position -14 that makes up 
part of the extended -10 region. In addition the final base within the -35 motif 
has a frequent substitution from a G to an A residue.  
 
Stem loop structures have been shown to be important in determining transcript 
VWDELOLW\ LQSURNDU\RWHV6WHPORRSVWUXFWXUHVFDQEHIRXQGDWERWK WKH¶DQG
WKH ¶ HQG RI WKH vacA transcript (Emory and Belasco, 1990, Emory et al., 
1992). All 17 of the Tox+ and Tox- strains tested by Forsyth et al., (1999) 
HQFRGHGSRWHQWLDO¶VWHPORRSVVWUXFWXUHV$WKHUWRQ95 et al., and Cover et 
al., 1994) however these appeared to be well conserved and they found no 
HYLGHQFH WKDW WKHVH ¶ VWHP ORRSV KDG DQ\ HIIHFW RQ GLIIHUHQFHV LQ vacA 
transcription between strains.    
 
To investigate whether the differences in vacA transcription between strains 
were due to mRNA stability, Forsyth et al., (1999) treated the 2 strains with 
rifampicin to inhibit RNA polymerase activity and assessed transcript levels 
using primer extension analysis, although this data was inconclusive. Using a 
sequence alignment of the published promoter regions of 19 H. pylori strains 
G. L. Narayanan (2005) identified a conserved stem loop structure which 
started at the +4 position of the mRNA transcript. Deletion of this stem loop 
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resulted in a reduction in vacA mRNA levels compared to the control. The 
alignment also revealed that this stem loop was well conserved except for 
differences at the +11 and +28 positions within the stem loop. Although the 
importance of these polymorphisms in determining vacA transcript level was 
not determined. &RQYHUVHO\ WKH ¶ VWHP ORRS VWUXFWXUHs appeared to have no 
affect on vacA transcription as no difference in vacA expression was observed 
ZKHQWKHZKROH¶HQGRIWKHXQWUDQVODWHGUHJLRQRIvacA from Tox- strain 86-
313 was replaced with that of Tox+ strain 60190 during the promoter exchange 
experiments by Forsyth et al., (1999). 
 
An inverted repeat upstream of the -35 motif was found to be present in 4 out 
of 8 clinical strains (Ayala et al., 2004). Inverted repeats are a common feature 
of regulator binding sites, however the role of the inverted repeat in the cysS ± 
vacA intergenic region in transcriptional regulation of vacA is yet to be 
determined.  
 
4.2 Aims 
Chapter 3 assessed the association between the level of vacA transcribed by an 
infecting strain with different disease parameters, showing that the level of 
vacA transcribed by an infecting strain in vivo is associated with severity of 
inflammation, activity and atrophy. Previous studies on vacA transcription have 
been carried out in vitro. They have led to the identification a vacA promoter, a 
VWHPORRSVWUXFWXUHDWWKH¶HQGRIWKHvacA mRNA transcript and an inverted 
repeat upstream of the -35 motif. These regions have been shown to be 
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naturally polymorphic between strains, however no associations between these 
differences and the level of vacA mRNA has been found in vivo or in vitro 
(Forsyth et al., 1998, Forsyth and Cover, 1999, Ayala et al., 2004, Narayanan, 
2005). The aims of this chapter are: 
x To determine whether naturally occurring polymorphic differences in 
the cysS ± vacA intergenic region contribute to different vacA 
transcriptional levels between clinical strains in vivo. 
x To determine whether vacA transcript level in vivo correlates with the 
vacA transcript level in the same strains in vitro using matched strains 
and biopsies. 
x To identify other potential binding sites for activators or repressors of 
transcription or structures that may affect mRNA stability; and to 
determine whether polymorphisms here are associated with differences 
in vacA transcription.  
x To determine pattern of vacA transcription throughout growth of 
clinical strains in vitro. 
x To confirm that differences in vacA transcription between strains are 
not due WR³UHDGWKURXJK´IURPcysS. 
4.3 Results 
4.3.1 Characterisation of the effect of natural polymorphisms 
in the cysS ± vacA intergenic region of clinical H. pylori 
strains in vivo. 
To determine the sequence of the cysS ± vacA intergenic region, clinical H. 
pylori strains were isolated and cultured from gastric biopsies taken from the 
corpus as detailed in section 2.4.4. Genomic DNA was extracted from H. pylori 
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strains using the methodology detailed in section 2.5.1. A 535 bp region 
including 47 bp of cysS, and a 159 bp region encoding the mature VacA 
cytotoxin was PCR-amplified from genomic DNA of the clinical H. pylori 
strains using the forward primer DL1 and the reverse primer VacR10. Both 
strands were sequenced using an Applied Biosystems 3100 Genetic analyser 
(Biopolymer Synthesis and Analysis unit, University of Nottingham, UK). 
Sequences retrieved were aligned using the MegAlign program (DNAstar), and 
ranked in order of levels of vacA mRNA/ 16s rRNA determined using real-time 
PCR data from chapter 3. The significance of the association between 
differences in transcript levels between strains and different bases present 
within the vacA promoter was analysed using the Mann-Whitney U test. 
 
Analysis of the cysS-vacA intergenic region highlighted many polymorphic 
differences within the vacA promoter (Figure 4.1). Naturally occurring 
differences within the -35, -10 and the extended -10 motifs were identified. In 
agreement with previous studies on the vacA promoter, in vitro polymorphic 
differences were seen at position -32 within the -35 motif where there was a 
frequent G to A substitution. A G to A substitution was also found at position -
14 within the extended -10 motif. However differences in the vacA transcript 
level between the different strains were not significantly associated with the 
polymorphic differences present at these sites. 
 
Inverted repeats upstream of the -35 motif identified previously by Ayala et al., 
(2004) were seen in 2 out of 27 strains, however the presence of an inverted 
repeat was unrelated to vacA mRNA levels in vivo in this study. 
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A stem loop structure beginning at the +4 site of the mRNA transcript has been 
identified previously (Narayanan, 2005). A G to A substitution was identified 
at position +11, and adenine to guanine and thymine to cytosine substitutions 
were seen at positions +17 and +18 respectively. Moreover these were not 
associated with the level of vacA transcript in vivo. However interestingly, 
strains possessing an A at position +28 within the second stem of the stem loop 
expressed more vacA than those that have a G at this position (P = 0.0089) 
(Figure 4.1.). 
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C A G C C A T T T T A C T T T - T T A A T C C T G T T A A G T T T T A - T A T T   
------------------+-------------------+-------------------+-------------------+- 
                  10                  20                  30                 40 
------------------+-------------------+-------------------+-------------------+- 
. . A T A T . . . . G . . . . - . . . . . . T . . . - . G A . . . . . - . . . .  194 
. . . . . . . G . . G . . . . - . . . . . . T . . . . . . . . . . G . - . G . .  187 
. . . . . . . G . . G . . . . - . . . . . . . . A . - G G . . . . . . - . . . .  242 
. . . . A . . . . . . . . . . - . . . . . . . . A . - G G . . . . . . - . . . .  126 
T . . . A . . A . . G . . . . - . . . . . . T . A . . . . . . . . C . - C . . .  206 
. . . . . . . G . . . . . . . - . . . . . . T . . . G . . T . . A . . - . - . C  255 
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Figure 4.1 Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The 
cysS-vacA intergenic regions were sequenced using the DL1 and VacR10 primers using 
an Applied Biosystems 3100 Genetic analyser (Biopolymer Synthesis and Analysis unit, 
University of Nottingham, UK). Sequences retrieved were aligned using the MegAlign 
program (DNAstar), and ranked in descending order according to the level of vacA 
mRNA/16s rRNA determined using real-time. The significance of differences in 
transcript levels between strains with different bases present within the vacA promoter 
were analysed using the Mann-Whitney U test. The upstream inverted repeat and the -35 
motif are highlighted in blue and green respectively. Perfect inverted repeats are 
highlighted in pink. Nucleotides that match the consensus sequence are represented by a 
dot. The vacA mRNA levels are reported next to the analysed promoter along with the 
strain name and vacA type.  
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Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The cysS-vacA 
intergenic regions were aligned using the MegAlign program (DNAstar), and ranked in 
descending order according to the level of vacA mRNA/16s rRNA determined using real-
time. The significance of differences in transcript levels between strains with different 
bases present within the vacA promoter were analysed using the Mann-Whitney U test. 
The -10 and extended -10 motifs are highlighted in pink, the +1 site in blue and WKH¶
stem loop structure in orange. Nucleotides that match the consensus sequence are 
represented by a dot. The vacA mRNA levels are reported next to the analysed promoter 
along with the strain name and vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The cysS-vacA 
intergenic regions were aligned using the MegAlign program (DNAstar), and ranked in 
descending order according to the level of vacA mRNA/16s rRNA determined using real-
time. The significance of differences in transcript levels between strains with different 
bases present within the vacA promoter were analysed using the Mann-Whitney U test. 
7KH¶VWHPORRSVWUXFWXUHLVKLJKOLJKWHGLQRUDQJH and the +28 position is highlighted in 
green. Nucleotides that match the consensus sequence are represented by a dot. The 
vacA mRNA levels are reported next to the analysed promoter along with the strain name 
and vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The cysS-vacA 
intergenic regions were aligned using the MegAlign program (DNAstar), and ranked in 
descending order according to the level of vacA mRNA/16s rRNA determined using real-
time. The significance of differences in transcript levels between strains with different 
bases present within the vacA promoter were analysed using the Mann-Whitney U test. 
Nucleotides that match the consensus sequence are represented by a dot. The vacA 
mRNA levels are reported next to the analysed promoter along with the strain name and 
vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The cysS-vacA 
intergenic regions were aligned using the MegAlign program (DNAstar), and ranked in 
descending order according to the level of vacA mRNA/16s rRNA determined using real-
time. The significance of differences in transcript levels between strains with different 
bases present within the vacA promoter were analysed using the Mann-Whitney U test. 
The Shine-Dalgarno sequence and the ATG start site are highlighted in blue and red 
respectively. Nucleotides that match the consensus sequence are represented by a dot. 
The vacA mRNA levels are reported next to the analysed promoter along with the strain 
name and vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The cysS-vacA 
intergenic regions were aligned using the MegAlign program (DNAstar), and ranked in 
descending order according to the level of vacA mRNA/16s rRNA determined using real-
time. The significance of differences in transcript levels between strains with different 
bases present within the vacA promoter were analysed using the Mann-Whitney U test. 
Nucleotides that match the consensus sequence are represented by a dot. The vacA 
mRNA levels are reported next to the analysed promoter along with the strain name and 
vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains in vivo. The cysS-vacA 
intergenic regions were aligned using the MegAlign program (DNAstar), and ranked in 
descending order according to the level of vacA mRNA/16s rRNA determined using real-
time. The significance of differences in transcript levels between strains with different 
bases present within the vacA promoter were analysed using the Mann-Whitney U test. 
Nucleotides that match the consensus sequence are represented by a dot. The vacA 
mRNA levels are reported next to the analysed promoter along with the strain name and 
vacA type. 
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4.3.2 Characterisation of the effect of natural polymorphisms 
in the cysS ± vacA intergenic region of clinical H. pylori 
strains in vitro. 
Previous studies have investigated the heterogeneity between vacA transcript 
levels between strains in vitro. To determine whether there is a correlation 
between vacA mRNA levels produced by strains in the gastric mucosa in vivo 
and in the same H. pylori strains grown in vitro strains were isolated from 
corporal gastric biopsies and cultured and their vacA mRNA level assessed by 
real-time PCR. 
4.3.3 Quantitative real-time PCR using RNA extracted from 
broth cultures. 
In order to quantify the amount of vacA transcript present per H. pylori cell in 
broth culture, RNA was extracted from H. pylori broth culture of strain 60190 
as described in section 2.6.1. Total RNA was quantified using the Nanodrop 
spectrophotometer. RNA samples were adjusted to 33.3ng/µl to normalise the 
concentration of RNA for subsequent DNAfree treatment and cDNA synthesis. 
DNA contamination was removed using a DNAfree kit (Ambion) as described 
in section 2.6.4. cDNA was synthesised using 1µg of total RNA using the 
Omniscript RT kit (Qiagen, UK) as described in section 2.6.5. A minus reverse 
transcriptase containing the cDNA master mix and RNA sample without 
reverse transcriptase was also produced for each sample to confirm the absence 
of residual DNA in the RNA samples.  
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Quantitative real-time PCR was performed on the Rotorgene 3000 using the 
methodology outlined in section 2.6.6. Differences in vacA mRNA levels 
between strains were assessed using the Pfaffl method of analysis. The level of 
vacA transcript per H. pylori cell in all the broth samples tested was compared 
to that of strain 60190, which was included in triplicate as a control in each 
real-time PCR run to control for inter-experimental variations.  
 
To determine the amplification efficiency of both vacA and 16s rRNA a sample 
of control cDNA (60190) was serially diluted in triplicate to produce a standard 
curve (Figure 4.2). The amplification efficiencies were calculated from the 
slopes of the standard curve according to the equation E = . The 
amplification efficiencies for vacA and 16s rRNA were 1.69 (Figure 4.2 (A)) 
and 1.88 (Figure 4.2 (B)) respectively, with R2 values of 0.989 and 0.988 
respectively. 
 
The optimised real-time PCR was performed in triplicate for each broth culture 
tested; the mean CT value was used to calculate the relative expression of vacA. 
The level of vacA mRNA per H. pylori cell was expressed relative to sample 
60190. Blanks containing the real-time PCR master mixes for both the vacA 
and 16s rRNA primers were tested on each run to confirm the absence of 
contamination in the master mix. 
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Melt curves for all samples tested, including the cDNA negative and blanks 
were checked on every run to confirm the absence of contamination (Figure 
4.3).  
4-158 
 
A 
 
B 
 
Figure 4.2 Standard curve and amplification efficiency of 16S (A) and vacA (B). To 
determine the amplification efficiencies of 16S and vacA using templates extracted from 
H. pylori broth culture, a sample of control cDNA 60190 was serially diluted to produce a 
standard curve. The amplification efficiencies were calculated from the slopes of the 
standard curve according to the equation E = . The amplification 
efficiencies for vacA and 16S rRNA were 1.88 and 1.69 respectively, with R2 values of 
0.988 and 0.989 respectively. 
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Figure 4.3 Melt curves of 16S and vacA PCR products synthesised from template 
extracted from broth culture. The melt curve shows the rate of change of relative 
fluorescence units (RFU) with time (T) (d-(RFU)/dT) on the Y axis against the 
temperature on the x axis. The melt curves are performed at the end of the amplification 
reactions to determine the melting temperature of the PCR product. The single peak in 
each melt curve indicates that only one product is present for each primer pair. The lack 
of peak in the RT ± reactions also indicates that no contamination or primer dimer 
artefacts were present. 
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4.3.4 Assessment of vacA transcript levels throughout the 
growth curves of H. pylori clinical strains 
Microarray studies and RNA dot blots have shown that vacA transcription 
appears to peak at late log to early stationary phase (Thompson et al., 2003, 
Narayanan 2005). To determine the growth profile of the clinical strains grown 
using the culture conditions in this study four clinical strains cultured on blood 
agar plates were used to inoculate 30 ml of SFBB supplemented with 5% FBS 
at a starting OD600 of 0.1. Cultures were contained in a 75cm3 tissue culture 
IODVNDQGJURZQZLWKVKDNLQJUSPDWÛ&LQDQDWPRVSKHUHRI&22 
and 80% humidity for 30 hours. Broth samples were taken at time points 0, 3, 
6, 9, 11, 12, 15, 18, 24.75, 27 and 29.5 hours, and the OD600 noted. Broth 
cultures were set up in triplicate for each clinical strain and samples were 
routinely Gram stained to confirm the absence of contamination. The growth 
profiles of the four clinical H. pylori strains show that although some of the 
strains grew to higher optical densities that others, all strains entered stationary 
phase at approximately 18 hours (Figure 4.4). 
 
Previous studies have shown that vacA transcription appears to peak at the 
switch between the exponential and stationary phase in laboratory strains. To 
assess whether this is the case in the clinical strains used in this study, and to 
be sure that the differences in vacA expression seen between strains in vitro 
would not be due to slight differences in growth, samples were taken for RNA 
extraction from the broth cultures detailed above at time points 15, 18 and 21, 
hours which correlated to late log or early stationary phase. One sample was 
taken for RNA extraction from each broth for each time point (i.e. 3 broths per 
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strain per time point). The level of vacA mRNA per bacterial cell was assessed 
by real-time PCR detailed in section 4.3.3 and was analysed using the Pfaffl 
method (Pfaffl, 2001). The level of vacA mRNA per cell was expressed relative 
to sample 60190 which was used as a control on every real-time PCR run. vacA 
mRNA expression did not differ significantly between the 15, 18 and 21 hour 
time points in all four clinical strains tested (Figure 4.5). Thus, samples of 
clinical strains were taken at 18 hours in subsequent experiments for 
quantitative real-time PCR analysis.      
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Figure 4.4 Growth profiles of clinical H. pylori strains 73B, 173B, 201B and 221B. The 
mean bacterial density (OD600) based on values from three separate broth cultures for 
each clinical strain was plotted against time (hours). Error bars show the standard 
deviation of the mean bacterial density at each time point.  
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Figure 4.5 Comparison of vacA  mRNA levels at 15, 18 and 21 hours in clinical H. pylori 
strains. The bar chart above shows the mean vacA mRNA level per H. pylori cell for 
clinical strains 73B, 173B, 201B and 221B at 15, 18 and 21 hours. The error bars show the 
standard deviation of the mean relative vacA mRNA level for each strain at each time 
point. The vacA mRNA level did not differ significantly between the 15, 18 and 21 hour 
time points in any strain tested. 
4-164 
 
 
4.3.5 Characterisation of the effect of natural polymorphisms 
in the cysS ± vacA intergenic region of clinical H. pylori 
strains in vitro. 
Thirty clinical strains were grown in broth culture, samples were taken for 
RNA extraction at 18hrs, and vacA mRNA levels were assessed by real-time 
PCR as detailed previously in sections 4.3.3 and 4.3.4. Alignments of the cysS 
± vacA intergenic regions of the clinical strains shown in section 4.3.1 were 
ranked in order of detectable vacA mRNA level per H. pylori cell in vitro. 
Differences in transcript levels between strains with different polymorphisms 
present within the vacA promoter were assessed using the Mann-Whitney U 
test. Up to 180 fold differences in vacA expression were observed between 
strains. In agreement with previous studies the sequence alignment shows that 
some strains differ in the nucleotide present at the final position in the -35 
region. Analysis of the clinical strains also shows that most strains possess a 
TGA extended -10 region but some strains possess a TAA motif. However the 
differences between strains in the -35 and extended -10 regions are not 
significantly associated with levels of vacA transcription. A potential region of 
interest is the inverted repeat upstream of the -35 motif identified by Ayala et 
al., (2004). The sequence alignment reveals that strains with a fully 
palindromic inverted repeat express significantly more vacA than other strains 
(P = 0.029). Interestingly, polymorphic differences at position +28 of the stem 
loop at the beginning of the vacA mRNA transcript were not associated with 
levels of vacA mRNA in vitro in this study (Figure 4.6). 
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. . . . . . . . . . . . . . . - . . . . . . . . A . - . G . . . . . . - . . . .  72 
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Figure 4.6 Comparison of the cysS ± vacA intergenic regions of clinical strains cultured in 
vitro. The cysS-vacA intergenic regions were sequenced using the DL1 and VacR10 
primers using an Applied Biosystems 3100 Genetic analyser (Biopolymer Synthesis and 
Analysis unit, University of Nottingham, UK). Sequences retrieved were aligned using the 
MegAlign program (DNAstar), and ranked in descending order according to the level of 
vacA mRNA/16s rRNA determined using real-time. The significance of differences in 
transcript levels between strains with different bases present within the vacA promoter 
were analysed using the Mann-Whitney U test. The upstream inverted repeat and the -35 
motif are highlighted in blue and green respectively. Perfect inverted repeats are 
highlighted in pink. Nucleotides that match the consensus sequence are represented by a 
dot. The vacA mRNA levels are reported next to the analysed promoter along with the 
strain name and vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains cultured in vitro. The 
cysS-vacA intergenic regions were aligned using the MegAlign program (DNAstar), and 
ranked in descending order according to the level of vacA mRNA/16s rRNA determined 
using real-time. The significance of differences in transcript levels between strains with 
different bases present within the vacA promoter were analysed using the Mann-Whitney 
U test. The -10 and extended -10 motifs are highlighted in pink, the +1 site in blue and, 
WKH¶VWHPORRSVWUXFWXUHLQRUDQJH1XFOHRWLGHVWKDWPDWFKWKHFRQVHQVXVVHTXHQFHDUH 
represented by a dot. The vacA mRNA levels are reported next to the analysed promoter 
along with the strain name and vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains cultured in vitro. The 
cysS-vacA intergenic regions were aligned using the MegAlign program (DNAstar), and 
ranked in descending order according to the level of vacA mRNA/16s rRNA determined 
using real-time. The significance of differences in transcript levels between strains with 
different bases present within the vacA promoter were analysed using the Mann-Whitney 
8 WHVW 7KH ¶ VWHP ORRS VWUXFWXUH LV KLJKOLJKWHG LQ RUDQJH DQG WKH  SRVLWLRQ LV
highlighted in green. Nucleotides that match the consensus sequence are represented by 
a dot. The vacA mRNA levels are reported next to the analysed promoter along with the 
strain name and vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains cultured in vitro. The 
cysS-vacA intergenic regions were aligned using the MegAlign program (DNAstar), and 
ranked in descending order according to the level of vacA mRNA/16s rRNA determined 
using real-time. The significance of differences in transcript levels between strains with 
different bases present within the vacA promoter were analysed using the Mann-Whitney 
U test. Nucleotides that match the consensus sequence are represented by a dot. The vacA 
mRNA levels are reported next to the analysed promoter along with the strain name and 
vacA type. 
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Comparison of the cysS ± vacA intergenic regions of clinical strains cultured in vitro. The 
cysS-vacA intergenic regions were aligned using the MegAlign program (DNAstar), and 
ranked in descending order according to the level of vacA mRNA/16s rRNA determined 
using real-time. The significance of differences in transcript levels between strains with 
different bases present within the vacA promoter were analysed using the Mann-Whitney 
U test. The Shine-Dalgarno sequence and the ATG start site are highlighted in blue and 
red respectively. Nucleotides that match the consensus sequence are represented by a dot. 
The vacA mRNA levels are reported next to the analysed promoter along with the strain 
name and vacA type. 
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4.3.6 The level of vacA mRNA in vivo does not correlate with 
the level of vacA mRNA in vitro 
To determine whether there is a correlation between the level of vacA 
transcription in gastric biopsies and the same clinical strains cultured in vitro; 
vacA mRNA levels in vitro were plotted against vacA levels in vitro. The 
scatter plot shows there is no correlation between vacA transcription levels in 
vivo and in vitro (Figure 4.7). 
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Figure 4.7 vacA mRNA level in vivo does not correlate with vacA mRNA level in vitro. The 
scatter plot above shows the relative level of vacA mRNA in vitro plotted against the 
relative level of vacA mRNA in vivo. The strains were grouped based on their vacA type to 
assess whether there was a type specific correlation.  
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4.3.7 Transcriptional readthrough from cysS is not 
responsible for the vacA mRNA level of a H. pylori 
strain.   
To confirm that transcriptional readthrough from the upstream gene cysS was 
not responsible for the differences in vacA mRNA levels between strains.  PCR 
using primers A1043 and C1226 was carried out using cDNA synthesised from 
RNA extracted from broth cultures of 7 clinical strains (conditions detailed in 
2.5.4). A1043 binds 9 bp downstream of cysS and 101 bp upstream of the vacA 
transcription start site. Genomic DNA isolated from strain 60190 was used as a 
positive control for the PCR. A product of approximately 479 bp was visible in 
the control lane containing PCR product amplified from genomic DNA from 
strain 60190. No bands were visible in lanes containing PCR product amplified 
from cDNA from clinical strains 60190, 206, 218, 126, 72, 187 and 242 
indicating that there was no transcriptional readthrough from cysS (Figure 4.8 
(A)). 
 
To ensure that the cDNA used in the PCR was of a sufficient concentration an 
additional PCR was carried out on the same cDNA using primers A3436 and 
C1226 which bind within the coding sequence of vacA. Genomic DNA from 
strain 60190 was again used as a positive control for the PCR using PCR 
conditions detailed in section 2.5.4. Bands were visible at approximately 259 
bp (for vacA type s1) and at 286 bp (for vacA type s2) in lanes containing PCR 
product amplified from cDNA from clinical strains using primers A3436 and 
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C1226, indicating that the concentration of cDNA used in the PCR was 
sufficient for amplification (Figure 4.8 (B)). 
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Figure 4.8 vacA mRNA levels are not due to transcriptional readthrough from cysS. A 
2% agarose gel containing PCR products amplified using primers A1043 and C1226. 
Lane M contains a 1kb DNA ladder, lane 1 contains PCR product amplified from 
genomic DNA from strain 60190, lane 2 contains a PCR blank, lanes 3 to 9 contain PCR 
product amplified from cDNA from clinical strains 60190, 206, 218, 126, 72, 187 and 242. 
Figure 4.8 (B) shows a 2% agarose gel containing PCR products amplified using primers 
A3436 and C1226 which bind within the coding sequence of vacA. Lane M contains a 1kb 
DNA ladder, lane 1 contains PCR product amplified from genomic DNA from strain 
60190, lane 2 contains a PCR blank, lanes 3 to 9 contain PCR product amplified from 
cDNA from clinical strains 60190 (s1), 206 (s1), 218 (s1), 126 (s1), 72 (s1), 187 (s1) and 242 
(s2). 
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4.4 Discussion 
Large variations in vacA mRNA levels between strains were observed. 752 fold 
differences were seen in vitro, and relative levels of vacA mRNA in vivo 
ranged from 30.22 to undetectable. Several polymorphic differences were 
identified within the vacA promoter, and naturally occurring differences within 
the -35, -10 and the extended -10 motifs were identified. In agreement with 
previous studies on the vacA promoter in vitro, polymorphic differences were 
seen at position -32 within the -35 motif where there was a frequent G to A 
substitution (Forsyth et al., 1998, Narayanan, 2005). Ayala et al., (2004) also 
found that the differences in vacA expression between 8 strains in vitro were 
unrelated to -10 and -35 sequences. Furthermore promoter exchange 
experiments between strains 60190 (Tox+) and 86-313 (Tox-) show that 
although the two strains show differences in vacA mRNA levels, the 
differences must be dictated by sequences outside the -10 and -35 motifs as the 
two regions are identical in the two strains (Forsyth and Cover, 1999).  
 
Forsyth et al., (1999) carried out site directed mutagenesis on the cysS ± vacA 
intergenic region to determine the importance of the promoter sequences on 
vacA transcription using a xylE reporter system. Site directed mutagenesis of 
the -10 region where the wild type sequence TAAAAG was changed to 
AGATCT resulted in a 15 fold reduction in vacA level. Changing the -35 motif 
from the wild type sequence TTTATG to AGATCT resulted in a 4 fold 
reduction in expression and the deletion of 6 nucleotides (TTTATG) from 
position -37 to -32 in strain 60190 resulted in a 6 fold reduction in vacA 
expression (Forsyth et al., 1998).  
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Narayanan (2005) analysed the vacA promoter sequences of a collection of 
published strains and found that in 4 out of 8 clinical strains there was a 
guanine to adenosine substitution at position -14. However, in the study by 
Forsyth et al., 1999 substitution of guanine to a thymine at the -14 position 
using site directed mutagenesis resulted in a 2 fold reduction in vacA transcript 
level (Forsyth et al., 1999). Substitutions at the -13 and -15 positions had no 
effect on vacA transcript levels (Forsyth et al., 1998). This lead to the 
conclusion that positions -12 and -14 may be important for RNA polymerase 
binding (Forsyth et al., 1998). In this study a guanine to adenosine substitution 
was also found at position -14 within the extended -10 motif. However 
differences in the vacA transcript level between the different strains in vivo and 
in vitro were not significantly associated with the polymorphic differences 
present at these sites. 
 
In this study, polymorphic differences were observed in the spacer region 
between the -10 and the -35 motifs, however polymorphic differences in this 
region were not associated with differences in vacA mRNA levels between 
strains. The finding that the specific sequence of the spacer region was not 
associated with differences in vacA mRNA level in this study agrees with the 
findings of Forsyth et al., 1999 where substituting CCTTA to GATCT from 
positions -23 to -19 did not affect levels of vacA transcription. However 
Forsyth et al concluded that spacing appeared to be important as introducing a 
10bp insertion between -24 and -23 reduced expression. Spacing of the -10 and 
-35 motifs in the clinical strains investigated in this study was well conserved 
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(apart from one strain in which a thymine residue was inserted at position -19 
(Figure 4.1 and Figure 4.6)). 
  
Prokaryotic mRNAs can have a half life between just a few minutes to several 
hours (Brawerman, 1987). Variation in mRNA stability in prokaryotes suggests 
that its rate of decay is involved in the regulation of gene expression. The 
complex mechanisms that determine mRNA stability are beginning to be 
understood (reviewed in Regnier and Arriano, 2000). H. pylori encodes at least 
four genes involved in RNA processing and degradation which include papS, 
rnc, rnpA and pnp (Tomb et al., 1997). Products of these genes are likely to 
form part of the degradosome in H. pylori. Therefore it would be likely that H. 
pylori utilises the differences in mRNA stability to regulate gene expression. 
Furthermore, H. pylori has been shown to utilise mRNA decay to regulate 
expression of the urease gene cluster in response to acidic pH (Akada et al., 
2000).  
 
A stem loop structure beginning at the +4 site of the mRNA transcript has been 
identified previously by analysing the upstream region of sequenced strains 
using such secondary structure programs as GeneQuest (DNAstar Inc) 
(Narayanan, 2005). The stem loop structure consists of an 11 bp stem that is 
strengthened by strong GC base pairing at the base of the stem and a loop 
which is 5 nucleotides in length. This stem loop structure is well conserved. 
However, in this study, strains possessing an A at position +28 within the 
second stem of the stem loop were found to express more vacA than those that 
have a G at this position (P = 0.0089).  
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Previous studies have showQWKDW¶WHUPLQDOVHFRQGDU\VWUXFWXUHVDUHHVVHQWLDO
for the stability of some mRNAs (Bechhofer and Dubnau, 1987, Belasco et al., 
1986). Emory et al.,  LGHQWLILHG D VWHP ORRS LQ WKH ¶875 RI E. coli 
ompA, ZKLFKZDVHVVHQWLDOIRULWVIXQFWLRQDVDQP51$VWDELOLVHU7KLV¶VWHP
loop protects the ompA transcript from degradation by RNaseE, that appears to 
EHJLQ GRZQVWUHDP RI WKH ¶ WHUPLQXV 'HOHWLRQ RI WKLV VWHP ORRS UHVXOWHG LQ
reduced stability of the vacA transcript, although no effect was seen on VacA 
protein levels in a stem loop deletion mutant (Narayanan, 2005). In contrast to 
this finding, promoter exchange experiments were conducted by Forsyth et al., 
 LQ ZKLFK WKH HQWLUH ¶ XQWUDQVODWHG UHJLRQ RI vacA from strain 86-313 
(Tox-) was replaced with that of strain 60190 (Tox+) no increase in vacA 
mRNA level was observed in the chimeric strain, suggesting that sequences in 
WKH ¶ XQWUDQVODWHG UHJLRQ GR QRW VLJQLILFDQWO\ DIIHFW vacA mRNA stability. 
However the untranslated regions were not sequenced in the 2 strains and it 
may be that the untranslated regions do not differ between the two strains 
investigated in the study. Ayala et al., (DOVRFRPSDUHGWKH¶XQWUDQVODWHG
mRNA regions of 8 H. pylori strains.  They found that differences in vacA 
transcription were unrelated to sequence differences in this region. However, 
WKHLUDQDO\VLVGLGQRWLQFOXGHWKHSXWDWLYH¶VWHPORRSWKDWVWDUWVDWSRVLWLRQ
and ends at position +30 as only sequences between the position +33 and the 
ATG start site were assessed.  
 
The presence of varying numbers of binding sites for transcription factors 
could potentially explain the differences in vacA mRNA level between strains. 
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Inverted repeats often represent binding sites for transcriptional regulators. 
Ayala et al., identified an inverted repeat upstream of the -35 motif in vacA that 
was present in 4 out of 8 strains. However its role in determining transcript 
levels was not determined. In this study it was observed that strains possessing 
a perfect inverted repeat expressed significantly higher levels of vacA in vitro. 
However deleting a 27 bp region from -66 to -40, as well as a 42 bp region 
from -108 to -67, resulted in no change in vacA transcript levels in strain 60190 
VX-1 CAT when compared to the control (Forsyth and Cover, 1999).   
 
No correlation was found between vacA transcription levels in vivo and in vitro 
using matched strains and biopsies. Regions within the promoter associated 
with differences in vacA production between strains also differed in vitro and 
in vivo. Different and opposing effects in vitro and in vivo may imply that vacA 
is regulated in vivo, and could be regulated in response to growth phase of the 
bacterium or by environmental factors. The majority of bacteria are thought to 
be in a state of non-growth in their natural environment, persisting in a 
nutrient-limited stationary phase (Kjelleberg et al., 1993). Difference in growth 
phase may explain the difference in vacA transcript levels between the same 
strains in vivo and in vitro. This is supported by several studies including 
microarray analysis which demonstrated that vacA expression is repressed after 
acid exposure at pH 5.0 (Merrell et al., 2003a). This was in contrast to non-
array based work which demonstrated that vacA was induced under acidic 
conditions (Barnard et al., 2004). Furthermore, RNA dot blot analysis revealed 
a significant increase in the accumulation of vacA transcripts under iron-
restricted conditions (Szczebara et al., 1999). Other studies have investigated 
4-182 
 
the affect of adhesion to host cells on vacA transcription, (Gieseler et al., 2005) 
observed using real-time, quantitative PCR (RT-qPCR) that expression of vacA 
increased during infection of AGS cells for 4 out of 8 H. pylori strains studied. 
Similar results were also obtained during infection of polymorphonuclear 
leukocytes in which 2 out of 8 strains produced higher levels of vacA mRNA. 
This observation has been confirmed by the previous work of van Amsterdam 
et al., (2003) in which it was observed that vacA expression was induced upon 
attachment to the human gastric cell line HM02. Furthermore, the level of vacA 
was significantly reduced in coccoid forms of H. pylori which are supposed to 
represent a viable but non-culturable form of H. pylori (Monstein and 
Jonasson, 2001). 
 
4.4.1 Conclusions 
Differences in sequences within the -35 and extended -10 motifs were not 
found to be significantly associated with differences in levels of vacA 
transcription in vivo or in vitro. However sequence variations at other positions 
within the sequence may have opposing effects. No correlation was found 
between vacA transcription levels in vivo and in vitro which may imply that 
vacA is regulated in vivo.  
 
Polymorphic differences at position +28 located within a putative stem loop in 
WKH¶875RIvacA were significantly associated with vacA mRNA levels in 
vivo. Stem loops at this position are often involved in mRNA stability and may 
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provide a mechanism for determining vacA mRNA levels between different H. 
pylori strains although this would have to be investigated further.  
 
It is possible that differences in vacA transcript levels between strains may be 
due to the effect of a transcriptional activator or repressor. Inverted repeats are 
often binding sites for transcriptional regulators. An inverted repeat located 
upstream of the -35 region in the vacA promoter has been identified previously. 
In this study it was observed that strains possessing a perfect inverted repeat 
expressed significantly higher levels of vacA in vitro. Mutagenesis work would 
have to be carried out to determine the effect of these positions on vacA 
expression. Further study of these regions may provide an insight into the 
process of transcriptional regulation in H. pylori and may be relevant to 
understanding how the bacterium persists in its gastric niche. 
 
4.5 Future Work 
In order to determine whether naturally occurring sequence differences 
between strains ZLWKLQWKHXSVWUHDPLQYHUWHGUHSHDWDQGWKH¶875VWHPORRS
are relevant in determining vacA transcript levels. Site directed mutagenesis 
would have to be carried out on the regions of interest. This will be 
investigated in chapter 5. 
 
In addition, differences in the VacA signal sequences may be involved in the 
efficiency of VacA secretion and may account for the heterogeneity in VacA 
protein levels between strains. The concentration of VacA in broth culture 
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supernatants were 10-fold higher in Tox+ strain 60190 than in Tox- strain 86-
338 even though vacA transcript levels did not differ significantly between the 
two strains. The effect of signal sequence differences on secreted VacA protein 
levels will be investigated further in chapter 6.  
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Chapter 5 
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5 Investigation into the effect of an upstream 
LQYHUWHGUHSHDWDQGD¶VWHP-loop structure in 
the vacA promoter region on vacA mRNA 
levels. 
5.1 Introduction 
In Chapter 4 the effect of naturally occurring differences in the cysS ± vacA 
intergenic region on vacA transcript levels in vivo and in vitro were 
investigated. A region of particular interest in vivo was a stem-loop structure at 
the +4 site of the vacA 5¶XQWUDQVODWHGUHJLRQ875LGHQWLILHGSUHYLRXVO\E\
Narayanan (2005). Work in chapter 4 showed that this region is polymorphic, 
particularly at position +28. In 11 out of 27 strains an A was present at this 
position whereas in the other 16 strains a G was present at this position. 
Interestingly, strains with an A at this position had significantly higher levels 
of vacA mRNA than those with a G at this position (P= 0.0062). This region 
was associated with high vacA transcript levels in vivo but not in vitro. 
 
7KH SRWHQWLDO WR IRUP D ¶ VWHP-loop is a common feature in many stable 
prokaryotic mRNAs, and such stem-loop structures have been implicated in 
mRNA stabilisation of many prokaryotic transcripts (Emory et al., 1992, 
Belasco et al., 1986, Hambraeus et al., 2000, Diwa et al., 2000, Xia et al., 
2002, Bricker and Belasco, 1999, Unniraman et al., 2002a, Unniraman et al., 
2002b, Bechhofer and Dubnau, 1987, Sandler and Weisblum, 1989, Sandler 
and Weisblum, 1988)¶VWHP-loop elements protect mRNA from degradation 
by the degradative endoribonuclease RNase E by inhibiting its binding to the 
IUHH ¶ HQG WKH P51$ (Belasco et al., 1986, Bouvet and Belasco, 1992, 
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Ehretsmann et al., 1992a, Emory et al., 1992, Hansen et al., 1994). Previous 
studies have found that the length of the stem structure, the size of the loop, the 
folding energy of the stem-loop and the length of the single stranded region 
prior to the stem-ORRS ZHUH DOO IDFWRUV RI ¶ VWHP-loops that affect mRNA 
stability (Bechhofer and Dubnau, 1987). 
 
Another endoribonuclease, RNase III, can initiate mRNA degradation by 
UHPRYLQJ VWDELOL]LQJ ¶ VWHP-loop structures (Matsunaga et al., 1996a, 
Matsunaga et al., 1996b), allowing the downstream mRNA to decay at a rate 
determined by nucleases other than RNase III. RNase III cleaves double 
stranded RNAs of low sequence complexity. Recognition of the substrate by 
RNase III is dependent on the length of the double helical structure with a 
minimum length of one full turn, or approximately 11bp (Court et al., 1993, 
Nicholson et al., 1999, Robertson et al., 1982). Two specific regions, a 3-bp 
proximal box (pb) and a 2-bp distal box (db) are also involved in RNase III 
binding (Zhang and Nicholson, 1997).  The presence of certain Watson-Crick 
base pairs at specific positions within the proximal and distal boxes strongly 
inhibit cleavage by RNase III (Zhang and Nicholson, 1997). 
  
mRNA degradation has been shown to be an important mechanism for 
controlling gene expression by controlling the availability of transcripts for 
translation (Emory et al., 1992, Hambraeus et al., 2000). The ability of some 
bacteria to selectively degrade mRNAs allows them to alter their patterns of 
gene expression in response to changes in their environment.  
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7KH¶VWHP-loop in vacA appears to be well conserved among clinical isolates 
and is present in all clinical H. pylori strains investigated and begins at the +4 
site. It consists of an 11bp stem that is strengthened by strong GC base pairing 
at the base of the stem and contains a loop which is 5 nucleotides in length. 
However, 11 out of 27 strains studied in chapter 4 possess an A at position +28 
whereas the other 16 strains had a G at this position (Figure 5.1.). Deletion of 
WKH¶VWHP-loop in a previous study showed vacA transcripts were less stable 
in stem-loop deletion mutant than transcript from the wild-type parent strain 
(Narayanan, 2005) 1DWXUDO SRO\PRUSKLF GLIIHUHQFHV LQ WKH ¶ VWHP-loop 
between strains appear to be associated with vacA mRNA level in vivo and 
could potentially contribute to vacA heterogeneity in vivo.  
 
The relative stability of the vacA transcripts in the parent strain 
60190/pCTB2::cat and the stem-loop deletion mutant 60190/ǻSL were 
investigated by Narayanan, 2005 by treating broth cultures of each of the two 
strains with rifampicin, which inhibits RNA polymerase by binding in the RNA 
exit channel which leads to a halt in transcription. By Northern blotting it was 
found that detectable vacA transcript from the parental strain 
60190/pCTB2::cat gradually decreased over two hours after the addition of 
rifampicin, whereas the stem-loop deletion mutant 60190/ǻSL contained no 
detectable vacA transcript 5 minutes after the addition of rifampicin, indicating 
that the vacA transcript produced by mutant strain 60190/ǻSL was less stable 
than that of strain 60190/pCTB2::cat. Surprisingly when VacA protein levels 
were assessed in 24 hour broth cultures no significant difference in VacA 
levels between the mutant and the parent strain was observed, possibly 
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indicating that there was a problem with the methodology or that deletion of 
the stem-loop did not affect the steady-state levels of vacA mRNA when grown 
for 24 hours (Narayanan, 2005). A reduction in vacA stability was seen only in 
the rifampicin experiment. Cultures used for protein analysis, were not treated 
with rifampicin, which may explain the disparity between the mRNA and 
protein data. 
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Figure 5.1 The putative stem-loop begiQVDW WKHVLWHRI WKH¶XQWUDQVODWHGUHJLRQRI
vacA. A Guanine to Adenine substitution is present at position +28 in 11 out of 27 strains 
tested in chapter 4 (Adapted from Narayanan, 2005). 
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Another potential region of interest highlighted in chapter 4 was the inverted 
repeat upstream of the -35 motif identified by Ayala et al., (2004). Sequence 
alignment reveals that strains with a fully palindromic inverted repeat express 
significantly more vacA than other strains (P= 0.01).  
 
A large number of perfect inverted repeats have been identified in prokaryotic 
genomes. These inverted repeats may represent transcription factor binding 
sites (Ladoukakis and Eyre-Walker, 2008). The presence of, and varying 
numbers of transcription factor binding sites with differences in binding 
affinity between strains could contribute to differences in vacA transcript levels 
observed between clinical isolates seen in chapter 4. 
 
Inverted repeats have also been shown to act as sites for genetic 
rearrangements mediated by misalignment and can cause duplications or 
deletions which include the repeat itself and any intervening sequence. Perfect 
inverted repeats can arise when one copy of a small, imperfect, inverted repeat 
corrects another copy of the inverted repeat via strand misalignment (Lovett, 
2004). 
 
5.1.1 Aims 
The aims of this chapter were to investigate the role of the naturally occurring 
SRO\PRUSKLF GLIIHUHQFHV LQ WKH ¶ 875 VWHP-loop and the inverted repeat 
upstream of the -35 motif and their role  in determining vacA transcript levels. 
Site directed mutagenesis and real-time PCR were used to compare the vacA 
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transcript levels of the mutant and wild-type parent strains. The presence of 
potential regulator binding sites in the region upstream of the -35 motif was 
also investigated using a computational prediction program. 
 
5.2 Results 
5.2.1 &KDUDFWHULVDWLRQRIWKHHIIHFWRIGHOHWLRQRIWKH¶VWHP-
loop on vacA mRNA levels 
 
To confirm the results observed by G.L. Narayanan (described in section 5.1), 
and to begin to optimise the culture conditions to characterise the mutant strain 
FRQVWUXFWHG LQ WKLV VWXG\JHQRPLF'1$ZDV LVRODWHG IURPVWUDLQǻ6/ 
(prepared previously by Narayanan (2005) - details of the production of this 
mutant are outlined in Figure 5.2.). A 578bp region including 120 bp upstream 
of the vacA start codon, the region encoding the VacA signal sequence and the 
first 252 base pairs of the region encoding the mature cytotoxin was amplified 
by PCR using primers A1043 and C1226. The PCR products were purified and 
sequenced from primer A1043 using an Applied Biosystems 3100 Genetic 
analyser (Biopolymer Synthesis and Analysis unit, University of Nottingham, 
UK). Sequences retrieved were aligned to 60190/pCTB2::cat using the 
MegAlign program (DNAstar). Sequencing confirmed the presence of the 
expected mutation (Figure 5.2) and that no secondary mutations were present. 
 
Broth cultures of strains 60190/pCTB2::cat and 60190/ǻSL were prepared as 
described in section 2.2.5 and grown with shaking at 100 rpm for 18 hours. 
Three separate cultures were prepared on separate occasions. Broth culture 
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supernatants were recovered by centrifugation (as detailed in section 2.7.1) and 
VacA protein levels assessed by Western blotting using the polyclonal primary 
antibody anti-VacA p58 using the methodology detailed in section 2.7.5, and 
density of the bands was determined using densitometry as described in section 
2.7.6. Samples were also taken from the same broth cultures for RNA 
extraction at 18 hours and the vacA mRNA level per bacterial cell was assessed 
by real-time PCR using the methodology described in section 4.3.3. 
Quantitative real-time PCR was performed in triplicate for each broth culture 
tested revealed that there were no significant differences in vacA transcript 
levels between the mutant strain 60190/ǻSL and the control strain 
60190/pCTB2::cat when strains were grown in liquid culture for 18 hours with 
mean vacA mRNA levels of 0.07 and 0.073 respectively (Figure 5.3). Western 
blot analysis showed that there were no significant differences in VacA protein 
levels between strain 60190/ǻSL and 60190/pCTB2::cat with mean relative 
densitometry values of 0.62 and 0.63 respectively (Figure 5.4). 
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------------------+-------------------+-------------------+------- 
                  10                  20                  30           
------------------+-------------------+-------------------+---------- 
A G C T T T T C A A A T T T T A C C T T T T T A C A C A T T C T A G C 60190pCTB2::cat 
A G C T T T T C A A A T T T T A C C T T T T T A C A C A T T C T A G C 60190/ǻSL 
 
--------+-------------------+-------------------+-------------------+ 
        40                  50                  60                  70 
--------+-------------------+-------------------+-------------------+ 
C A A A A A T T C T A G C A A T A T T G C T T T T T A A T C T T G T T 60190pCTB2::cat 
C A A A A A T T C T A G C A A T A T T G C T T T T T A A T C T T G T T 60190/ǻSL 
 
------------------+-------------------+-------------------+---------- 
                  80                  90                  100          
------------------+-------------------+-------------------+---------- 
G A G T T T T A T G T T T A T T T A C C T T A A T T T G A T A A A A G 60190pCTB2::cat 
G A G T T T T A T G T T T A T T T A C C T T A A T T T G A T A A A A G 60190/ǻSL 
 
--------+-------------------+-------------------+-------------------+ 
        110                 120                 130                 140 
--------+-------------------+-------------------+-------------------+ 
T T T A A T A T T G G T T G T A G A T A C T G C A T A T T T A T A G C 60190pCTB2::cat 
T T T A A T A T T A G - - - - - - - - - - - - - - - - - - - - - - - - 60190/ǻSL 
 
------------------+-------------------+-------------------+---------- 
                  150                 160                 170          
------------------+-------------------+-------------------+---------- 
C T T A A T C G T A A A T G C A A C A G A A A T T T T C T A G T T T A 60190pCTB2::cat 
- - - - A T C T T A A A T G C A A C A G A A A T T T T C T A G T T T A 60190/ǻSL 
 
--------+-------------------+-------------------+-------------------+ 
        180                 190                 200                 210 
--------+-------------------+-------------------+-------------------+ 
A A G T C G C A C C C T T T G T G C A A A A A A T T G T T T T A C A A 60190pCTB2::cat 
A A G T C G C A C C C T T T G T G C A A A A A A T T G T T T T A C A A 60190/ǻSL 
 
------------------+-------------------+-------------------+---------- 
                  220                 230                 240          
------------------+-------------------+-------------------+---------- 
G A A A A G A A G A A A G G A A A G A A A T G G A A A T A C A A C A A 60190pCTB2::cat 
G A A A A G A A G A A A G G A A A G A A A T G G A A A T A C A A C A A 60190/ǻSL 
 
Figure 5.2 6HTXHQFH$OLJQPHQWRIǻ6/ The stem-ORRSGHOHWLRQPXWDQWǻ6/
and the control strain 60190/pCTB2::cat were sequenced using primer A1043. Sequences 
were aligned using the MegAlign program (DNAStar). The stem-loop region is 
highlighted in orange and the +1 site in blue. Mutated nucleotides are highlighted in pink. 
0XWDQW ǻ6/ ZDV FRQVWUXFWHG SUHYLRXVO\ E\ */ 1DUD\DQDQ XVLQJ LQYHUVH 3&5
using Pfu polymerase and pCTB2::cat as a template. Primers were designed to flank the 
stem-loop region resulting in deletion of the stem-loop%JO,,VLWHVZHUHDGGHGWRWKH¶
ends of the primers. PCR products were purified and digested with Bgl II followed by 
Dpn I treatment to remove methylated template DNA. The Bgl II sites were ligated with 
T4 ligase then transformed into E. coli Novablue cells. Antibiotic resistant colonies were 
selected; the DNA isolated then sequenced using primer C1226. The ligation reactions 
were transformed by homologous recombination into H. pylori strain 60190. Genomic 
DNA was extracted and PCR amplified using primer sets DL1, C0374 to confirm the 
correct location of the insertion and primers A1043, C1226 to confirm the presence of the 
correct mutation and the absence of secondary mutations.   
Stem 1             Loop          Stem 2            +1 
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Figure 5.3 vacA mRNA levels of strains 60190/pCTB2::cat DQGǻ6/JURZQIRU
hours in broth culture. 6WUDLQV ǻ6/ Q  DQG FRQWURO VWUDLQ S&7%FDW
(n=3) were grown in broth culture for 18 hours and vacA mRNA levels were determined 
using real-time PCR. Mean vacA P51$ OHYHOV RI  DQG  IRU ǻ6/ DQG
60190/pCTB2::cat respectively. The difference in the means of two strains was 
determined by t-test: two sample assuming unequal variance (two-tail). Error bars show 
the standard error.  
 
 
Figure 5.4 VacA Western blot of control strain 60190/pCTB2::cat and stem-loop deletion 
PXWDQWǻ6/ 18 hour broth culture supernatants were resolved by SDS-PAGE and 
immunoblotted with anti-VacA p58 antibody. Broth cultures were corrected to the same 
cell density and equal sample volumes loaded as follows: strain 60190 (lane 1), A130 (lane 
2), 60190/pCTB2::cat FXOWXUHDQGODQHVDQGUHVSHFWLYHO\ǻ6/FXOWXUH
1, 2 and 3 (lanes 6, 7 and 8 respectively).  
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5.2.2 Effect of co-culture on vacA mRNA levels  
Emory et al UHSRUWHGWKDWWKHVWDELOLVLQJHIIHFWRID¶VWHP-loop structure 
in E. coli ompA was greater under conditions of metabolic stress. Additionally 
the presence of adenosine rather than guanine at position +28 of the vacA ¶
UTR was associated with high vacA transcript levels in vivo but not in vitro. To 
begin to try to recreate in vivo culture conditions the mutant strain 60190/ǻSL 
and control strain 60190/pCTB2::cat were co-cultured with AGS cells using 
the methodology outlined in section 2.2.7 As a negative control wells 
containing H. pylori strains 60190/pCTB2::cat and 60190/ǻSL and no AGS 
cells were prepared in the same way and included on the same 24 well plate . 
The number of cultures analysed for each strain from each time point for each 
growth condition used are detailed in Figure 5.5 (A) and (B). Culture samples 
were removed from the wells by manual agitation after 30 minutes, 3 hours and 
22 hours of incubation and vacA transcript levels assessed using quantitative 
real-time PCR as described in section 4.3.3.   
 
When co-cultured with AGS cells, a 67% and 42% reduction in vacA transcript 
levels were observed in strain 60190/ǻSL at 30 minutes and 22 hours 
respectively when compared to that of the control strain 60190/pCTB2::cat. No 
significant difference in vacA mRNA levels was seen at 3 hrs (Figure 5.5 (A)). 
vacA mRNA levels were reduced by 62% and 72% in strain 60190/ǻSL 
compared to strain 60190/pCTB2::cat at 30 minutes and 22 hours when H. 
pylori cells were cultured in F12 Ham medium without AGS cells (Figure 5.5 
(B)). Again, no significant reduction in vacA transcript levels was observed in 
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strain 60190/ǻSL when cultured in F12 Ham medium for 3 hours. vacA mRNA 
levels in both strains (60190/pCTB2::cat and 60190/ǻSL) were approximately 
70% higher after 30 minutes when strains were co-cultured with AGS cells. 
vacA mRNA levels in strain 60190/pCTB2::cat were 50% higher at 22hrs 
when cultured in F12 Ham medium without AGS cells. No significant 
difference in vacA transcript levels in strain 60190/ǻSL was observed at 22hrs 
when the two growth conditions were compared. No significant differences in 
vacA transcript levels were observed in either strain when the two growth 
conditions were compared at 3 hours (Figure 5.5 (A) and (B)). 
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A 
 
B 
 
Figure 5.5 vacA P51$OHYHOVRIVWUDLQVS&7%FDWDQGǻ6/JURZQIRU
minutes, 3 hours and 22 hours in (A) co-culture with AGS cell and (B) in F12 Ham 
medium without AGS cells determined using quantitative real-time PCR. (A) Mean vacA 
mRNA levels when co-cultured with AGS cells 60190/pCTB2::cat 30 minutes 0.12 (n=3), 
3 hours 0.021 (n=6), 22 hours 0.018 (n=6);  ǻ6/PLQXWHV Q KRXUV
0.025 (n=6), 22 hours 0.01 (n=6). (B) Mean vacA mRNA levels when cultured in F12 Ham 
medium 60190/pCTB2::cat 30 minutes 0.034 (n=3), 3 hours 0.026 (n=2), 22 hours 0.037 
Q ǻ6/PLQXWHVQ hours 0.023 (n=2), 22 hours 0.01 (n=2). The 
difference between the means of two strains was determined by t-test: two sample 
assuming unequal variance (two-tail). Error bars show the standard error. 
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5.2.3 H. pylori culture in F12 Ham medium was optimised for 
analysis of vacA transcript levels at early time points  
H. pylori strains 60190/pCTB2::cat and 60190/ǻSL were cultured in 10ml of 
F12 Ham medium supplemented with L-glutamine and 10% FBS as detailed in 
section 2.2.6 and incubated for either 20 minutes, 40 minutes or 3 hours. 
Relative vacA transcript levels were determined using quantitative real-time 
PCR as detailed in sections 4.3.3. The number of cultures analysed for each 
strain from each time point used are detailed in Figure 5.6.  
 
vacA mRNA levels were significantly lower in the stem-loop deletion mutant 
60190/ǻSL by 55% (P = 0.008), 46% (P = 0.03) and 66% (P = 0.0024) at time 
points 20 minutes, 40 minutes and 180 minutes respectively when compared to 
strain 60190/pCTB2::cat (Figure 5.6).  
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Figure 5.6 vacA P51$OHYHOVRIVWUDLQVS&7%FDWDQGǻ6/JURZQIRU
minutes, 40 minutes and 180 minutes in 10ml F12 Ham medium determined using 
quantitative real-time PCR. Mean vacA mRNA levels 60190/pCTB2::cat 20 minutes 0.12 
Q PLQXWHVQ PLQXWHVQ  ǻ6/PLQQ 
40 minutes 0.046 (n=3), 180 minutes 0.012 (n=3). The difference between the means of two 
strains was determined by t-test: two sample assuming unequal variance (two-tail). Error 
bars show the standard error. 
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5.2.4 &RQVWUXFWLRQRIWKH¶875VWHP-loop mutant: 60190/SL 
GtoA  
To determine whether the presence of an adenine rather than a guanine at 
SRVLWLRQZLWKLQWKH¶VWHP-loop of the start of the untranslated region of 
vacA was important in determining differences in vacA levels between strains, 
a guanine to adenine mutation was introduced at position +28 of the vacA ¶
UTR using the QuikChange site-directed mutagenesis kit (Stratagene, UK). 
The plasmid pCTB2::cat (Forsyth et al., 1998) was used as a template which 
FRQWDLQV WKH¶HQGRI cysS, the cysS-vacA intergenic region, 274 bp of vacA 
coding sequence from H. pylori 60190 and a chloramphenicol acetyl 
transferase (catJHQHLQVHUWHGDWWKH¶ terminus of cysS (Letley et al., 2003). 
Complementary primers +4 GtoA Forward and +4 GtoA Reverse, 31 
nucleotides in length were designed to span the site that was to be mutated with 
the mutations included in the middle of the primer. These primers were used to 
replicate the wild type plasmid template pCTB2::cat which incorporated the 
mutation into the resulting plasmids. Mutant plasmids were treated with Dpn1 
to remove the methylated parent plasmid and transformed into NovaXG 
=DSSHUV(OHFtrocompetent cells E\HOHFWURSRUDWLRQXVLQJWKHPDQXIDFWXUHU¶V
protocol. Chloramphenicol resistant colonies were selected and plasmid DNA 
was extracted and the presence of the mutation confirmed by sequencing, then 
introduced into H. pylori strain 60190 by natural transformation. Mutant vacA 
alleles were incorporated into the chromosomal vacA gene by double 
homologous recombination which was selected for by chloramphenicol 
resistance. Two independent isolates of colonies of 60190/SL GtoA mutants 
were selected. To confirm that the insert had transformed into the correct 
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location in the genome, DNA was isolated from both isolates of 60190/SL 
GtoA and amplified using primers DL1 and C0374 that bind externally to the 
inserted region. PCR products amplified from strain 60190/SL GtoA had a 
product size of approximately 2 Kb, whereas those amplified from the wild-
type were approximately 900bp, indicating that the insertion had transformed 
into the correct location. To confirm the presence of the correct mutation and 
the absence of secondary mutations 120 bp region upstream of the vacA start 
codon, the region encoding the first 252bp of the region encoding the mature 
cytotoxin was PCR amplified from genomic DNA of the inverted repeat 
mutant 60190/SL GtoA using the forward primer A1043 and the reverse primer 
C1226 then sequenced using primer A1043 using an Applied Biosystems 3100 
Genetic analyser (Biopolymer Synthesis and Analysis unit, University of 
Nottingham, UK). Sequences retrieved were aligned using the MegAlign 
program (DNAstar). Sequencing confirmed the presence of the expected 
mutation (Figure 5.7) and that no secondary mutations were present in the vacA 
sequence and the sequence upstream of vacA.  
 
5.2.5 Analysis of vacA mRNA levels in wild-type and mutant 
strains 
H. pylori strains 60190/pCTB2::cat, 60190/ǻSL and 60190/SL GtoA were 
cultured in 10ml of F12 Ham medium with L-glutamine and 10% FBS, and 
incubated for 30 minutes and 180 minutes then analysed by real-time PCR 
using the methodology described in section 4.3.3. Four separate cultures were 
analysed for each strain at each time point. Two independent isolates of strain 
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60190/SL GtoA cultured in triplicate and the data from each combined to give 
a total of eight cultures of strain 60190/SL GtoA in total.   
 
Steady state levels of vacA mRNA were significantly higher in strain 60190/SL 
GtoA at 30 minutes and 180 minutes, with a 2 fold (P = 0.004),  and 4.4 fold 
(P = 0.00028) increase in vacA transcript levels respectively when compared to 
control strain 60190/pCTB2::cat. vacA mRNA levels were significantly 
reduced in the stem-loop deletion mutant 60190/ǻSL by 75% (P = 0.0081) and 
61% (P = 0.0143) at 30 minutes and 180 minutes respectively when compared 
to strain 60190/pCTB2::cat (Figure 5.8). 
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G C T T T T C A A A T T T T A C C T T T T T A C A C A T T C  Majority 
------------------+-------------------+-------------------+- 
                  10                  20                  30 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
T A G C C A A A A A T T C T A G C A A T A T T G C T T T T T  Majority 
------------------+-------------------+-------------------+- 
                  40                  50                  60 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
A A T C T T G T T G A G T T T T A T G T T T A T T T A C C T  Majority 
------------------+-------------------+-------------------+- 
                  70                  80                  90 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
T A A T T T G A T A A A A G T T T A A T A T T G G T T G T A  Majority 
------------------+-------------------+-------------------+- 
                  100                 110                 120 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
G A T A C T G C A T A T T T A T A G C C T T A A T C G T A A  Majority 
------------------+-------------------+-------------------+- 
                  130                 140                 150 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . A . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . A . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
A T G C A A C A G A A A T T T T C T A G T T T A A A G T C G  Majority 
------------------+-------------------+-------------------+- 
                  160                 170                 180 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
C A C C C T T T G T G C A A A A A A T T G T T T T A C A A G  Majority 
------------------+-------------------+-------------------+- 
                  190                 200                 210 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/SL GtoA Sc3 
 
 
Figure 5.7 The stem-loop deletion mutant 60190/SL GtoA and the control strain 60190 
pCTB2::cat were sequenced using primer A1043. Sequences were aligned using the 
MegAlign program (DNAStar). The stem-loop region is highlighted in orange and the +1 
site in blue. Mutated nucleotides are highlighted in pink.  
Stem 1 
Loop Stem 2 
+1 
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Figure 5.8 vacA P51$OHYHOVRIVWUDLQVS&7%FDWDQGǻ6/JURZQIRU
minutes and 180minutes in 10ml F12 Ham medium determined using quantitative real-
time PCR. Mean vacA mRNA levels 60190/pCTB2::cat 30 minutes 0.149 (n=4), 180 
minutes 0.015 (n=4);  60190/SL GtoA 30 minutes 0.3 (n=8), 180 minutes 0.066 (n=8). 
ǻ6/PLQXWHVQ PLQXWHVQ 7KHGLIIHUHQFHEHWZHHQWKH
means of two strains was determined by t-test: two sample assuming unequal variance 
(two-tail). Error bars show the standard error. 
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5.2.6 Disruption of the upstream inverted repeat has no 
effect on vacA mRNA levels. 
To determine whether the presence of a perfect inverted repeat upstream of the 
-35 motif in the cysS-vacA intergenic region was important in determining 
differences in vacA levels between strains the first 6 nucleotides of the perfect 
inverted repeat were changed from AGCAAT to CATAGA as described 
previously in section 5.2.4 using the plasmid pCTB2::cat as a template. The 
same nucleotides were used but in a different order to maintain the similar 
Gibbs free energy. The mutant plasmids were introduced into H. pylori strain 
60190 by natural transformation and double homologous recombination which 
was selected for by chloramphenicol resistance. The transformation of vacA 
into the correct location in the genome and the presence of the expected 
mutation and the absence of secondary mutations (Figure 5.9) was confirmed 
using the methodology described in section 5.2.4.  
 
As the presence of a perfect inverted repeat was associated with high vacA 
mRNA levels in vitro strains two independent isolates of the inverted repeat 
mutant 60190/IRDIS (60190/IRDIS sc1 and sc4) and control strain 
60190/pCTB2::cat were cultured for 18hrs in SFBB as detailed in section 2.2.5 
and the level of vacA transcript determined using quantitative real-time PCR as 
described in section 4.3.3. Three separate cultures of each strain for each time 
point were used. Data from strains 60190/IRDIS sc1 and sc4 were combined to 
give a total number of six independent cultures of 60190/IRDIS. No significant 
difference in vacA mRNA levels was observed between the two strains with a 
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mean vacA transcript level of 0.144 and 0.125 for 60190/pCTB2::cat and 
60190/IRDIS respectively (Figure 5.10).  
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------------------+-------------------+------------------- 
                  10                  20                  30 
------------------+-------------------+-------------------+- 
G C T T T T C A A A T T T T A C C T T T T T A C A C A T T C  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  40                  50                  60 
------------------+-------------------+-------------------+- 
T A G C C A A A A A T T C T A G C A A T A T T G C T T T T T  60190/pCTB2::cat 
. . . . . . . . . . . . . . C A T . G A . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . C A T . G A . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  70                  80                  90 
------------------+-------------------+-------------------+- 
A A T C T T G T T G A G T T T T A T G T T T A T T T A C C T  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  100                 110                 120 
------------------+-------------------+-------------------+- 
T A A T T T G A T A A A A G T T T A A T A T T G G T T G T A  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  130                 140                 150 
------------------+-------------------+-------------------+- 
G A T A C T G C A T A T T T A T A G C C T T A A T C G T A A  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  160                 170                 180 
------------------+-------------------+-------------------+- 
A T G C A A C A G A A A T T T T C T A G T T T A A A G T C G  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  190                 200                 210 
------------------+-------------------+-------------------+- 
C A C C C T T T G T G C A A A A A A T T G T T T T A C A A G  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
------------------+-------------------+-------------------+- 
                  220                 230                 240 
------------------+-------------------+-------------------+- 
A A A A G A A G A A A G G A A A G A A A T G G A A A T A C A  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  60190/IRDIS Sc4 
 
 
Figure 5.9 The disrupted inverted repeat mutant 60190/IRDIS and the control strain 
60190/pCTB2::cat were sequenced using primer A1043. Sequences were aligned using the 
MegAlign program (DNAStar). The inverted repeat is highlighted in blue. Mutated 
nucleotides are highlighted in pink. 
Inverted Repeat 
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Figure 5.10 vacA mRNA levels of strains 60190/pCTB2::cat and 60190/IRDIS grown for 
18 hours in broth culture determined using real-time PCR. Mean vacA mRNA levels of 
0.144 and 0.125 for 60190/pCTB2::cat (n=4) and 60190/IRDIS (n=8) respectively. The 
difference between the means of two strains was determined by t-test: two sample 
assuming unequal variance (two-tail). Error bars show the standard error.  
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5.2.7 Search for transcription factor binding sites within the 
cysS-vacA intergenic region 
$ 75$16)$& 0DWFK VHDUFK ZDV FDUULHG RXW XVLQJ WKH VHTXHQFHV RI WKH
intergenic regions of the 33 strains investigated in chapter 4 and on an 
extended sequence of 11 strains which consisted of a 771 bp region including 
WKH¶HQGRIcysS the cysS-vacA intergenic region and the region encoding the 
ILUVW ES RI WKH WUDQVODWHG ¶ HQG RI vacA (Figure 5.11). The TRANSFAC 
0DWFK SURJUDP FRQWDLQV GDWD RQ NQown transcription factors and their 
experimentally proven binding sites, enabling a search for potential regulator 
binding sites in promoter sequences which have not yet been studied in detail. 
Only two strains (121 and 206) showed a match with a previously identified 
transcription factor binding site. The predicted binding site was 26 nucleotides 
in length and spanned the -35 region. However the sequence match was that of 
transcription factor CRP (cyclic AMP receptor protein also called CAP for 
catabolite activator protein) for which there is no known homologue in H. 
pylori suggesting that this was not a reliable match.   
 
Inverted repeats have also been shown to act as sites for genetic 
rearrangements mediated by misalignment and can cause duplications or 
deletions which include the repeat itself and any intervening sequence. Perfect 
inverted repeats can arise when one copy of a small, imperfect, inverted repeat 
³FRUUHFWV´DQRWKHUFRS\RIWKHLQYHUWHGUHSHDWYLDVWUDQGPLVDOLJQPHQW(Lovett, 
2004). To investigate whether the perfect repeats present in strains 192, 206 
and 60190 had arisen by strain misalignment. The GeneQuest program 
(DNAStar) was used to search for other copies of imperfect versions of the 
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inverted repeat within the extended 771 bp sequence of 11 clinical strains. No 
other inverted repeats were observed within the sequence available. However a 
63 bp deletion was observed in 6 out of 11 strains 18 bases upstream of the 
inverted repeatFigure 5.11). Direct repeats were observed directly upstream of 
the deleted region. The same direct repeat was observed 41 bases downstream 
of the first direct repeat in strains where the 63 bp region was still present 
indicating that this region had been lost through misalignment of the two 
repeats. Deletion of this 63 bp region did not correlate with vacA transcript 
levels in vivo and in vitro.  
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           Direct repeat 1 
A C G C C T C C A A T T T T A C C T T T T T A C A C A T T C  Majority 
------------------+-------------------+-------------------+- 
                  250                 260                 270 
------------------+-------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  233  
. . . . . . . . C . . . . . . . . . . . . . . . . . . . . .  256  
G . T T T . . A . . . . . . . . . . A . . . . . . . . . . .  121  
. . . . . . . . C . . . . . . . . . . . . . . . . . . . . .  249  
G . T T T . . A . . . . . . . . . . . . . . . . . . . . . .  206  
. . . . . . . . C . . . . . . . . . . . . . . . . . . . . .  126  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . T  194  
. . . . . . . . C . . . . . . . . . . . . . . . . . . . . .  242  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  255  
G . T T T . . A . . . . . . . . . . . . . . . . . . . . . .  60190 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Tx30a 
 
T A G C C A A A A - - - - - - - - - - - - - - - - - - - - -  Majority 
------------------+-------------------+-------------------+- 
                  280                 290                 300 
------------------+-------------------+-------------------+- 
. . . . . . . . . T T T T C A G T A A G A G A G G C T T T T  233  
. . . . . . . . . T T T T C A G T A A G A G A G G T T T T T  256  
. . . . . . C . . A T T C C A A T G A G A G A A G T T T T T  121  
. . A . . . . . . T T T T C A G T A A G A G A G G C T T T T  249  
. . . . . . C . . A T T C C A A T G A G A G A A G T T T T T  206  
. . . . . C . . . - - - - - - - - - - - - - - - - - - - - -  126  
. . . . . . C . . - - - - - - - - - - - - - - - - - - - - -  194  
. . . . . C . . . - - - - - - - - - - - - - - - - - - - - -  242  
. . . . . . C . . - - - - - - - - - - - - - - - - - - - - -  255  
. . . . . . . . . - - - - - - - - - - - - - - - - - - - - -  60190 
. . . . . C . . . - - - - - - - - - - - - - - - - - - - - -  Tx30a 
 
           Direct Repeat 2 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  Majority 
------------------+-------------------+-------------------+- 
                  310                 320                 330 
------------------+-------------------+-------------------+- 
T G A G C T T T T C A A A T T T T A C A T T T T T A C A C A  233  
T A A G C T T T T C A A A T T T T A C A T T T T T A C A C A  256  
T A A A C A C C T C C A A T T T T A C C T A T T T A C A C A  121  
T A A G C T T T T C A A A T T T T A C A T T T T T A C A C A  249  
T A A A C G C C T C C A A T T T T A C C T A T T T A C A C A  206  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  126  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  194  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  242  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  255  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  60190 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  Tx30a 
 
- - - - - - - - - - - - A T T T C A G C A A T T T T A C T T  Majority 
------------------+-------------------+-------------------+- 
                  340                 350                 360 
------------------+-------------------+-------------------+- 
T T C T A G C C C A A A . . . . . . . . . . . . . . . . . .  233  
T T C T A G C C C A A A . . . . . . . . . . . . . . . . . .  256  
T T C T A A C C A C A A . . . C T . . . . . . A . . G . . .  121  
T T C T A G C C C A A A . . . . . . . . C . . . . . . . . .  249  
T T C T A A C C A T A A . . . C T . . . . . . A . . G . . .  206  
- - - - - - - - - - - - . . . . . . . . . . . . . . . . . .  126  
- - - - - - - - - - - - C . . . . . A T . T . . . . G . . .  194  
- - - - - - - - - - - - . . . . . . . . C . . G . . G . . .  242  
- - - - - - - - - - - - . . . . . . . . C . . G . . . . . .  255  
- - - - - - - - - - - - . . . C T . . . . . . A . . G . . .  60190 
- - - - - - - - - - - - . . . . . . . . C . . . . . . . . .  Tx30a 
Figure 5.11 Direct repeats were observed directly upstream of the 63 bp deleted region. 
The same direct repeat was observed 41 bases downstream of the first direct repeat in 
strains where the 63 bp region had not been deleted. The extended cysS-vacA intergenic 
regions were sequenced using primer A1043. Sequences were aligned using the MegAlign 
program (DNAStar). The upstream direct repeat is highlighted in yellow and the 
downstream repeat is highlighted in pink. A dot represents a match with the consensus 
sequence and a dash represents the absence of a nucleotide.  
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5.3 Discussion 
The control of mRNA stability is an important mechanism for controlling 
expression of many prokaryotic genes by controlling availability of transcripts 
for translation into protein (Emory et al., 1992, Hambraeus et al., 2000, 
Bechhofer and Dubnau, 1987, Carrier and Keasling, 1997b, Carrier and 
Keasling, 1997a). H. pylori has been shown to utilise mRNA decay to regulate 
the expression of the urease gene cluster in response to acidic pH (Akada et al., 
2000). mRNA degradation in bacteria appears to be initiated by one or more 
endoribnucleolytic cleavages followed by digestion of the cleavage products by 
¶WR¶H[RULERQXFleases (Cannistraro et al., 1986, Emory and Belasco, 1990). 
Six ribonucleases are known to be involved in mRNA decay in E. coli, three of 
which are site specific endoribonucleases: RNase E, RNase G and RNase III. 
The other three are exoribonucleases: RNase II, polynucleotide phosphorylase 
and oligoribonuclease.  
 
mRNA degradation in E. coli is primarily mediated by the single strand 
specific endoribonuclease RNase E (Ehretsmann et al., 1992a, Ehretsmann et 
al., 1992b, McDowall et al., 1994). RNase E requirHVDIUHHVLQJOHVWUDQGHG¶
RNA region to bind to the target mRNA before scanning the transcript for 
cleavage sites which are VXEVWUDWHV WKDW OLH ¶ WR AU dinucleotides in single-
stranded segments (Mackie, 1991, Mackie and Genereaux, 1993, Ehretsmann 
et al., 1992a, Ehretsmann et al., 1992b, Emory and Belasco, 1990). RNase E 
cleavage is considered to be the rate limiting step in mRNA degradation 
(Kushner, 2002). Stem-loop structures ORFDWHG LQ WKH ¶ 875 RI PDQ\
5-214 
 
prokaryotic transcripts have been found to protect mRNA from degradation by 
LQKLELWLQJ51DVH(ELQGLQJWRWKH¶HQGRIWKHWUDQVFULSW(Belasco et al., 1986, 
Bouvet and Belasco, 1992, Ehretsmann et al., 1992a, Ehretsmann et al., 1992b, 
Emory et al., 1992, Hansen et al., 1994) WKXVSUHYHQWLQJWKH¶WR¶GLJHVWLRQ
of cleavage products by exoribonucleases. The half life of the normally labile 
blaA transcript was increased by the addition of a stem-ORRSVWUXFWXUHWRWKH¶
terminal end of the transcript (Georgellis et al., 1992). 'HOHWLRQRIWKH¶VWHP-
loop of the ompA transcript reduces its half-life by a factor of 5 (Emory et al., 
1992). In the absence of the ompA ¶VWHP-loop, degradation was found to start 
GRZQVWUHDPRIWKH¶HQG(Emory et al., 1992)6HYHUDOIHDWXUHVRIWKH¶VWHP-
loop structures appear to be important in determining transcript stability: the 
length of the stem, the size of the loop and the folding energy of the stem-loop 
(Bechhofer and Dubnau, 1987). Mutational analysis by Emory et al., (1992) 
also revealed that the length of the single stranded region is crucial for mRNA 
stability, as the presence of a single stranded region of more than 4 nucleotides 
DW WKH¶ WHUPLQXV UHGXFHGP51$VWDELOLW\ (Emory et al., 1992). However it 
has been suggested that the optimum position of the stem-loop could be strain 
specific, as some bacteria have stem-loops at distances slightly further than 5 
QXFOHRWLGHVIURPWKHH[WUHPH¶HQG(Regnier and Arraiano, 2000).  
 
Alternatively the increase in steady-state vacA mRNA levels could be due to a 
difference in RNase III. Endoribonuclease RNase III has been shown to 
UHPRYH WKH ¶ VWHP-loops responsible for mRNA stability (Regnier and 
Arraiano, 2000). RNase III cleaves double stranded RNAs of low sequence 
complexity. Recognition of the substrate by RNase III is dependent on the 
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length of the double helical structure with a minimum length of one full turn or 
approximately 11bp (Court el al., 1993, Nicholson et al., 1999, Robertson et 
al., 1982). Watson-Crick base pair sequence elements also participate in 
controlling substrate reactivity. Two specific regions, a 3-bp proximal box (pb) 
and a 2-bp distal box (db) are involved in RNase III binding with the presence 
of certain Watson-Crick base pairs at specific positions within the proximal 
and distal boxes, strongly inhibiting cleavage by RNase III (Zhang and 
Nicholson, 1997, Li and Nicholson, 1996). Introduction of one or more of these 
excluded Watson-Crick base pairs into either the proximal or distal box in a 
model substrate inhibited cleavage by RNase III due to an interference in 
RNase III binding (Zhang and Nicholson, 1997). A possible explanation for the 
differences in vacA transcript levels seen between 60190/SL GtoA and the 
control strain 60190/pCTB2::cat could be that the presence of adenine rather 
WKDQ JXDQLQH DW WKH  SRVLWLRQ ZLWKLQ WKH ¶ VWHP-loop of vacA creates an 
excluded Watson-Crick base pair which inhibits RNase III binding and 
cleavage. An RNase III sequence homologue has been identified in H. pylori 
(Tomb et al., 1997), although its role in determining vacA transcript stability 
remains to be determined. 
 
vacA mRNA levels were significantly reduced in the stem-loop deletion mutant 
60190/ǻSL by 55% (P = 0.008), 46% (P = 0.03) and 66% (P = 0.0024) at time 
points 20 minutes, 40 minutes and 180 minutes respectively when compared to 
strain 60190/pCTB2::cat (Figure 5.6). Strains 60190/ǻSL and 
60190/pCTB2::cat were co-cultured with AGS cells. After 30 minutes and 22 
hours 67% and 42% reductions in vacA transcript levels were observed in 
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strain 60190/ǻSL respectively when compared to that of the control strain 
60190/pCTB2::cat. Oddly, no significant difference in vacA mRNA levels was 
seen at 3 hrs (Figure 5.5 (A)). vacA mRNA levels were reduced by 62% and 
72% in strain 60190/ǻSL compared to strain 60190/pCTB2::cat at 30 minutes 
and 22 hours when H. pylori cells were cultured in F12 Ham medium without 
AGS cells (Figure 5.5 (B)). vacA mRNA levels were significantly reduced in 
the stem-loop deletion mutant 60190/ǻSL by 75% (P = 0.0081) and 61% (P = 
0.0143) at 30 minutes and 180 minutes respectively when compared to strain 
60190/pCTB2::cat (Figure 5.8). The increase and decrease in the vacA mRNA 
levels between the control strain 60190 pCTB2::cat and the mutant strains 
60190 SL GtoA and 60190 SL respectively may represent a difference in 
mRNA stability between the strains. The vacA mRNA level in ǻSL may be due 
to an increase in stem-loop stability that protects from degradation by RNase E. 
Previous studies have found that the length of the stem structure, the size of the 
loop, the folding energy of the stem-loop and a single stranded region of no 
PRUH WKDQ  QXFOHRWLGHV IURP WKH ¶WHUPLQXV RI WKH 51$ VHJPHQW ZHUH DOO
IDFWRUV RI ¶ VWHP-loops that affect mRNA stability (Emory and Belasco, 
1990). The presence of the stem-loop is more important than its primary 
sequence to the activity of the ompA mRNA stabiliser. The location of this 
stem-loop is crucial to its stabilizing effect against RNase E. 
 
Steady state levels of vacA mRNA were significantly higher in strain 60190/SL 
GtoA when grown in 10ml of F12 Ham medium for 30 minutes and 180 
minutes, with a 2 fold (P = 0.004),  and 4.4 fold (P = 0.00028) increase in vacA 
transcript levels respectively when compared to control strain 
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60190/pCTB2::cat. The increase in vacA mRNA level in strain 60190/SL GtoA 
may be due to an increase in stem-loop stability that protects the transcript 
from degradation by RNase E. Another possibility is that the presence of 
unfavourable Watson-Crick base pairing within the putative proximal box in 
strains with an A at the +28 position hinders binding of RNase III inhibiting 
cleavage of this stem-loop and thus increasing the stability of the transcript in 
these strains.  
 
No RNase E homologues have been identified in H. pylori. However, there is 
no RNase E sequence homologue in the genome of Bacillus subtilis (Kunst et 
al., 1997) there is evidence for an RNase E like activity in this organism 
(Condon et al., 1997, Belasco et al., 1986). The C-terminal half of E. coli 
RNase E is not highly conserved evolutionarily (Kido et al., 1996). A 
significantly divergent rnase E gene in H. pylori may explain its lack of 
LGHQWLILFDWLRQ$OVRWKHSRVVLELOLW\WKDWWKH¶875VWHP-loop is a binding site 
for a trans-acting factor cannot be excluded either. Results of a preliminary 
experiment suggest that the differences in vacA transcript levels seen between 
the wild-type and the mutant strains are due to mRNA stability. Liquid cultures 
of stem-loop mutant strains 60190/ǻSL and 60190/SL GtoA, and the control 
strain 60190/pCTB2::cat were split into two; rifampicin was added to one half 
of the culture to arrest transcription, and the other half was untreated. RNA was 
isolated from cultures at time intervals of 60 minutes and 120 minutes and the 
levels of vacA mRNA present per bacterial cell for each strain were assessed 
simultaneously using real-time PCR. The amount of vacA mRNA degradation 
in each of the strains was determined by calculating the percentage reduction in 
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the level of vacA mRNA in cultures with rifampicin added compared to the 
cultures without rifampicin. A 30% reduction in the level of vacA mRNA was 
observed in the wild-type control strain 60190/pCTB2::cat, whereas only a 6% 
reduction in vacA transcript level was observed in the strain 60190/SL GtoA 
indicating that the presence of an adenine rather than a guanine at position +28 
within the stem-loop increased transcript stability. Deletion of the stem-loop 
reduced the stability of the vacA transcript with a 41% reduction in vacA 
transcript levels in the stem-loop deletion mutant 60190/ǻSL compared to the 
control. However, due to time constraints only one experiment was performed. 
Further replicate experiments would need to be carried out to confirm that 
differences in vacA transcript levels are truly due to differences in mRNA 
stability.  
 
7KH HIIHFW RI GHOHWLRQ RI WKH ¶ VWHP-loop was dependent on the growth 
conditions used. vacA mRNA levels were significantly reduced in 60190/ǻSL 
compared to the control when co-cultured with AGS cells or cultured in tissue 
culture medium. No reduction in vacA mRNA levels were seen when strain 
60190/ǻSL was grown in SFBB supplemented with 5% FBS with shaking for 
18 hours. When co-cultured with AGS cells or grown in 300µl of F12 Ham 
medium for 3 hours in a 24 well plate there was no reduction in vacA transcript 
levels in strain 60190/ǻSL compared to the control. Interestingly, when strains 
were cultured in 10ml of F12 Ham medium for 3 hours a 61% (P = 0.0143) 
reduction was observed. Differences in growth phase or nutrient availability 
may explain the differences in vacA transcript levels observed between the 
different culture conditions used in this study. Previous studies have shown that 
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vacA expression is regulated in response to growth phase (Forsyth and Cover, 
2000, Boonjakuakul et al0RUHRYHUPRVWNQRZQ¶P51$VWDELOLVHUV
function only under specific environmental conditions. In rapidly growing E. 
coli FXOWXUHVWKH¶875FDQVWDELOLVHWKHompA transcript resulting in a half life 
of 17 minutes. However the half life of ompA is growth rate regulated and falls 
to approximately 4 minutes in slow growing cells (Emory and Belasco, 1990). 
Stem-ORRSVWUXFWXUHVLQWKH¶875KDYHEHHQVKRZQWRIXQFWLRQDVJURZWKUDWH
regulated mRNA stabilisers in Serratia marcescens and Enterobacter 
aerogenes and appear to be highly conserved amongst enteric bacteria (Chen et 
al., 1991). The stability of the succinate dehydrogenase (SDH) and subtilisin 
transcripts of Bacillus subtilis are also growth rate dependent (Melin et al., 
1989, Resnekov et al., 1990). Several groups have reported regulation of 
mRNA stability in response to nutrient deprivation. After 24 hours of total 
energy, carbon, nitrogen and phosphorus starvation the mRNA half life of 
Vibrio angustum S14 increased 6 fold (Albertson et al., 1990). The E. coli 
ompA and blaA transcripts show increased stability when cultures are moved 
from aerobic to anaerobic conditions during slow growth (Georgellis et al., 
1992, Georgellis et al., 1993). mRNA stability plays a prominent role in the 
control of gene expression in response to cold shock; the cspA transcript in E. 
coli LV XQVWDEOH DW Û& KRZHYHU ZKHQ WHPSHUDWXUHV DUH UHGXFHG WR Û& LWV
stability increases from 12 seconds to 20 minutes (Brandi et al., 1996, 
Goldenberg et al., 1996, Fang et al., 1997). 
 
Interestingly, vacA mRNA levels in both strains 60190/pCTB2::cat and 
60190/ǻSL were approximately 70% higher at 30 minutes when strains were 
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co-cultured with AGS cells than without. This is in agreement with previous 
studies that also showed that vacA expression is up regulated upon binding to 
epithelial cells (Gieseler et al., 2005, Szczebara et al., 1999, van Amsterdam et 
al., 2003). An increase in vacA transcript levels has also been observed during 
infection of PMNs (Gieseler et al., 2005). However the expression patterns 
were dependent on the infecting strain and were also dependent on time 
(Gieseler et al., 2005).  
 
Narayanan, (2005) investigated vacA mRNA stability in the stem-loop deletion 
mutant 60190/ǻSL and the control strain 60190/pCTB2::cat. RNA was isolated 
from cultures at time intervals after transcription inhibition with rifampicin and 
vacA transcript levels were assessed by Northern blot. vacA transcripts in 
60190/ǻSL were less stable than vacA transcripts in strain 60190/pCTB2::cat. 
However there were no detectable differences in VacA protein levels between 
the two strains. In this study when strains 60190/ǻSL and 60190/pCTB2::cat 
were cultured for 18 hours in SFBB no detectable difference in vacA transcript 
levels or protein levels were observed. The disparity between the two studies 
could possibly be explained by the culture conditions used in the two studies; 
Narayanan (2005) analysed cultures treated with rifampicin when investigating 
transcript levels between the two strains, separate 24 hour broth cultures with 
no rifampicin were used when protein levels were determined. It may be that 
when strains are rapidly growing (e.g. in 24 hour broth culture in complex 
media), the effect of differences in mRNA stability may not be apparent. 
Treatment with rifampicin blocks transcription and as a result growth will also 
be severely impaired. It may be that the effect of the differing mRNA stability 
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between the two strains would be detectable only in this state of metabolic 
stress.  
 
Figure 4.6 in chapter 4 shows that strains with a fully palindromic inverted 
repeat express significantly more vacA than other strains (P= 0.01). No 
difference in vacA transcript levels were observed between the control strain 
60190/pCTB2::cat and 60190/IRDIS indicating that this region was not 
important in determining vacA transcript levels in vitro. The significant 
association seen in chapter 4 may be due to changes outside the inverted repeat, 
furthermore, the sequence of the inverted repeat does not match any known 
UHJXODWRUELQGLQJVLWHV$75$16)$&0DWFKVHDUFKFDUULHGRXWRQWKHcysS-
vacA intergenic sequence revealed a match to a CRP binding site in strains 121 
and 206 which was 26 nucleotides in length and spanned the -35 motif. 
However no CRP homologue has been identified in H. pylori and may 
represent a false positive result.   
 
Inverted repeats have also been shown to act as sites for genetic 
rearrangements mediated by misalignment, and can cause duplications or 
deletions which include the repeat itself and any intervening sequence (Lovett 
et al., 2004). Perfect inverted repeats can arise when one copy of a small, 
imperfect, inverted repeat corrects another copy of the inverted repeat via 
strand misalignment (Lovett et al., 2004). No other inverted repeats were 
REVHUYHG ZLWKLQ WKHES VHTXHQFH LQFOXGLQJ WKH¶ HQGRI cysS, the cysS-
vacA LQWHUJHQLFUHJLRQDQGWKH¶HQGRIWKHvacA coding sequence. This would 
suggest that the perfect inverted repeat in strains 60190, 206 and 121 had not 
5-222 
 
arisen through strand misalignment between two imperfect inverted repeats. A 
63 bp deletion was observed in 6 out of 11 strains 18 bases upstream of the 
inverted repeat. Direct repeats were observed directly upstream of the deleted 
region: the same direct repeat was observed 41 bases downstream of the first 
direct repeat in strains where the 63 bp region was still present, indicating that 
this region had been lost through misalignment of the two repeats. Deletion of 
this 63 bp region did not correlate with vacA transcript levels in vivo or in vitro 
which would suggest that this region is not important in determining vacA 
transcript levels. Garner et al. (1995) also observed that a 63bp deletion 
occurred in 3 out of 6 strains analysed. They also found that the presence or 
absence of this 63bp region was not associated with the cytotoxin phenotype in 
these strains (Garner and Cover, 1995). 
 
5.3.1 Conclusions 
The presence of the stem-ORRS LQ WKH ¶ 875 RI vacA is important in 
determining steady-state levels of vacA transcript. Replacing a G with an A at 
position +28 a substitution present in wild-type clinical strains, resulted in an 
increase in the level of vacA mRNA. This finding is in agreement with the 
observation in chapter 4, which showed the presence of an A at the +28 
position was significantly associated with higher levels of vacA transcript in 
clinical strains in vivo. In agreement with previous studies, vacA expression 
was up-regulated when bound to AGS cells. No difference in vacA mRNA 
levels were observed between the stem-loop deletion mutant and the control 
when strains were cultured in SFBB, but differences in vacA expression were 
5-223 
 
observed when cultured in tissue culture medium which may indicate that vacA 
expression is either dependent on growth phase or the differing environmental 
or nutritional factors between the two different types of culture media used. 
Preliminary results suggest that the differences in vacA transcript levels 
observed between the two stem-loop mutants and the control strain are due to 
differences in mRNA stability, however further studies would have to be 
carried out to confirm this finding and to determine the mechanism by which 
WKH¶VWHP-loop regulates vacA transcript levels.  
 
Figure 4.6 in chapter 4 showed that strains with a fully palindromic inverted 
repeat express significantly more vacA than other strains (P= 0.01). No 
difference in vacA transcript levels were observed between the control strain 
60190/pCTB2::cat and 60190/IRDIS indicating that this region was not 
important in determining vacA transcript levels in vitro. The significant 
association seen in chapter 4 may be due to changes outside the inverted repeat. 
Furthermore, the sequence of the inverted repeat did not share significant 
sequence homology to known prokaryotic regulator binding sites. A 63 bp 
deletion, observed in 6 out of 11 strains 18 bases upstream of the inverted 
repeat appeared to be lost through misalignment of the two repeats. Deletion of 
this 63 bp region did not correlate with vacA transcript levels in vivo or in vitro 
which would suggest that this region is not involved in determining vacA 
transcript levels. 
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5.4 Future work 
Preliminary results suggest that the differences in vacA transcript levels seen 
between the wild-type strain 60190/pCTB2::cat and the mutant strains 
60190/ǻSL, 60190/SL GtoA are due to mRNA stability, However, further 
replicate experiments are required to determine whether this is reliable. Further 
studies are also needed to determine the mechanism of vacA mRNA 
degradation in H. pylori. One example might be to assess the involvement of 
RNase III in determining vacA transcript levels by knocking out rnc gene 
encoding RNase III in H. pylori and assessing its effect on vacA transcript 
levels. 
 
Several studies have shown that acid exposure affects vacA transcription. 
These studies generally showed that vacA expression was induced under acidic 
conditions (Barnard et al., 2004, Merrell et al., 2003a, Choi et al., 2001). One 
study indicated that vacA expression was repressed after acid exposure at pH 
5.0 (Gancz et al., 2006). Two other studies found no difference in vacA 
expression in response to acid exposure (Allan et al., 2001, Ang et al., 2001). 
vacA transcription has also been shown to be up regulated in response to iron 
depletion in vitro (Szczebara et al., 1999, Merrell et al., 2003). Other studies 
have shown that vacA transcript levels are increased by attachment to epithelial 
cells (van Amsterdam et al., 2003, Bach et al., 2002, Graham et al., 2002, 
Salama et al., 2000, Gieseler et al., 2005). Additionally, vacA expression has 
been found to be growth phase dependent (Thompson et al., 2003, Narayanan, 
2005, Forsyth and Cover, 2000, Boonjakuakul et al., 2004). It would be 
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LQWHUHVWLQJ WR LQYHVWLJDWH ZKHWKHU WKH ¶ VWHP-loop in vacA plays a role in 
regulating vacA production in response to these environmental conditions. 
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Chapter 6
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6 Characterisation of the effect of polymorphic 
differences in the region encoding the VacA 
signal cleavage recognition site on VacA 
production. 
6.1 Introduction 
Many secreted bacterial proteins possess a signal sequence in their N-terminus, 
which directs secretion by the general secretion pathway. The signal peptidase 
then cleaves the signal sequence from the N-terminus of membrane and 
secreted proteins after they have been translocated across the cytoplasmic 
membrane. Bacterial signal sequences possess a positively charged N-terminus 
that orientates the signal in the inner membrane (N-region), a hydrophobic core 
that forms a membrane spanning helix (H-region), and a polar C-terminal 
region (C-region) that contains a cleavage recognition site that acts as a 
substrate for the leader peptidase. The C-region must have a ȕ stranded 
formation to be recognised by the signal peptidase (Izard and Kendall, 1994). 
Analysis of a large number of signal sequences has shown there is a 
characteristic pattern of small apolar residues at positions -1 and -3 relative to 
the cleavage site. Alanine, glycine and serine are preferred at the -1 position. In 
addition to alanine, glycine and serine, larger residues such as valine, 
threonine, leucine and isoleucine can be accommodated at the -3 position. Such 
structural regularity in the -3 and -1 region is considered to be necessary for 
recognition of the signal peptide cleavage site by leader peptidase. A helix 
breaking residue is needed at position -6. It has been observed that these 
positions are the most important with respect to processing, with positions -2, -
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4, -5 and +1 being of secondary importance (von Heijne, 1983, von Heijne, 
1984, Perlman and Halvorson, 1983). However, the presence of proline at the 
+1 position has been shown to prevent cleavage of the signal peptide (Barkocy-
Gallagher and Bassford, 1992, Nilsson and von Heijne, 1992). 
 
The signal region of VacA is polymorphic. VacA type s1 and VacA type s2 not 
only differ in the position of their signal cleavage site, which determines their 
toxicity (with type s2 possessing a 12-amino acid hydrophilic N-terminal 
extension (Letley et al., 2003, Letley and Atherton, 2000), but also in the 
amino acids present at various positions within the signal sequence (Figure 
6.1). Both VacA type s1 and s2 have alanine present at the -1 position. Studies 
on the processing of E. coli alkaline phosphatase, show that the presence of 
alanine, glycine and serine at the -1 position allows processing, with alanine 
providing the highest rate of processing (Karamyshev et al., 1998). Serine is 
present at position -3 in type s1 VacA, whereas type s2 VacA has leucine 
present at this position. Studies on the effect of sequence variation on the 
processing of the M13 procoat protein revealed that, only procoat proteins with 
small amino acids (serine and glycine) at the -3 position were efficiently 
cleaved in vivo, whereas presence of leucine at the -3 position retarded 
cleavage (Shen et al., 1991). However it has been suggested that the effect of 
some amino acid substitutions at position -3 on processing may vary from 
protein to protein, as mutant maltose-binding proteins with leucine, threonine 
or valine at the -3 position were processed efficiently (Fikes et al., 1990).  
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A characteristic feature of bacterial signal sequences is the presence of a helix-
destabilizing residue such as a proline or glycine between the -4 and the -6 
position of the peptide. In type s1 VacA, proline is present at -6, whereas in 
type s2 glycine is present at this position. Although proline and glycine are 
both effective helix breakers, procoat substituted with a glycine at the -6 
position was not processed in vivo, and had reduced processing in vitro, 
compared to the wild type with proline at -6 (Shen et al., 1991). It is thought 
that proline helps alter the conformation of the polypeptide chain surrounding 
the cleavage site, allowing efficient cleavage of the signal peptide. In addition 
to the differences between VacA type s1 and s2 at the -1, -3, and -6 positions, it 
has also been observed that there are differences in the signal sequences 
between VacA type s1a strains that possess a glutamine at the -4 position and, 
type s1b VacA that has glutamate at -4 (Figure 6.1). However a study of the 
processing of mutant alkaline phosphatases showed that only lysine when 
present at the -4 position affects processing (Karamyshev et al., 1998). 
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Figure 6.1 Signal sequences of VacA type s1a, s1b and s2. The cleavage site of each 
sequence is indicated by an arrow. Type s2 VacA possesses a 12-amino acid N-terminal 
extension and so differs in its cleavage site to s1 type vacA. All three signal sequences 
possess an alanine at the -1 position. Type s1a and s1b, VacA have a serine at position -3 
and a proline at the -6 position, whereas type s2 VacA has leucine at position -3 and a 
glycine at position -6. 
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The presence of only type I signal peptidase is typical for many Gram-negative 
bacteria such as, E. coli, Haemophilus influenzae, Pseudomonas fluorescens, 
Salmonella typhimurium and Yersinia pestis (Dalbey and Wickner, 1985). The 
best characterised type I signal peptidase is that of E. coli which is also known 
as leader peptidase (Lep), and is encoded by the lepB gene (Wolfe et al., 1983, 
Zwizinski et al., 1981). The E. coli signal peptidase is a 35.9 kDa protein with 
2 N-terminal transmembrane segments (residues 4-28 and 58-76) that enclose a 
small cytoplasmic domain (residues 29-57) which preceed the large C-terminal 
catalytic domain (residues 77-323). (Wolfe et al., 1983, Moore and Miura, 
1987, San Millan et al., 1989). Bacterial signal peptidases are generally well 
conserved particularly in five regions known as boxes A, B, C, D, and E. 
Studies on the three dimensional structure of the E. coli signal peptidase Lep, 
revealed that it has predominantly ȕ ± sheet formation that consists of two anti-
parallel ȕ ± sheet domains (Tschantz et al., 1995). Domain II contains box A 
which forms the N-terminal anchor. Domain I represents the catalytic domain 
which contains boxes B, C, D and E. All of these domains form part of or are 
close to the active site of the signal peptidase (See Figure 6.12.). The E. coli 
signal peptidase Lep has two small hydrophobic clefts that form the S1 and S3 
binding pockets that accommodate the -1 and -3 residues of the signal peptide 
(Figure 6.11). The residues that form the S1 and S3 pockets are primarily 
hydrophobic. However, the S3 pocket is broader and not as deep as the S1 
pocket which is consistent with the finding that larger residues can be 
accommodated at the -3 position of the signal peptide (Nielsen et al., 1997b, 
Nielsen et al., 1997a, Antelmann et al., 2001).  
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The amount of VacA produced by a strain has been shown to be important in 
H. pylori pathogenesis. In chapter 3 a significant positive association was 
found between the vacA mRNA level of an infecting strain and the severity of 
inflammation, activity, atrophy and infection density in the gastric mucosa. A 
small study carried out by Narayanan, (2005) showed that there was an 
association between high vacA transcript levels and the occurrence of ulcers or 
erosions in the patient. Additionally, it has been shown that large amounts of 
toxin produce greater damage in animal models (Ogura et al., 2000).  Previous 
studies on bacterial signal sequences have shown that the primary structure 
affects processing efficiency and therefore the amount of protein secreted (von 
Heijne, 1983). 
 
6.1.1 Aims 
The aim of this chapter was to assess the importance of the natural 
polymorphisms in the VacA signal sequence on toxin production in the toxic 
strain 60190, and the non-toxic strain Tx30a. Sequence differences between the 
signal peptidase LepB of strains 60190 and Tx30a were also investigated.  
 
6.2 Results 
Isogenic H. pylori vacA mutants were constructed by D.P. Letley prior to this 
study, details of the mutations made and their construction is outlined below. 
Isogenic H. pylori vacA mutants were made in which serine had been replaced 
by leucine at position -3 (60190/S(-3)L) of the signal peptide, and proline had 
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been replaced by glycine at position -6 (60190/P(-6)G) in the VacA sequence 
of strain 60190. Double mutants in which both proline and serine at positions -
6 and -3 were replaced by glycine and leucine respectively 60190/(P(-6)GS(-
3)L) had also been constructed. Isogenic vacA mutants of H. pylori strain 
Tx30a in which leucine had been substituted for serine at position -3 
(Tx30a/L(-3)S), and glycine had been replaced by proline at position -6 
(Tx30a/G(-6)P) in the VacA sequence of strain Tx30a were also constructed. 
Again double mutants were also created in which both glycine and leucine at 
positions -6 and -3 were substituted for proline and serine respectively 
(Tx30a/G(-6)PL(-3)S).  
 
The plasmid templates used for site-directed mutagenesis of vacA were 
pCTB2::cat for the 60190 mutants, and pA153::cat for the Tx30a mutants. 
Both pBOXHVFULSW EDVHG YHFWRUV FRQWDLQHG WKH ¶ end of the upstream gene 
cysteinyl-tRNA synthetase (cysS) DQG WKH ¶  RU  QXFOHRWLGHV RI vacA 
respectively. In both cases a chloramphenicol acetyl transferase cassette (cat) 
derived from pBSC103 (Wang and Taylor, 1990) was inserted upstream of 
vacA, immediately ¶ WR cysS (Letley et al., 2003). The codons that encode 
amino acids at positions -3 and -6 were mutagenised using the 4XLN&KDQJH
Site-Directed Mutagenesis Kit (Stratagene, UK). For each mutation, 
complementary primers between 33 and 36 nucleotides in length were designed 
to span the site that was to be mutated with the mutations included in the 
middle of the primer. To allow simple screening, mutations were designed to 
either introduce or remove a restriction endonuclease site. These primers were 
then used to replicate the wild-type plasmid templates, which incorporated the 
6-234 
 
mutation into the resulting plasmids.  The mutagenesis reactions were treated 
with DpnI restriction endonuclease which cleaves at the site GmeATC where 
the adenosine is methylated. Because the wild-type plasmid was purified from 
an E. coli strain that methylates the DNA it will be cleaved by the DpnI 
enzyme, whereas the in vitro synthesised mutated plasmid is not methylated so 
therefore it is not cleaved by the enzyme.  The DpnI treated plasmids were then 
transformed into the E. coli VWUDLQ '+Į, and chloramphenicol resistant 
transformants selected. This resulted in the enrichment of mutated plasmids 
due to the cleaved wild-type plasmid being unable to replicate. To identify 
mutated transformants, plasmid DNA was extracted and screened by restriction 
analysis using the restriction sites that were created or removed in the 
mutagenesis step. At this stage the mutations were confirmed by sequencing. 
The mutagenised plasmids were then introduced into their homologous H. 
pylori strains by natural transformation. Mutated vacA alleles were 
incorporated into the chromosomal vacA gene by double homologous 
recombination which was selected for by chloramphenicol resistance. The 
presence of the mutations was confirmed by restriction analysis. To control for 
the insertion of the chloramphenicol acetyl transferase cassette (cat) upstream 
of the vacA promoter, control strains 60190/pCTB2::cat and Tx30a/pA153::cat 
were also prepared by introducing the wild-type plasmids into their 
homologous strains, in the same manner. Previous VacA ELISA assays have 
revealed that introducing cat upstream of the vacA promoter region does not 
affect VacA levels for both strains used (Letley et al., 2003), these strains were 
used as controls. 
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6.2.1 The mutations made by site directed mutagenesis in 
the signal region of Helicobacter pylori strains, 60190 
and Tx30a were confirmed by sequencing. 
To determine the presence of the appropriate mutations in the chromosomal 
vacA gene and the absence of any secondary mutations, a 651bp and a 578bp 
region including 220 bp upstream of the vacA start codon, the region encoding 
the VacA signal sequence and the first 371 and 358 base pairs of the region 
encoding the mature cytotoxin was PCR-amplified from genomic DNA of 
wild-type H. pylori strain 60190 and Tx30a, and each independent isolate of 
their isogenic vacA signal sequence mutant derivatives using the forward 
primer A1043 and the reverse primer VacR10. Two independent isolates of 
each mutant were sequenced. Both strands were sequenced using an Applied 
Biosystems 3100 Genetic analyser (Biopolymer Synthesis and Analysis unit, 
University of Nottingham, UK). Sequences retrieved were aligned using the 
MegAlign program (DNAstar). Sequencing confirmed the presence of the 
expected mutation (Figure 6.2 (60190) and Figure 6.3 (Tx30a)) and that no 
secondary mutations were present in the vacA sequence and the sequence 
upstream of vacA.  
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M E I Q Q T H R K I N R P L V S L A L V  Majority 
------------------+-------------------+- 
                  10                  20 
------------------+-------------------+- 
M E I Q Q T H R K I N R P L V S L A L V  60190 
. . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . . . . . . . . . . .  60190/S(-3)L (1) 
. . . . . . . . . . . . . . . . . . . .  60190/S(-3)L (2) 
. . . . . . . . . . . . . . . . . . . .  60190/P(-6)G (1) 
. . . . . . . . . . . . . . . . . . . .  60190/P(-6)G (2) 
. . . . . . . . . . . . . . . . . . . .  60190/P(-6)GS(-3)L (1) 
. . . . . . . . . . . . . . . . . . . .  60190/P(-6)GS(-3)L (2) 
 
G A L V S I T P Q Q L H A A F F T T V I  Majority 
------------------+-------------------+- 
                  30                  40 
------------------+-------------------+- 
G A L V S I T P Q Q S H A A F F T T V I  60190 
. . . . . . . . . . . . . . . . . . . .  60190/pCTB2::cat 
. . . . . . . . . . L . . . . . . . . .  60190/S(-3)L (1) 
. . . . . . . . . . L . . . . . . . . .  60190/S(-3)L (2) 
. . . . . . . G . . . . . . . . . . . .  60190/P(-6)G (1) 
. . . . . . . G . . . . . . . . . . . .  60190/P(-6)G (2) 
. . . . . . . G . . L . . . . . . . . .  60190/P(-6)GS(-3)L (1) 
. . . . . . . G . . L . . . . . . . . .  60190/P(-6)GS(-3)L (2) 
 
I P A I V G G I A T   Majority 
------------------+- 
                  50 
------------------+- 
I P A I V G G I A T   60190 
. . . . . . . . . .   60190/pCTB2::cat 
. . . . . . . . . .   60190/S(-3)L (1) 
. . . . . . . . . .   60190/S(-3)L (2) 
. . . . . . . . . .   60190/P(-6)G (1) 
. . . . . . . . . .   60190/P(-6)G (2) 
. . . . . . . . . .   60190/P(-6)GS(-3)L (1) 
. . . . . . . . . .   60190/P(-6)GS(-3)L (2) 
 
Figure 6.2 Sequence alignment of wild-type H. pylori strain 60190, and its isogenic VacA 
signal sequence mutant derivatives. Each strain was sequenced using the forward primer 
A1043 and the reverse primer VacR10. The appropriate mutation was confirmed by 
nucleotide sequencing on both strands using an Applied Biosystems 3100 Genetic 
analyser (Biopolymer Synthesis and Analysis unit, University of Nottingham, UK) 
Sequences retrieved were aligned using the MegAlign program (DNAstar). Mutants are 
named according to the wild type residue replaced, its position relative to the signal 
sequence cleavage site (shown in parentheses) and the residue substituted. The deduced 
amino acid sequence of the signal peptide and first 17 residues of mature VacA are 
shown.  
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M E I Q Q T H R K I N R P I I S L A L V  Majority 
------------------+-------------------+- 
                  10                  20 
------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . .  Tx30a  
. . . . . . . . . . . . . . . . . . . .  Tx30a/pA153::cat 
. . . . . . . . . . . . . . . . . . . .  Tx30a/L(-3)S (1) 
. . . . . . . . . . . . . . . . . . . .  Tx30a/L(-3)S (2) 
. . . . . . . . . . . . . . . . . . . .  Tx30a/G(-6)P (1) 
. . . . . . . . . . . . . . . . . . . .  Tx30a/G(-6)P (2) 
. . . . . . . . . . . . . . . . . . . .  Tx30a/G(-6)PL(-3)S (1) 
. . . . . . . . . . . . . . . . . . . .  Tx30a/G(-6)PL(-3)S (2) 
 
G V L M G T E L G A N T P N D P I H S E  Majority 
------------------+-------------------+- 
                  30                  40 
------------------+-------------------+- 
. . . . . . . . . . . . . . . . . . . .  Tx30a  
. . . . . . . . . . . . . . . . . . . .  Tx30a/pA153::cat 
. . . . . . . S . . . . . . . . . . . .  Tx30a/L(-3)S (1) 
. . . . . . . S . . . . . . . . . . . .  Tx30a/L(-3)S (2) 
. . . . P . . . . . . . . . . . . . . .  Tx30a/G(-6)P (1) 
. . . . P . . . . . . . . . . . . . . .  Tx30a/G(-6)P (2) 
. . . . P . . S . . . . . . . . . . . .  Tx30a/G(-6)PL(-3)S (1) 
. . . . P . . S . . . . . . . . . . . .  Tx30a/G(-6)PL(-3)S (2) 
 
S R A F F T T V I I   Majority 
------------------+- 
                  50 
------------------+- 
. . . . . . . . . .   Tx30a  
. . . . . . . . . .   Tx30a/pA153::cat 
. . . . . . . . . .   Tx30a/L(-3)S (1) 
. . . . . . . . . .   Tx30a/L(-3)S (2) 
. . . . . . . . . .   Tx30a/G(-6)P (1) 
. . . . . . . . . .   Tx30a/G(-6)P (2) 
. . . . . . . . . .   Tx30a/G(-6)PL(-3)S (1) 
. . . . . . . . . .   Tx30a/G(-6)PL(-3)S (2) 
 
Figure 6.3 Sequence alignment of wild-type H. pylori strain Tx30a, and its isogenic VacA 
signal sequence mutant derivatives. Each strain was sequenced using the forward primer 
A1043 and the reverse primer VacR10. The appropriate mutation was confirmed by 
nucleotide sequencing on both strands using an Applied Biosystems 3100 Genetic 
analyser (Biopolymer Synthesis and Analysis unit, University of Nottingham, UK) 
Sequences retrieved were aligned using the MegAlign program (DNAstar). Mutants are 
named according to the wild type residue replaced, its position relative to the signal 
sequence cleavage site (shown in parentheses) and the residue substituted. The deduced 
amino acid sequence of the signal peptide and first 17 residues of mature VacA are 
shown.  
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6.2.2 Mutagenesis of the signal peptide affects VacA 
production in H. pylori strain 60190. 
The effect of replacing serine and proline found at positions -3 and -6 of the 
type s1 VacA signal sequence respectively with leucine and glycine that are 
present at these positions in the signal sequence of the type s2 strain was 
investigated. To do this, VacA levels of 24 hour broth culture supernatants of 
the control strain 60190 pCTB2::cat and the isogenic mutant strains 60190/S(-
3)L, 60190/P(-6)G, and 60190/P(-6)GS(-3)L (between eighteen and twenty-
two broths were analysed for each mutant) were analysed by ELISA using the 
primary anti-VacA p58 antibody, and the secondary antibody goat anti-rabbit 
IgG peroxidise conjugate (Sigma, UK). VacA amounts were expressed as 
ELISA A490 units, which were then corrected for the bacterial OD600 of the 
broth cultures (as described in section 2.7.8). Multiple broths were tested for 
each independent isolate for each mutant. Mean values for independent isolates 
were similar; hence the results for each independent isolate for each mutant 
were combined for subsequent analysis. Replacing serine with leucine at 
position -3 did not significantly reduce the amount of VacA present compared 
to the control strain 60190/pCTB2::cat (Figure 6.4). The amount of VacA in 24 
hour broth culture supernatant was significantly reduced for the isogenic 
mutant strain 60190/P(-6)G compared with the control strain (reduction of 28% 
(P <0.05)). Substitutions at both the -6 and -3 positions in the isogenic mutant 
strain 60190/P(-6)GS(-3)L also resulted in a significant reduction of VacA 
present in the broth culture supernatant compared to the control (Reduction of 
23% (P <0.05)), similar to that of the single 60190/P(-6)G mutation. The vacA 
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null mutant strain was also included to ensure that any antibody binding was 
specific. 
 
To confirm the data obtained by ELISA, western blots were performed on the 
same broth culture supernatant samples used for ELISA. The samples were 
first corrected for bacterial broth culture OD600 and separated by SDS-PAGE. 
VacA was detected, again using the primary anti-VacA antibody anti-p58 and 
the secondary antibody, goat anti-rabbit IgG peroxidase conjugate (Sigma, UK) 
(details of the methodology are outlined in section 2.7.5). The western blots 
confirmed the results observed for the ELISA, with no reduction seen for the 
60190 strains with a serine to leucine substitution at position -3 compared to 
the control. A reduction in the amount of VacA produced was seen for both 
isogenic mutant strains 60190/P(-6)G and 60190/P(-6)GS(-3)L. A 
representative western blot is shown in Figure 6.5. 
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Figure 6.4 Mean VacA ELISA values for the control H. pylori strain 60190/pCTB2::cat 
and its isogenic VacA signal sequence mutant derivatives. Supernatants from 24hr broth 
cultures (a minimum of n=18) were analysed by ELISA and corrected for bacterial 
density OD600. Bars show mean amount of VacA produced by isogenic mutants of strain 
60190. The error bars show the standard error. The significance of the difference in the 
mean of the control and mutant strains was determined using a T-test: two sample 
assuming unequal variance (two-tail) (* = P <0.05). 
 
 
Figure 6.5 A representative VacA western blot of control strain 60190/pCTB2::cat and its 
isogenic VacA signal sequence mutant derivatives. 24 hour broth culture supernatants 
were separated by SDS-PAGE and immunoblotted with anti-VacA p58 antibody. Broth 
cultures were corrected to the same cell density and equal sample volumes were loaded as 
follows: Strains 60190/pCTB2::cat (lane 1), 60190/S(-3)L (lane 2), 60190/P(-6)G (lane 3), 
60190/P(-6)GS(-3)L (lane 4). Samples are from non adjacent lanes of the same gel.  
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6.2.3 Mutagenesis of the signal peptide reduces VacA 
production in H. pylori strain Tx30a. 
As the substitutions made in the 60190 isogenic mutants 60190/P(-6)G and 
60190/P(-6)GS(-3)L resulted in a significant reduction in the amount of VacA 
present in the broth culture supernatants the reciprocal substitutions to the s2 
signal sequence were also investigated. ELISAs to determine the amount of 
VacA produced by the Tx30a isogenic signal sequence mutants compared to 
the Tx30a/pA153::cat control were carried out in the same way as before, 
again using twenty-four-hour broth culture supernatants, (between thirteen and 
fourteen broths were analysed for each mutant) and using the primary anti-
VacA antibody anti-p58 and the secondary antibody goat anti-rabbit IgG 
peroxidise conjugate (Sigma, UK). VacA amounts were expressed as ELISA 
A490 units, which were then corrected for the bacterial OD600 of the broth 
cultures. Replacing leucine with serine at position -3 significantly reduced the 
amount of VacA present in the cell culture supernatant compared to the Tx30a 
pA153::cat control by 54% (P <0.005) (Figure 6.6). The amount of VacA 
present in the 24 hour broth culture supernatant was also considerably reduced 
when glycine was replaced with proline at position -6, showing a reduction of 
51% compared to the control (P  <0.005). Substitutions at both the -6 and -3 
positions further reduced VacA production, with a reduction of 77% compared 
to the control (P <0.005). 
 
The results obtained using an ELISA were again confirmed by western 
blotting. The same broth culture supernatant samples used for the Tx30a 
ELISA were corrected for bacterial broth culture OD600 and separated by SDS-
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PAGE. VacA was detected by western blotting, using the same primary and 
secondary antibodies as before. The results confirm the results observed for the 
ELISA, with reductions seen for both Tx30a strains with single mutations 
present at positions -3 and at -6. An even further reduction was seen for Tx30a 
strains with double mutations present at positions -3 and -6 of the VacA signal 
sequence (Figure 6.7). 
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Figure 6.6 Mean VacA ELISA values for the control H. pylori strain Tx30a/pA153::cat 
and its isogenic VacA signal sequence mutant derivatives. Supernatants from 24hr broth 
cultures (a minimum of n=13) were analysed by ELISA and corrected for bacterial 
density OD600. Bars show mean amount of VacA produced by isogenic mutants of strain 
Tx30a. The error bars show the standard error. The significance of the difference in the 
mean of the control and mutant strains was determined using a T-test: two sample 
assuming unequal variance (two-tail) (** = P <0.005). 
 
 
Figure 6.7 A representative VacA western blot of control strain Tx30a/pA153::cat and its 
isogenic VacA signal sequence mutant derivatives. 24 hour broth culture supernatants 
were separated by SDS-PAGE and immunoblotted with anti-VacA p58 antibody. Broth 
cultures were corrected to the same cell density and equal sample volumes were loaded as 
follows: Strains Tx30a/pA153::cat (lane 1), L(-3)S (lane 2), G(-6)P (lane 3), G(-6)PL(-3)S 
(lane 4). Samples are from non adjacent lanes from the same gel.  
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6.2.4 The mutant constructs pA153::cat and pA153::cat G(-
6)PL(-3)S were transformed into H. pylori strain 60190 
and the level of VacA secreted assessed. 
To investigate whether it was the signal sequence or the strain background that 
was responsible for levels of VacA production, the mutant plasmid pCTB2::cat 
P(-6)GS(-3)L containing vacA from strain 60190 in which proline at the -6 
position had been replaced with glycine and serine at the -3 position was 
replaced with leucine was transformed into H. pylori strain Tx30a, thus 
restoring the amino acids present at -3 and -6 to those normally present in 
Tx30a to assess whether VacA protein levels would be restored. The mutant 
plasmid pA153::cat G(-6)PL(-3)S containing vacA from strain Tx30a in which 
glycine at the -6 position had been replaced with proline, and leucine at the -3 
position was replaced with serine was transformed into H. pylori strain 60190 
by natural transformation to restore the amino acids present at -3 and -6 to 
those normally present in 60190. The mutant plasmids were introduced into 
their heterologous H. pylori strain backgrounds by natural transformation using 
the protocol described in section 2.5.2. The mutant vacA alleles incorporated 
into the chromosomal vacA gene by double homologous recombination. Strains 
that had incorporated the mutant vacA alleles were selected for by 
chloramphenicol resistance. Two independent isolates of strain 
60190/pA153::cat G(-6)PL(-3)S were selected. To confirm that the insert had 
transformed into the correct location in the genome, DNA was isolated from 
both isolates and amplified using primers DL1 and C0374 that bind externally 
to the inserted region. PCR products amplified from strain 60190/pA153::cat 
G(-6)PL(-3)S had a product size of approximately 2000bp, whereas PCR 
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product amplified from the wild-type strain 60190 had a product size of 
approximately 900bp indicating that the insertion had transformed into the 
correct location. To confirm the presence of the correct mutation and the 
absence of secondary mutations a 578 bp region was PCR amplified from 
genomic DNA of the inverted repeat mutant 60190/pA153::cat G(-6)PL(-3)S 
using the forward primer A1043 and the reverse primer VacR10 then 
sequenced in both directions using primers A1043 and VacR10 using an 
Applied Biosystems 3100 Genetic analyser (Biopolymer Synthesis and 
Analysis unit, University of Nottingham, UK). Sequences retrieved were 
aligned using the MegAlign program (DNAstar). Sequencing confirmed the 
presence of the expected mutation and that no secondary mutations were 
present in the vacA sequence and the sequence upstream of vacA.  
 
The effect of transforming the double mutant constructs into the heterologous 
strain background was investigated. To do this, VacA levels of 24 hour broth 
culture supernatants of the control strains 60190, 60190/pA153::cat, the vacA 
null mutant 60190/A130 and the isogenic mutant strain 60190/pA153::cat G(-
6)PL(-3)S (three broths cultures of each strain were prepared for strain 
60190/pA153::cat G(-6)PL(-3)S two broths of isolate sc1 and one broth of 
isolate sc2 were cultured.) were analysed by western blotting. The samples 
were first corrected for bacterial broth culture OD600 and separated by SDS-
PAGE. VacA was detected, using the primary anti-VacA antibody anti-p58 and 
the secondary antibody, goat anti-rabbit IgG peroxidase conjugate (Sigma, UK) 
and the relative band density was determined by densitometry (Figure 6.9). A 
27% reduction in VacA protein level was seen in strain 60190/pA153::cat 
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when compared to the control strain 60190. However this reduction was not 
significant (P = 0.25) (Mean band density 0.83 and 1.13 respectively). A 
significant reduction of 95% was seen for strain 60190/pA153::cat G(-6)PL(-
3)S when compared to 60190 (P = 0.028) (Mean band density of 
60190/pA153::cat G(-6)PL(-3)S 0.053). VacA levels were 94% lower for 
strain 60190/pA153::cat G(-6)PL(-3)S when compared to 60190/pA153::cat (P 
= 0.008). 
  
 
6-247 
 
M E I Q Q T H R K I N R P I I S L A L V  Majority 
------------------+-------------------+- 
                  10                  20 
------------------+-------------------+- 
M E I Q Q T H R K I N R P I I S L A L V  Tx30a 
. . . . . . . . . . . . . . . . . . . .  60190/pA153::cat (1)  
. . . . . . . . . . . . . . . . . . . .  60190/G(-6)PL(-3)S 1 (1)  
. . . . . . . . . . . . . . . . . . . .  60190/G(-6)PL(-3)S 3 (2)  
 
G V L M G T E L G A N T P N D P I H S E  Majority 
------------------+-------------------+- 
                  30                  40 
------------------+-------------------+- 
G V L M G T E L G A N T P N D P I H S E  Tx30a 
. . . . . . . . . . . . . . . . . . . .  60190/pA153::cat (1)  
. . . . P . . S . . . . . . . . . . . .  60190/G(-6)PL(-3)S 1 (1)  
. . . . P . . S . . . . . . . . . . . .  60190/G(-6)PL(-3)S 3 (2)  
 
S R A F F T T V I I P A I V G G I A T G  Majority 
------------------+-------------------+- 
                  50                  60 
------------------+-------------------+- 
S R A F F T T V I I P A I V G G I A T G  Tx30a 
. . . . . . . . . . . . . . . . . . . .  60190/pA153::cat (1)  
. . . . . . . . . . . . . . . . . . . .  60190/G(-6)PL(-3)S 1 (1)  
. . . . . . . . . . . . . . . . . . . .  60190/G(-6)PL(-3)S 3 (2)  
 
A A V G T V S G L L S W G L K Q A E Q A  Majority 
------------------+-------------------+- 
                  70                  80 
------------------+-------------------+- 
A A V G T V S G L L S W G L K Q A E Q A  Tx30a 
. . . . . . . . . . . . . . . . . . . .  60190/pA153::cat (1)  
. . . . . . . . . . . . . . . . . . . .  60190/G(-6)PL(-3)S 1 (1)  
. . . . . . . . . . . . . . . . . . . .  60190/G(-6)PL(-3)S 3 (2)  
 
Figure 6.8 Sequence alignment of wild-type H. pylori strain 60190, and its isogenic VacA 
signal sequence mutant derivatives. Each strain was sequenced using the forward primer 
A1043 and the reverse primer VacR10. The appropriate mutation was confirmed by 
nucleotide sequencing on both strands using an Applied Biosystems 3100 Genetic 
analyser (Biopolymer Synthesis and Analysis unit, University of Nottingham, UK) 
Sequences retrieved were aligned using the MegAlign program (DNAstar). Mutants are 
named according to the wild type residue replaced, its position relative to the signal 
sequence cleavage site (shown in parentheses) and the residue substituted. The deduced 
amino acid sequence of the signal peptide and first 17 residues of mature VacA are 
shown. 
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Figure 6.9 VacA western blots of strains 60190, 60190/pA153::cat and 60190/pA153::cat 
G(-6)PL(-3)S. 24 hour broth culture supernatants were separated by SDS-PAGE and 
immunoblotted with anti-VacA p58 antibody. Broth cultures were corrected to the same 
cell density and equal sample volumes were loaded as follows: 60190 (lane 1), A130 VacA 
null mutant (lane 2), 60190/pA153::cat (lane 3), and 60190/pA153::cat G(-6)PL(-3)S (lane 
4). 
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6.2.5 Cell pellets of wild type and mutagenised H. pylori 
strains 60190 and Tx30a were analysed by western 
blotting. 
Although the secretion pathway that VacA shares with autotransporter proteins 
predicts that mature VacA would be found in the culture supernatant, studies by 
(Fitchen et al., 2005), and (Ilver et al., 2004) have observed that up to 50 % of 
the secreted VacA associates with the bacterial cells that produce it. To ensure 
the difference in the amounts of VacA observed in the supernatant samples 
were actually due to a difference in production and not due to different 
amounts of VacA adsorbing to the H. pylori cell surface, the cell pellets of the 
broth cultures were analysed. The cell pellets of the broth cultures used to 
analyse the amount of VacA present in the cell culture supernatants were 
sonicated, corrected for bacterial OD600 and analysed by SDS-PAGE and 
western blotting. The western blots in Figure 6.10 show that there was no 
difference in the amount of VacA adsorbed to the surface of the H. pylori cells 
in the broth culture samples, and thus confirmed that the differences in the 
amount of VacA present in the cell culture supernatants seen was 
representative of the amount of VacA produced by the H. pylori strains.   
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Figure 6.10 Bacterial cell adsorbed VacA levels of control strains and VacA signal 
sequence mutants. 24 hour broth culture whole cell extracts were separated by SDS-
PAGE and immunoblotted with anti-VacA p58 antibody. Broth cultures were corrected 
to the  same cell density and equal sample volumes were loaded as follows: Gel (A) 60190 
wild-type (lane 1), A130 VacA null mutant (lane 2), 60190/pCTB2::cat (lanes 3 and 4), 
60190/S(-3)L (lanes 5 and 6), 60190/P(-6)G (lanes 7 and 8), 60190/P(-6)GS(-3)L (lanes 9 
and 10). Gel (B) Tx30a wild-type (lane 1), A130 VacA null mutant (lane 2), 
Tx30a/pA153::cat (lanes 3 and 4), Tx30a/L(-3)S (lanes 5 and 6), Tx30a/G(-6)P (lanes 7 
and 8), Tx30a/G(-6)PL(-3)S (lanes 9 and 10). Gel (C) 60190 wild-type (Lane 1), A130 
VacA null mutant (lane 2), 60190/pA153::cat (Lane 3), 60190/pA153::cat G(-6)PL(-3)S 
(Lane 4). 
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6.2.6 Could differences in the signal peptidase explain 
differences in signal peptide processing between 
strains 60190 and Tx30a 
Although positions -6 and -3 appear to be important in determining secreted 
VacA levels, differences in processing between the 60190 and Tx30a do not 
appear to be solely due to the sequence of the signal peptide. Gram-negative 
bacteria commonly possess only one signal peptidase. The best characterised 
Gram-negative signal peptidase is that of E. coli (Lep encoded by the lepB 
gene). To investigate the importance of the signal peptidase determining signal 
sequence processing, the sequence of the signal peptidase was analysed in both 
60190 and Tx30a.   
 
6.2.7 BLAST search for lepB in 26695 
The lepB sequence of H. pylori strain 26695 (vacA type s1/i1/m1) was used in 
a BLAST search against the E. coli lepB sequence. The BLAST results show 
that H. pylori lepB sequence from strain 26695 was 33% identical and 44% 
similar to that of lepB in E. coli (P =8 x 10-20). The general topology is 
conserved although differences were seen in domains B-E and in the active site 
residues (Figure 6.12).  
  
6.2.8 The LepB sequences of 60190 and Tx30a differ but not 
in the -1 and -3 cleavage recognition pockets.   
The amino acid sequences of the LepB signal peptidase in H. pylori strains 
60190 and Tx30a were analysed to determine whether they differed in the 
cleavage recognition pockets that accommodate the amino acids at positions -1, 
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-3 and in the cleavage recognition site. To do this primers were designed to 
amplify the a 300 base pair region of lepB containing sequence encoding the -1 
and -3 cleavage recognition pockets using primers LepB forward and LepB 
reverse detailed in section 2.5.4.1 and amplified by PCR using cycling 
conditions detailed in sections 2.5.4. The PCR products sequenced using an 
Applied Biosystems 3100 Genetic analyser (Biopolymer Synthesis and 
Analysis unit, University of Nottingham, UK). Sequences retrieved were 
aligned using the MegAlign program (DNAstar). The sequence alignments 
show that the amino acid sequence of Lep differs between H. pylori strains 
60190 and Tx30a at positions 189, 200 and 279. However, the regions that 
encode the S1 and S3 cleavage recognition pockets that accommodate the 
amino acids at positions -1, -3 in the signal peptide cleavage recognition site 
are conserved between the two strains (Figure 6.12). 
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Figure 6.11 Diagram showing the location of the S3 and S1 binding pockets in relation to 
the -1 and -3 residues in the signal peptide cleavage recognition site. The black arrow 
indicates the site of cleavage. The S1 and S3 pockets are highlighted in yellow and pink 
respectively.  
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                       10        20        30        40        50        60        70        80        90       100                   
              ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
E. coli Lep   MANMFALILVIATLVTGILWCVDKFFFAPKRRERQAAAQAAAGDSLDKATLKKVAPKPGWLETGASVFPVLAIVLIVRSFIYEPFQIPSGSMMPTLLIGD  
26695         -----------------MKFLRSVYAFCS-----------------------------SWVGT-------IVIVLLVIFFIAQAFIIPSRSMVGTLYEGD  
60190         -----------------MKFLRSVYAFCS-----------------------------SWVGT-------IIIVLLVIFFIAQAFIIPSRSMVGTLYEGD  
Tx30a         -----------------MKFLRSVYAFCS-----------------------------SWVGT-------IIIVLLVIFFIAQAFIIPSRSMVGTLYEGD  
 
                      110       120       130       140       150       160       170       180       190       200          
              ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
E. coli Lep   FILVEKFAYGIKDP-------------IYQKTLIETGHPKRGDIVVFKYPEDPKLDYIKRAVGLPGDKVTYDPVSKELTIQPGCSSGQACENALPVTYSN  
26695         MLFVKKFSYGIPIPKIPWIELPVMPDFKNNGHLIEGDRPKRGEVVVFIPPHEKKSYYVKRNFAIGGDEVLFT--NEGFYLHP--FESDTDKNYIAKHYPN  
60190         MLFVKKFSYGIPIPKIPWIELPVMPDFKNNGHLIEGDRPKRGEVVVFIPPHEKKSYYVKRNFAIGGDEVLFT--NEGFYLHP--FESDTDKNYIAKHYPN  
Tx30a         MLFVKKFSYGIPIPKIPWIELPVMPDFKNNGHLIEGDRPKRGEVVVFIPPHEKKSYYVKRNFAIGGDEVLFT--NEGFYLHP--FESDMDKNYIAKHYPD  
 
                      210       220       230       240       250       260       270       280       290       300          
              ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
E. coli Lep   VEPSDFVQTFSRRNGGEATSGFFEVPKNETKENGIRLSERKETLGDVTHRILTVPIAQDQVGMYYQQPGQQLATWIVPPGQYFMMGDNRDNSADSRYWGF  
26695         AMTKEFMG------------KIFVLNPYKNEHPGIHYQKDNETF-HLMEQLATQGAEANISMQLIQMEGEKVFYKKINDDEFFMIGDNRDNSSDSRFWGS  
60190         AMTKEFMG------------KIFVLNPYKNEHPGIHYQKDNETF-HLMEQLATQGAEANISMQLIQMEGEKVFYKKINDDEFFMIGDNRDNSSDSRFWGS  
Tx30a         AMTKEFMG------------KIFVLNPYKNEHPGIHYQKDNETF-HLMEQLATQGAEANISMQLIQMEGERVFYKKINSDEFFMIGDNRDNSSDSRFWGS  
 
                      310       320       330       340       350       360      
              ....|....|....|....|....|....|....|....|....|....|....|....| 
E. coli Lep   VPEANLVGRATAIWMSFDKQ------EGEWPTGLRLSRIGGIH-----------------  
26695         VAYKNIVGSPWFVYFSLSLKNSLEMDAENNPKKRYLVRWERMFKSVGGLEKIIKKENATH  
60190         VAYKNIVGSPWFVYFSLSLKNSLEMDAENNPKKRYLVRWERMFKSVEGLEKIIKKENATH  
Tx30a         VAYKNIVGSPWFVYFSLSLKNSLEMDAENNPKKRYLVRWERMFKSVEGLEKIIKKENATH  
 
 
Figure 6.12 Sequence alignment of the deduced amino acid sequences of E. coli Lep and the H. pylori Lep homologue in strains 26695 (s1), 60190 (s1) and Tx30a 
(s2). Residues that form the S1 binding pocket are highlighted in yellow; residues of the S3 binding pocket are highlighted in pink and residues that form both the S1 and S3 
binding pockets are highlighted in green. Amino acids that differ between strains 60190 and Tx30a are highlighted in blue. The sequence corresponding to the boxes B, C, D 
and E that form the catalytic domain are boxed. The Lep sequence of strains differ at positions 189, 200 and 279, however there are no differences within the S1 and S3 
binding pockets. 
B 
C D 
E 
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6.2.9 The mutations made in the signal sequence of 60190 
and Tx30a do not force cleavage to occur at another 
site 
To investigate whether the mutations made in both the 60190 and Tx30a the 
signal sequence mutants create an alternative cleavage site SignalP analysis 
was carried out on the wild-type and mutant signal sequences. The SignalP 
software predicts the presence and location of signal peptide cleavage sites in 
amino acid sequences. To do this the amino acid sequences of the wild-type 
strains 60190 and Tx30a and their mutant derivatives were entered into the 
SignalP 3.0 Server http://www.cbs.dtu.dk/services/SignalP/. The Gram-
negative bacteria organism group was selected and both the neural networks 
and hidden Markov models were used as the method of analysis. The analysis 
showed that replacing serine with leucine at the -3 position, and proline with 
glycine at the -6 position did not alter the signal peptide cleavage site when 
compared to that of the wild type signal sequence of 60190. There was also no 
change in the position of the signal peptide cleavage site when the double 
mutant 60190/P(-6)GS(-3)L was analysed. Similarly there was no change in 
the cleavage site compared to that of the wild-type Tx30a signal sequence 
when the Tx30a mutant strains Tx30a/G(-6)P, Tx30a/L(-3)S and Tx30a/G(-
6)PL(-3)S were analysed. Thus, changing the amino acids present at positions -
3 and -6 in the VacA signal recognition site of both strains 60190 and Tx30a 
appear to have no effect on the position of the signal peptide cleavage site. The 
location of the signal peptide cleavage sites of the VacA signal sequences of 
wild-type strains 60190 and Tx30a determined by SignalP analysis are in 
agreement with the positions of the cleavage sites of these strains determined 
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using N-terminal protein sequencing carried out by Atherton et al., 1995 (see 
appendix for SignalP graphs showing the predicted location of the signal 
peptide cleavage sites for the 60190 and Tx30a signal sequence mutants). 
 
6.3 Discussion 
The aim of this chapter was to determine whether natural polymorphisms in the 
region encoding the VacA signal sequence affect toxin production, in the toxic 
strain 60190, and the non-toxic strain Tx30a. Firstly the effect of replacing the 
amino acids normally present in type s1 VacA with those amino acids present 
in type s2 VacA was characterised. The effect of the reciprocal changes in 
amino acids was also assessed. Secondly the effect of transforming the double 
mutant constructs into the heterologous strain background was investigated. 
Finally, the sequences of the LepB signal peptidase in H. pylori strains 60190 
and Tx30a were analysed to determine whether they differed in the cleavage 
recognition pockets that accommodate the amino acids at positions -1 and -3 in 
the cleavage recognition site.  
  
Investigation into the affect of changing serine and proline found at positions   
-3 and -6 of the type s1 VacA signal sequence with leucine and glycine 
respectively revealed that substituting serine for leucine at position -3 of the s1 
VacA signal sequence did not significantly reduce the amount of VacA in the 
broth culture supernatant. This was surprising as previous studies (Shen et al., 
1991) have shown that the -1 and -3 positions are the most important with 
respect to processing, and investigations into the effect of sequence variation 
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on the processing of the M13 procoat protein revealed that only procoats with 
small amino acids (serine and glycine) at the -3 position were efficiently 
cleaved in vivo, whereas the presence of leucine at this position retarded 
cleavage (Shen et al., 1991). However in support of the work in this report, it 
has been suggested that the effect of some amino acid substitutions at position -
3 on processing may vary from protein to protein, as mutant maltose-binding 
proteins with leucine, threonine or valine at the -3 position were processed 
efficiently (Fikes et al., 1990). Replacing proline with glycine at the -6 position 
showed a significant reduction in the amount of VacA secreted into broth 
culture (28% reduction). This result is in agreement with previous studies on 
signal peptides that show that the -6 position of the signal sequence is 
important for leader peptidase binding and catalysis. It has been proposed that 
signal peptides are efficiently processed when proline is preset at the -6 
SRVLWLRQDVSUROLQH LV DEOH WREUHDN WKHĮ-helical hydrophobic segment of the 
leader peptide and bring the cleavage site of the signal sequence close to the 
active site of the leader peptidase. Substitutions at both the -3 and -6 positions 
in the double mutant 60190/P(-6)GS(-3)L resulted in a similar decrease in 
VacA secretion (Reduction of 23%) to that of the single proline to glycine 
mutant, this result is likely to reflect the effect of the proline to glycine 
substitution at the -6 position of the signal sequence. It could be speculated that 
these differences affect signal sequence processing efficiency. Although the 
results here do show that the primary sequence of the substrate is important for 
processing efficiency, it is still not sufficient to account for all the specificity of 
the signal peptidase. As the leader peptidase only cleaves precursor proteins 
some specific conformation of the substrate probably at the level of the 
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secondary and tertiary structure will be important for the substrate specificity 
of the leader peptidase (Shen et al., 1991).  
 
The results obtained for the Tx30a mutants were surprising, as changing those 
amino acids normally present at the -3 and -6 positions in the VacA signal 
sequence of the non-toxic type s2 strain to those normally present at these 
positions in the signal sequence of the toxic s1 strain actually resulted in a 
reduction of secreted VacA. Previous studies on the effect of sequence 
variation on the processing of the M13 procoat protein revealed that only 
procoat proteins with small amino acids (serine and glycine) at the -3 position 
were efficiently cleaved in vivo, and the presence of leucine at the -3 position 
retarded cleavage (Shen et al., 1991). From this it was expected that replacing 
leucine with serine at the -3 position would result in an increase in VacA 
levels. However, replacing leucine with serine at position -3 resulted in VacA 
levels that were approximately half of that of the Tx30a/pA153::cat control 
strain (reduction of 54% ( P <0.005)). This finding could be explained by the 
work of  Fikes et al. 1990 who has suggested that the effect of some amino 
acid substitutions at position -3 on processing may vary from protein to 
protein, as mutant maltose-binding proteins with leucine, threonine or valine at 
the -3 position were processed efficiently (Fikes et al., 1990). The Tx30a/G(-
6)P isogenic mutants also showed significantly reduced VacA production 
compared to the control showing a reduction of 51%. This was also a 
surprising result as although proline and glycine are both effective helix 
breakers, studies on the M13 procoat protein have shown that substitution of 
glycine at the -6 position prevented processing in vivo, and reduced processing 
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in vitro, compared to the wild type with proline at -6 (Shen et al., 1991). It is 
thought that proline helps alter the conformation of the polypeptide chain 
surrounding the cleavage site, allowing efficient cleavage of the signal peptide. 
The VacA levels seen for the double isogenic mutant Tx30a/G(-6)PL(-3)S 
reflected the sum of effects of the single mutations made at positions -3 and -6.  
 
Transformation of the s2 signal sequence in which the amino acids at the -6 
and -3 positions had been replaced with those normally found in s1 strains 
(pA153::cat G(-6)PL(-3)S) in to the s1 strain 60190 resulted in a 95% 
reduction in secreted VacA levels when compared to strain 60190. A 27% 
reduction was seen when the s2 signal sequence was transformed into the 
60190 strain background. This suggests that the primary sequence including 
the amino acids adjacent to the -6 and -3 residues affects the efficiency of 
cleavage of the signal peptide. The order of the amino acids in the signal 
sequence are likely to affect the secondary and tertiary structure of the signal 
peptide which is likely to affect the specificity of the signal peptidase and 
therefore affect cleavage of the signal peptide.  
 
Although the amino acid sequence of the putative H. pylori signal peptidase 
differed between the s1 and the s2 strains at 3 positions, the differences were 
not in the putative S1 and S3 binding pockets. Thus, the differences in VacA 
levels between strains 60190 and Tx30a are unlikely to be due to differences in 
the signal peptidase between strain 60190 and Tx30a.  
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The s1 type H. pylori strains have a signal peptide cleavage site that is more 
efficiently cleaved than s2 strains. It is possible that the amino acid differences 
in the s1 and s2 type signal sequences have arisen through mutation or 
recombination but have not been selected out because the s2 form of VacA is 
non-toxic.  
 
The SignalP analysis suggests that the mutations made at the -6 and the -3 
positions are unlikely to create an alternative signal peptide cleavage site. I 
tried to confirm this experimentally using N-terminal protein sequencing on the 
VacA isolated from broth cultures of the double mutant strains 60190 P(-
6)GS(-3)L and Tx30a G(-6)PL(-3)S. Although VacA was detectable by 
Coomassie staining there was insufficient protein to get an accurate read. 
 
6.4 Conclusions 
In conclusion the work in this study has reinforced the findings of other studies 
that show the amino acids present at the -6 and -3 positions of signal peptide 
cleavage sites are important for the levels of protein secreted. The amino acids 
adjacent to the -6 and -3 positions also appear to be important for the levels of 
VacA produced. It is likely that changes to the primary structure of the signal 
sequence affects processing of the signal peptide, although the possibility that 
the mutations made may have an effect at other stages of protein production 
cannot be ruled out. No differences in the catalytic domains and S1 and S3 
binding pockets of the putative H. pylori signal peptidase were observed 
between strain 60190 and Tx30a indicating that the differences in VacA levels 
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between strains 60190 and Tx30a are unlikely to be due to differences in the 
signal peptidase between strain 60190 and Tx30a. 
 
6.4.1 Limitations 
H. pylori has very specific growth requirements including an optimal 
temperature of 37°C, a carbon-dioxide rich 5% micro-aerophilic atmosphere, 
high humidity and a rich medium. To encourage similar rates of growth a 
starting OD600 of 0.1 at 600 nm was used for all broths as it has been reported 
that a higher inoculum reduces lag phase (Jiang and Doyle, 2000). 
Furthermore, all broths were corrected for optical density, to ensure that the 
amount of VacA detected was not due to differences in cell number. To further 
control for variation in growth, multiple broths were tested for each construct, 
and statistical analysis was used to take into account any variation. However 
even with these controls in place, the differences in growth for each broth 
cannot be ignored. This could be checked by growing further broths and taking 
a sample from each to determine the levels of vacA transcript by real time 
quantitative PCR to ensure that the result seen was a reflection of peptide 
processing efficiency and not differences in levels of vacA transcription.  
 
Another source of error may have been in the construction of the signal 
sequence mutants, as in vitro synthesis of DNA could lead to secondary 
mutations due to lack of error-correction. To ensure this was not the case, the 
region mutagenised was sequenced. It is possible that other mutations may 
arise elsewhere in the genome during transformation and through passage of 
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the strains that could, possibly have an effect on VacA production. However, 
this is unlikely as duplicate isolates tested for each mutant showed similar 
levels of VacA. In addition the double mutants for both 60190 and Tx30a 
support the effect of the single mutants.    
 
6.5 Future work 
Transformation of pCTB2::cat and pCTB2::cat P(-6)GS(-3)L into the Tx30a 
strain background was unsuccessful. Given more time it would be interesting to 
see whether strain Tx30a/pCTB2::cat shows an increase in secreted VacA 
levels compared to Tx30a and whether strain Tx30a/pCTB2::cat P(-6)GS(-3)L 
shows reduced levels of secreted VacA compared to Tx30a/pCTB2::cat. 
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7 Discussion 
7.1 Summary of results and their significance 
7.1.1 Genetic determinants of vacA production 
Heterogeneity in vacA transcription between strains cultured in vitro was 
previously shown to exist and this difference in transcript level correlated with 
differences in VacA protein level (Forsyth et al., 1998; Forsyth et al., 1999; 
Ayala et al., 2004). vacA transcription has been shown to be initiated by a 
single promoter which is in the 285bp intergenic region located between the 
upstream housekeeping gene, cysteinyl-tRNA synthase (cysS) and the start of 
vacA (Forsyth et al., 1998). The vacA promoter has a conserved -35 region 
(TTTATG), a conserved -10 region (TAAAAA) and a TGN motif adjacent to 
the -10 motif (Forsyth et al., 1998). Using site directed mutagenesis and a xylE 
reporter system, Forsyth et al., (1999) concluded that -35 and -10 sequences 
along with promoter element spacing are important for binding. However, two 
small studies carried out on small numbers of clinical strains in vitro found that 
the differences in vacA expression between strains were unrelated to naturally 
occurring polymorphic differences in the -10 and -35 sequences (Ayala et al., 
2004; Narayanan, 2005).   
 
The previous studies on the vacA promoter were carried out on a small number 
of strains cultured in vitro (Ayala et al., 2004; Narayanan, 2005) and the 
mutagenesis carried out by Forsyth et al., (1999) was random. Furthermore, 
Forsyth et al. did not investigate the polymorphic differences that occur 
naturally between clinical strains. This study investigated the effect of naturally 
 7-265 
 
occurring differences in the vacA promoter on vacA production in vivo and in 
vitro in a large number of strains. Polymorphisms that were associated with 
significantly higher levels of vacA transcript in vivo and in vitro were further 
investigated using site directed mutagenesis. 
 
In this study large variations in vacA mRNA levels between strains were 
observed in vitro and in vivo. In agreement with other studies differences in the 
vacA transcript level between the different strains in vitro and in vivo were not 
significantly associated with the polymorphic differences present within the -
35 and extended -10 motifs. Polymorphic differences were observed in the 
spacer region between the -10 and the -35 motifs, however polymorphic 
differences in this region were not associated with differences in vacA mRNA 
levels between strains. Spacing of the -10 and -35 motifs in the clinical strains 
investigated in this study was well conserved. 
 
In a previous study by Narayanan, (2005) using a sequence alignment of the 
published promoter regions of 19 H. pylori strains, Narayanan (2005) identified 
a conserved stem loop structure at the +4 position of the mRNA transcript. 
Deletion of this stem loop resulted in a reduction in vacA mRNA levels in 
vitro. The alignment also revealed that this stem loop was well conserved 
except for differences at the +11 and +28 positions within the stem loop. The 
importance of these polymorphisms in determining vacA transcript level was 
not determined at that time.  
 
 7-266 
 
In this study it was found that strains naturally possessing an A at position +28 
within the second stem of the stem loop were found to express more vacA than 
those that have a G at this position in vivo (P = 0.0089). Site directed 
mutagenesis where the G present at position +28 in the wild-type strain was 
replaced with an A resulted in an increase in the level of vacA mRNA. 
 
The presence of varying numbers of binding sites for transcription factors 
could potentially explain the differences in vacA mRNA level between strains. 
Inverted repeats often represent binding sites for transcriptional regulators. In a 
small study by Ayala et al. (2004) an inverted repeat upstream of the -35 motif 
was found to be present in 4 out of 8 clinical strains (Ayala et al., 2004). 
Inverted repeats are a common feature of regulator binding sites, however the 
role of the inverted repeat in the cysS ± vacA intergenic region in 
transcriptional regulation of vacA was not determined. 
 
In this study it was observed that strains possessing a perfect inverted repeat 
expressed significantly higher levels of vacA in vitro. However, when the 
perfect inverted repeat present in strain 60190 was disrupted using site directed 
mutagenesis no difference in vacA transcript levels were observed between the 
control strain and the mutant indicating that this region was not important in 
determining vacA transcript levels in vitro. Furthermore, the sequence of the 
inverted repeat did not share significant sequence homology to known 
prokaryotic regulator binding sites. 
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7.1.2 Environmental determinants of vacA expression 
Several studies have shown that vacA is regulated in response to environmental 
stimuli. Microarray analysis demonstrated that vacA expression is repressed 
after acid exposure at pH 5.0 (Merrell et al., 2003a). This was in contrast to 
non-array based work which demonstrated that vacA was induced under acidic 
conditions (Barnard et al., 2004). Furthermore, RNA dot blot analysis revealed 
a significant increase in the accumulation of vacA transcripts under iron-
restricted conditions (Szczebara et al., 1999). Other studies have shown that 
vacA expression is up regulated upon binding to epithelial cells (Gieseler et al., 
2005; Merrell et al., 2003; Szczebara et al., 1999; van Amsterdam et al., 2003). 
An increase in vacA transcript levels has also been observed during infection of 
PMNs (Gieseler et al., 2005). However the expression patterns were dependent 
on the infecting strain and were also dependent on time (Gieseler et al., 2005). 
Previous studies have also shown that vacA expression is regulated in response 
to growth phase (Forsyth and Cover, 2000; Boonjakuakul et al., 2004).  
 
Results obtained in this study showed that there was no correlation between 
vacA transcript levels of H. pylori strains in vivo when compared to the same 
strains cultured in vitro using matched strains and biopsies. Regions within the 
promoter associated with differences in vacA production between strains also 
differed in vitro and in vivo, which would suggest that vacA transcription is 
regulated in vivo, and could be regulated in response to growth phase of the 
bacterium or by environmental factors. 
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In agreement with previous studies, vacA expression was up-regulated when 
the wild-type and mutant H. pylori strains were co-cultured with AGS cells. No 
difference in vacA mRNA levels were observed between the stem-loop deletion 
mutant and the control when strains were cultured in SFBB, but differences in 
vacA expression were observed when cultured in tissue culture medium. This 
may indicate that vacA expression is either dependent on growth phase or the 
differing environmental or nutritional factors between the two different types 
of culture media used. 
 
7.1.3 Regulation of production at the level of protein 
secretion 
Analysis of a large number of signal sequences has shown there is a 
characteristic pattern of small apolar residues at positions -1 and -3 relative to 
the cleavage site. Alanine, glycine and serine are preferred at the -1 position. 
Larger residues such as valine, threonine, leucine and isoleucine can also be 
accommodated at the -3 position, although some studies have shown that 
presence of leucine at the -3 position retarded cleavage (Shen et al., 1991) 
(Fikes et al., 1990). Such structural regularity in the -3 and -1 region is 
considered to be necessary for recognition of the signal peptide cleavage site 
by a leader peptidase.  
 
The presence of a helix breaking residue such as proline or glycine at the -6 
position has also been shown to be important for processing (von Heijne, 1983, 
Perlman and Halvorson, 1983). Although proline and glycine are both effective 
helix breakers, some studies have shown that some signal peptides with glycine 
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at the -6 position are not processed in vivo, and had reduced processing in vitro, 
compared to the wild type with proline at -6 (Shen et al., 1991). It is thought 
that proline helps alter the conformation of the polypeptide chain surrounding 
the cleavage site, allowing efficient cleavage of the signal peptide. 
 
The signal region of VacA is polymorphic. VacA type s1 and VacA type s2 not 
only differ in the position of their signal cleavage site, which determines their 
toxicity (with type s2 possessing a 12-amino acid hydrophilic N-terminal 
extension (Letley et al., 2003, Letley and Atherton, 2000), but also in the 
amino acids present at various positions within the signal sequence. Both VacA 
type s1 and s2 have alanine present at the -1 position.  
 
Serine is present at position -3 in type s1 VacA, whereas type s2 VacA has 
leucine present at this position. In type s1 VacA, proline is present at -6, 
whereas in type s2 glycine is present at this position. In this study mutant 
strains in which the more favourably cleaved amino acids present at the -3 and 
-6 positions of the s1 strain 60190 were replaced with the less favourably 
cleaved amino acids present in the s2 strain Tx30a were characterised. The 
reciprocal changes were also made. Secondly the effect of transforming the 
double mutant constructs into the heterologous strain background was 
investigated. Finally, the sequences of the LepB signal peptidase in H. pylori 
strains 60190 and Tx30a were analysed to determine whether they differed in 
the cleavage recognition pockets that accommodate the amino acids at 
positions -1 and -3 in the cleavage recognition site.  
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Characterisation of these mutants showed that the amino acids present at the -6 
and -3 positions of signal peptide cleavage sites is important for the levels of 
protein secreted. However, the amino acids adjacent to the -6 and -3 positions 
also appear to be important for the levels of VacA produced. It is likely that 
changes to the primary structure of the signal sequence affects processing of 
the signal peptide. No differences in the catalytic domains and S1 and S3 
binding pockets of the putative H. pylori signal peptidase were observed 
between strain 60190 and Tx30a indicating that the differences in VacA levels 
between strains 60190 and Tx30a are unlikely to be due to differences in the 
signal peptidase between strain 60190 and Tx30a. The s1 type H. pylori strains 
have a signal peptide cleavage site that is more efficiently cleaved than s2 
strains. It is possible that the amino acid differences in the s2 type signal 
sequences have arisen through mutation or recombination but have not been 
selected out because the s2 form of VacA is non-toxic.  
 
7.1.4 VacA and disease 
The particular vacA genotype of an infecting strain determines toxin production 
(Israel et al., 2001), and is a marker for the pathogenicity of an individual 
strain (Atherton et al., 1995; Rhead et al., 2007). Numerous studies have 
investigated the association between VacA type and disease outcome in 
different populations. vacA s1 genotypes are more frequently associated with 
higher levels of inflammation in the gastric mucosa, peptic ulceration and 
gastric adenocarcinoma than s2 types (Atherton et al., 1995; Atherton et al., 
1997; Evans et al., 1998; Kidd et al., 1999; van Doorn et al., 1998; Rhead et 
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al., 2007; Basso et al., 2008). Corpus neutrophil infiltration was found to be 
more severe in patients infected with an m1 type strain than those infected with 
an m2 type strain (Umit et al., 2009). The vacA i1 type is a risk factor for 
peptic ulcer disease and has been shown to be associated with duodenal ulcer 
disease as well as gastric cancer (Basso et al., 2008; Rhead et al., 2007). 
 
Several lines of evidence indicate that VacA may enable H. pylori colonization 
of the gastric mucosa. Competition experiments with an isogenic vacA null 
mutant and a wild type strain in a mouse model indicated that VacA may play a 
role in colonisation of the gastric mucosa (Salama et al., 2001). Salama et al. 
(2001) suggested that VacA causes tissue damage leading to alteration of the 
local pH and nutrient release allowing H. pylori to survive in the mucosa. 
Another suggestion was that cell damage caused by VacA plays a role in the 
local inhibition of acid secretion, which facilitates H. pylori colonisation 
(Salama et al., 2001). VacA has been shown directly damage the gastric 
epithelium, and it has been proposed that a gastric mucosal inflammatory 
response may occur as a consequence of the VacA mediated damage. Many 
previous studies provide evidence that VacA may be directly involved in 
proinflammatory signalling. (Boncristiano et al., 2003; Hisatsune et al., 2007; 
Supajatura et al., 2002; Kim et al., 2007). 
 
In East Asian and Southeast Asian countries, the association between vacA 
allelic diversity and clinical outcome is not well established as the vacA allelic 
type is quite homogeneous, with the majority of the population being infected 
with type s1/i1 strains (Maeda et al., 1998; Yamaoaka et al., 1998). However, 
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it is possible that a high prevalence of the more virulent vacA s1/i1 type strains 
may contribute to the high incidence of gastric cancer in this region of the 
world (Rhead et al., 2007).  
 
In a mouse model of infection oral administration of H. pylori sonicate from 
strains of the vacA s1 type reproduced several aspects of the histological 
lesions observed in biopsies from patients with gastric ulcer disease. These 
included epithelial vacuolation, infiltration of mononuclear cells into the 
lamina propria, loss of gastric gland structure and ulceration (Telford et al., 
1994a, Ghiara et al., 1995). Sonicate of a non-toxigenic s2 strain did not induce 
histological lesions, indicating that the active s1 cytotoxin is necessary to 
induce gastric damage (Telford et al., 1994). Oral administration of purified 
VacA into the same mouse model induced the same histological lesions as 
those obtained with the crude extract, although inflammatory cell infiltration 
(Telford et al., 1994) and neutrophil infiltration was not observed (Supajatura 
et al., 2002). Interestingly gerbils infected with an isogenic vacA null mutant 
had significantly fewer ulcers when compared to those infected with an 
isogenic wild type toxigenic strain (Ogura et al., 2000). However the severity 
of gastritis in the gerbils infected with a null mutant was not significantly 
different from that seen in gerbils infected with the wild type strain (Ogura et 
al., 2000). 
 
VacA amount as well as the type and activity is thought to have important 
implications for disease; a small study carried out by Narayanan, (2005) 
showed that there was an association between the occurrence of ulcers or 
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erosions in the patient and a high level of vacA transcript produced by an 
infecting strain in vivo.  
 
In this study the association between the amount of vacA mRNA produced by a 
strain and the severity of pre-cancerous changes in the corpus of the patient 
were assessed using real-time PCR and histopathology. A significant positive 
association was seen between the level of vacA transcript produced per H. 
pylori cell and the severity of inflammation, activity and the presence of 
atrophy in the corpus of infected patients. A positive correlation between the 
vacA level of an infecting strain and the density of infection in the corpus was 
observed. However, no association was found between vacA transcript level 
and disease outcome as determined during the endoscopy.  
 
7.2 Conclusions 
In conclusion natural polymorphic differences within a stem loop at the start of 
the vacA transcript determines differences in vacA mRNA levels between 
clinical H. pylori strains in vivo. There is no correlation between the level of 
vacA mRNA produced by the same strain in vivo and cultured in vitro, 
implying that, in agreement with other studies, vacA transcription is regulated 
in vivo. Amino acid differences at the -6 and -3 positions of signal peptide 
cleavages sites between s1 and s2 strains are important for the levels of VacA 
secreted. However, the amino acids adjacent to the -6 and -3 positions also 
appear to be important for the levels of VacA produced. No differences in the 
catalytic domains and S1 and S3 binding pockets of the putative H. pylori 
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signal peptidase were observed between these strains indicating that the 
differences in VacA levels between strains 60190 and Tx30a are unlikely to be 
due to differences in the signal peptidase between strain 60190 and Tx30a. The 
s1 type H. pylori strains have a signal peptide cleavage site that is more 
efficiently cleaved than s2 strains. A significant positive association was seen 
between the level of vacA transcript produced per H. pylori cell and the 
severity of inflammation, activity and the presence of atrophy in the corpus of 
infected patients. A positive correlation between the vacA level of an infecting 
strain and the density of infection in the corpus was observed. However, no 
association was found between vacA transcript level and disease outcome as 
determined during the endoscopy.  
 
7.3 Future work 
7.3.1 Genetic determinants of vacA production 
Preliminary results suggest that the differences in vacA transcript levels 
observed between the two stem-loop mutants and the control strain are due to 
differences in mRNA stability, however further studies would have to be 
carried out to confirm this finding and to determine the mechanism by which 
WKH ¶ VWHP-loop regulates vacA transcript levels. One example might be to 
assess the involvement of RNase III in determining vacA transcript levels by 
knocking out the rnc gene encoding RNase III in H. pylori and assessing its 
effect on vacA transcript levels. 
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Several studies have shown that vacA is regulated in response to environmental 
stimuli such as pH (Barnard et al., 2004; Merrell et al., 2003; Choi et al., 2001; 
Gancz et al., 2006), depleted levels of iron (Szczebara et al., 1999, Merrell et 
al., 2003), the presence of epithelial cells (van Amsterdam et al., 2003; Kim et 
al., 2004; Bach et al., 2002; Graham et al., 2002; Salama et al., 2000; Gieseler 
et al., 2005) and the growth phase of the bacterium (Thompson et al 2003; 
Narayanan, 2005; Forsyth and Cover, 2000; Boonjakuakul et al., 2004). It 
ZRXOG EH LQWHUHVWLQJ WR LQYHVWLJDWH ZKHWKHU WKH ¶ VWHP-loop in vacA plays a 
role in regulating vacA production in response to these environmental 
conditions. 
 
The urease gene cluster has been shown to be regulated post-transcriptionally 
by mRNA decay in response to environmental pH (Akada et al., 2000). 
Together with the finding that H. pylori has relatively few transcriptional 
regulators (Scarlato et al., 2001), turnover of RNA is expected to be a 
mechanism regulating gene expression in H. pylori. It would be interesting to 
investigate whether other H. pylori genes are regulated post-transcriptionally 
E\P51$GHFD\DQGZKHWKHUWKLVLVPHGLDWHGE\¶VWHPORRSVWUXFWXUHV 
 
7.3.2 VacA and disease 
In Western populations such as the USA and Western Europe, strains of the 
vacA s1/m1 type have been shown to be associated with peptic ulceration, and 
gastric cancer (Atherton et al., 1995; Atherton et al., 1997; Rhead et al., 2007; 
Basso et al., 2008). The vacA i1 type is also a risk factor for peptic ulcer 
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disease, duodenal ulcer disease and gastric cancer (Basso et al., 2008; Rhead et 
al., 2007). In East Asian and Southeast Asian countries the association between 
vacA allelic diversity and clinical outcome is not well established as the 
population is predominantly infected with strains of the s1/i1 type (Maeda et 
al., 1998; Yamaoka et al., 1998). There is a high incidence of gastric cancer in 
this population which could be explained by the high prevalence of the more 
virulent vacA s1/i1 type strains (Rhead et al., 2007). However, not all 
individuals infected with more virulent strains go on to develop disease. It 
would be interesting to repeat the study carried out in this chapter on different 
populations to determine whether differences in vacA expression between H. 
pylori strains of the same vacA type in vivo could explain the imperfect 
correlation between vacA type and disease.  
 
Studies have shown that the pattern of gastritis is important in determining 
disease outcome with antral predominant gastritis being associated with 
duodenal ulceration and a pangastritis being epidemiologically linked with 
gastric ulcers and gastric adenocarcinoma. It would be interesting to look at 
whether there is a correlation between the level of vacA transcript in the antrum 
and in the corpus, and to investigate whether there is a relationship between 
vacA transcript level and the pattern of gastritis.   
 
The vacA genotype of an infecting strain has been found to be a good marker 
of disease. Work in this thesis showed that there is a relationship between vacA 
transcript levels produced by a strain and the severity of inflammation, activity 
and atrophy in the corpus. Several putative virulence factors including the cag 
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pathogenicity island, BabA and in-frame OipA alleles are present in strains of 
the more toxic s1 vacA type more frequently than in strains of the non-toxic 
vacA s2 type (Atherton et al., 1995; van Doorn et al., 1998; Gerhard et al., 
1999; Cao and Cover, 2002; Yamaoka et al., 2002; Dossumbekova et al., 
2006). It is therefore difficult to determine which of these putative virulence 
factors is the most important in the pathogenesis of gastroduodenal disease. 
However other factors such as variations in acid production, the immune 
response of the infected individual, environmental factors such as smoking and 
diet and other H. pylori virulence factors may also have an effect on 
histopathological severity and the disease status of the patient. It is likely that 
the development of disease in humans is not due to the action of one single 
factor and that a combination of these factors contribute to development of 
disease. It is important to carry out further studies to assess the relative 
importance of these other factors in H. pylori associated disease. 
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